Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA single nuclei brain specificity"	"RNA single nuclei brain distribution"	"RNA single nuclei brain specificity score"	"RNA single nuclei brain specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Secretome function"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Brain expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	Interactions	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Cancer prognostics - Bladder Urothelial Carcinoma (TCGA)"	"Cancer prognostics - Breast Invasive Carcinoma (TCGA)"	"Cancer prognostics - Breast Invasive Carcinoma (validation)"	"Cancer prognostics - Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA)"	"Cancer prognostics - Colon Adenocarcinoma (TCGA)"	"Cancer prognostics - Colon Adenocarcinoma (validation)"	"Cancer prognostics - Glioblastoma Multiforme (TCGA)"	"Cancer prognostics - Glioblastoma Multiforme (validation)"	"Cancer prognostics - Head and Neck Squamous Cell Carcinoma (TCGA)"	"Cancer prognostics - Kidney Chromophobe (TCGA)"	"Cancer prognostics - Kidney Renal Clear Cell Carcinoma (TCGA)"	"Cancer prognostics - Kidney Renal Clear Cell Carcinoma (validation)"	"Cancer prognostics - Kidney Renal Papillary Cell Carcinoma (TCGA)"	"Cancer prognostics - Liver Hepatocellular Carcinoma (TCGA)"	"Cancer prognostics - Liver Hepatocellular Carcinoma (validation)"	"Cancer prognostics - Lung Adenocarcinoma (TCGA)"	"Cancer prognostics - Lung Adenocarcinoma (validation)"	"Cancer prognostics - Lung Squamous Cell Carcinoma (TCGA)"	"Cancer prognostics - Lung Squamous Cell Carcinoma (validation)"	"Cancer prognostics - Ovary Serous Cystadenocarcinoma (TCGA)"	"Cancer prognostics - Ovary Serous Cystadenocarcinoma (validation)"	"Cancer prognostics - Pancreatic Adenocarcinoma (TCGA)"	"Cancer prognostics - Pancreatic Adenocarcinoma (validation)"	"Cancer prognostics - Prostate Adenocarcinoma (TCGA)"	"Cancer prognostics - Rectum Adenocarcinoma (TCGA)"	"Cancer prognostics - Rectum Adenocarcinoma (validation)"	"Cancer prognostics - Skin Cuteneous Melanoma (TCGA)"	"Cancer prognostics - Stomach Adenocarcinoma (TCGA)"	"Cancer prognostics - Testicular Germ Cell Tumor (TCGA)"	"Cancer prognostics - Thyroid Carcinoma (TCGA)"	"Cancer prognostics - Uterine Corpus Endometrial Carcinoma (TCGA)"
SFTPA1	"COLEC4, SFTP1, SP-A, SP-A1"	ENSG00000122852	"Surfactant protein A1"	Q8IWL2	10	79610939-79615455	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1049	"lung: 6866.0"	"Cell type enriched"	"Detected in some"	23	"Alveolar cells type 2: 13843.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"Lung Adenocarcinoma (TCGA): 1545.4;Lung Squamous Cell Carcinoma (TCGA): 424.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	27	"plasmacytoid DC: 2.7"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 2.7"	"Cancer enriched"	"Detected in single"	7	"lung cancer: 6.4"	"Lung - Alveolar cells type 2"									"CAB016793, HPA042638, HPA045752, HPA049368"	Supported				"Secreted in other tissues"	Other	NA	NA			"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 57: Lung - Lung function"	"Cluster 37: Neurons - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 72: Alveolar cells - Lung function"	3			"CAB016793: , HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731"																"unprognostic (1.48e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.55e-1)"					"unprognostic (3.26e-1)"						"unprognostic (1.22e-1)"	
SFTPC	"BRICD6, PSP-C, SFTP2, SMDP2, SP-C"	ENSG00000168484	"Surfactant protein C"	P11686	8	22156913-22164479	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	795	"lung: 17877.0"	"Cell type enriched"	"Detected in some"	27	"Alveolar cells type 2: 98114.0"	"Cell type enhanced"	"Detected in many"		"committed oligodendrocyte precursor: 12.3;oligodendrocyte: 18.7"	"Group enriched"	"Detected in some"	278	"Lung Adenocarcinoma (TCGA): 1709.6;Lung Squamous Cell Carcinoma (TCGA): 551.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Sarcoma: 1.5;skin cancer: 1.3"	"Lung - Alveolar cells type 2, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010928	Enhanced				"Secreted in other tissues"	Other	NA	NA				"Cluster 57: Lung - Lung function"	"Cluster 11: White matter - Signal transduction"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 72: Alveolar cells - Lung function"	138			"HPA010928: AB_1857425"					"unprognostic (9.11e-1)"											"unprognostic (4.93e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.10e-1)"								"unprognostic (3.80e-1)"			"unprognostic (5.93e-2)"	
SFTPA2	"COLEC5, SP-A2"	ENSG00000185303	"Surfactant protein A2"	Q8IWL1	10	79555852-79560407	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	405	"lung: 10463.2"	"Cell type enriched"	"Detected in some"	18	"Alveolar cells type 2: 17736.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	21	"Lung Adenocarcinoma (TCGA): 2193.8;Lung Squamous Cell Carcinoma (TCGA): 630.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"lung cancer: 6.8;prostate cancer: 6.9"	"Lung - Alveolar cells type 2, Prostate - Prostate glandular cells"									"CAB002439, HPA042638, HPA045752, HPA049368"	Enhanced				"Secreted in other tissues"	Other	NA	NA				"Cluster 57: Lung - Lung function"	"Cluster 37: Neurons - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 72: Alveolar cells - Lung function"	19			"CAB002439: AB_564143, HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731"	"unprognostic (4.66e-2)"		"unprognostic (4.41e-1)"		"unprognostic (4.82e-3)"	"unprognostic (8.96e-3)"										"unprognostic (1.86e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.09e-1)"			"unprognostic (4.17e-4)"	"unprognostic (9.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.89e-1)"		"unprognostic (1.36e-1)"	
SCGB3A2	"LU103, PNSP1, UGRP1"	ENSG00000164265	"Secretoglobin family 3A member 2"	Q96PL1	5	147870682-147882191	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	123	"lung: 1229.1"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1445.1;Club cells: 1181.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	6	"Lung Adenocarcinoma (TCGA): 1224.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	50	"basophil: 72.2"	"Lineage enriched"	"Detected in many"	50	"granulocytes: 72.2"	"Low cancer specificity"	"Detected in all"				"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	"No annotated function"	NA	NA		230000	"Cluster 46: Basophils - Proteolysis"	"Cluster 57: Lung - Lung function"	"Cluster 4: Non-specific - mRNA splicing & Cell cycle"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 72: Alveolar cells - Lung function"					"unprognostic (1.97e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.68e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.31e-2)"		"unprognostic (1.55e-1)"		"unprognostic (5.98e-5)"	"unprognostic (5.21e-2)"		"unprognostic (3.80e-1)"		"unprognostic (2.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.51e-2)"		"unprognostic (1.25e-1)"	"unprognostic (9.61e-2)"		"unprognostic (1.30e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.35e-3)"
CLDN18	SFTPJ	ENSG00000066405	"Claudin 18"	P56856	3	137998735-138033655	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	51	"lung: 244.4;stomach 1: 706.2"	"Group enriched"	"Detected in some"	32	"Alveolar cells type 1: 661.9;Alveolar cells type 2: 361.3;Gastric mucus-secreting cells: 1092.4"	"Cell type enhanced"	"Detected in many"		"ependymal cell: 12.9"	"Group enriched"	"Detected in some"	7	"Pancreatic Adenocarcinoma (TCGA): 147.1;Stomach Adenocarcinoma (TCGA): 234.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Gastric cancer: 17.9;pancreatic cancer: 12.4"	"Lung - Alveolar cells type 1, Stomach - Gastric mucous cells, Testis - Spermatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013010, CAB013243, HPA018446"	Enhanced		Approved	"Cell Junctions"			NA	NA				"Cluster 48: Stomach - Proteolysis"	"Cluster 17: Choroid plexus - Cilium"	"Cluster 2: Mucus-secreting cells - Unknown function"	"Cluster 45: Non-specific - Mixed function"	2	"Cell Junctions"		"CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866"			"unprognostic (1.94e-2)"		"unprognostic (1.08e-1)"	"unprognostic (4.42e-1)"									"unprognostic (4.42e-2)"	"unprognostic (1.49e-3)"	"unprognostic (9.79e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.55e-1)"			"unprognostic (3.21e-2)"	"unprognostic (7.49e-4)"		"unprognostic (2.76e-2)"	"unprognostic (1.39e-1)"		"unprognostic (2.45e-1)"			
SFTPB	"SFTP3, SP-B"	ENSG00000168878	"Surfactant protein B"	P07988	2	85657314-85668741	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	31	"lung: 3453.9"	"Group enriched"	"Detected in some"	14	"Alveolar cells type 1: 6026.1;Alveolar cells type 2: 12958.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	6	"Lung Adenocarcinoma (TCGA): 3804.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in some"		"thyroid cancer: 19.2"	"Lung - Alveolar cells type 2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002440, HPA034820, HPA062148"	Enhanced				"Secreted in other tissues"	Other	NA	NA		36000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 57: Lung - Lung function"	"Cluster 4: Non-specific - mRNA splicing & Cell cycle"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 72: Alveolar cells - Lung function"				"CAB002440: AB_564142, HPA034820: AB_2674347, HPA062148: AB_2684697"	"unprognostic (3.93e-3)"		"unprognostic (1.81e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.01e-2)"				"unprognostic (1.81e-1)"	"unprognostic (7.72e-5)"		"unprognostic (9.63e-2)"			"unprognostic (1.14e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.49e-3)"				"unprognostic (1.71e-2)"		"unprognostic (6.79e-2)"		"unprognostic (1.85e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.42e-2)"
SFTPD	"COLEC7, SFTP4, SP-D"	ENSG00000133661	"Surfactant protein D"	P35247	10	79937467-79982614	"Predicted secreted proteins"	"Gaseous exchange, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"lung: 492.1"	"Cell type enriched"	"Detected in many"	6	"Alveolar cells type 2: 1469.1"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 37.7"	"Group enriched"	"Detected in many"	15	"Lung Adenocarcinoma (TCGA): 210.7;Lung Squamous Cell Carcinoma (TCGA): 57.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 10.0;non-classical monocyte: 36.5"	"Lineage enriched"	"Detected in many"	18	"monocytes: 36.5"	"Low cancer specificity"	"Detected in some"			"Lung - Alveolar cells type 2, Skin - Keratinocyte (other)"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB004578, HPA044582, HPA056768"	Enhanced				"Secreted in other tissues"	Immunity	NA	NA		5300000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 57: Lung - Lung function"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 1: Neuronal - Visual perception"	"Cluster 72: Alveolar cells - Lung function"	2			"CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232"	"unprognostic (3.07e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-2)"					"unprognostic (5.28e-2)"		"unprognostic (1.03e-4)"	"unprognostic (1.31e-2)"	"unprognostic (8.81e-6)"			"unprognostic (1.31e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.84e-1)"		"unprognostic (1.54e-1)"				"unprognostic (7.25e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.62e-2)"
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117287353-117425942	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"epididymis: 57.2;lung: 30.7"	"Cell type enriched"	"Detected in some"	8	"Alveolar cells type 2: 148.5"	"Group enriched"	"Detected in some"	4	"deep-layer corticothalamic and 6b: 2.9;upper-layer intratelencephalic: 2.3"	"Cancer enriched"	"Detected in some"	4	"Lung Adenocarcinoma (TCGA): 20.0"	"Region enhanced"	"Detected in some"		"cerebral cortex: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bile duct cancer: 5.6;Bone cancer: 8.7;Brain cancer: 5.6"	"Lung - Alveolar cells type 2, Skin - Sebaceous gland cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles			NA	NA				"Cluster 50: Epididymis - Male reproductive secretion"	"Cluster 53: Neurons - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 72: Alveolar cells - Lung function"	12	Vesicles		"HPA049098: AB_2680628, HPA072424: AB_2686519"									"unprognostic (1.32e-1)"							"unprognostic (1.03e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.14e-3)"	"unprognostic (9.03e-2)"												
AGER	"RAGE, SCARJ1, sRAGE"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184322	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lung: 704.7"	"Cell type enriched"	"Detected in many"	21	"Alveolar cells type 1: 2481.0"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 11.5"	"Group enriched"	"Detected in some"	12	"Lung Adenocarcinoma (TCGA): 16.2;Lung Squamous Cell Carcinoma (TCGA): 8.0;Thyroid Carcinoma (TCGA): 9.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Kidney cancer: 2.2"	"Lung - Alveolar cells type 1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	Other	NA	NA		91000		"Cluster 57: Lung - Lung function"		"Cluster 15: Kidney cancer - Membrane components"	"Cluster 72: Alveolar cells - Lung function"	12	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "			"unprognostic (5.72e-2)"												"unprognostic (3.51e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.72e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.45e-1)"		"unprognostic (1.77e-3)"									"unprognostic (2.14e-1)"	
GGTLC1	"dJ831C21.1, dJ831C21.2, GGTLA3, GGTLA4"	ENSG00000149435	"Gamma-glutamyltransferase light chain 1"	Q9BX51	20	23985050-23988779	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"lung: 31.3;testis: 18.0"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 226.1;Late spermatids: 126.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	15	"Lung Adenocarcinoma (TCGA): 24.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Lung - Alveolar cells type 1, Testis - Early spermatids, Testis - Late spermatids"									"HPA045635, HPA047534"	Uncertain						NA	NA				"Cluster 44: Testis - Spermatogenesis"		"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 72: Alveolar cells - Lung function"	1			"HPA045635: AB_2679400, HPA047534: AB_2680079"																"unprognostic (1.42e-4)"	"unprognostic (5.21e-1)"	"unprognostic (4.88e-3)"												"unprognostic (3.48e-1)"	
MS4A15		ENSG00000166961	"Membrane spanning 4-domains A15"	Q8N5U1	11	60756867-60776733	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	11	"lung: 42.5"	"Cell type enriched"	"Detected in some"	6	"Alveolar cells type 1: 23.1"	"Cell type enhanced"	"Detected in single"		"deep-layer corticothalamic and 6b: 2.8"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 18.1"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.2"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.1;lung cancer: 2.8;Myeloma: 2.9"	"Lung - Alveolar cells type 1"	"Region enriched"	"Detected in some"	28	"olfactory bulb: 166.8"	"Region enriched"	"Detected in some"	27	"olfactory bulb: 27.3"	HPA054563			Approved	"Plasma membrane,Cytosol"			NA	NA			"Cluster 16: Non-specific - Cell proliferation"	"Cluster 57: Lung - Lung function"	"Cluster 37: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 72: Alveolar cells - Lung function"		"Plasma membrane"	Cytosol	"HPA054563: "	"unprognostic (2.23e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.72e-2)"													"unprognostic (2.96e-4)"	"unprognostic (2.54e-2)"	"unprognostic (7.49e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.20e-1)"							"unprognostic (2.17e-1)"	"unprognostic (1.41e-3)"			
NAPSA	"KAP, Kdap, NAP1, NAPA"	ENSG00000131400	"Napsin A aspartic peptidase"	O96009	19	50358472-50365830	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"lung: 1011.1"	"Group enriched"	"Detected in many"	11	"Alveolar cells type 1: 1756.1;Alveolar cells type 2: 4693.6"	"Low cell type specificity"	"Detected in some"			"Cancer enriched"	"Detected in many"	11	"Lung Adenocarcinoma (TCGA): 1516.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.8;plasmacytoid DC: 4.9"	"Group enriched"	"Detected in many"	9	"B-cells: 2.8;dendritic cells: 4.9"	"Cancer enhanced"	"Detected in some"		"lung cancer: 13.4;lymphoma: 19.4;ovarian cancer: 32.3"	"Kidney - Proximal tubular cells, Lung - Alveolar cells type 2, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB009591, HPA045280, HPA047236, HPA047744"	Enhanced				"Secreted in other tissues"	Enzyme	NA	NA		12000000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 57: Lung - Lung function"		"Cluster 15: Kidney cancer - Membrane components"	"Cluster 72: Alveolar cells - Lung function"	4			"CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143"			"unprognostic (5.26e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.34e-2)"						"unprognostic (5.21e-7)"	"unprognostic (3.16e-4)"	"unprognostic (3.48e-2)"			"unprognostic (1.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.88e-3)"	"unprognostic (5.54e-2)"		"unprognostic (1.48e-1)"									"unprognostic (1.54e-2)"	"unprognostic (2.58e-2)"
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73980811-73982027	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"bone marrow: 29.2;lung: 10.2;lymphoid tissue: 30.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.3;Ductal cells: 5.9;Enteroendocrine cells: 9.3;Granulosa cells: 30.8;NK-cells: 24.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Colon Adenocarcinoma (TCGA): 4.1;Pancreatic Adenocarcinoma (TCGA): 1.4;Rectum Adenocarcinoma (TCGA): 2.5;Stomach Adenocarcinoma (TCGA): 2.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.9"	"Immune cell enriched"	"Detected in single"	5	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.0"	"Not detected"	"Not detected"			"Minor Salivary Gland - Minor salivary glandular cells, Spleen - Platelets"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"	Cytokine	NA	NA	7700000	3100000000	"Cluster 4: Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 57: Platelets - Hemostasis"	22			"CAB026008: , HPA052485: AB_2681847"					"unprognostic (8.32e-2)"	"unprognostic (1.60e-2)"																"unprognostic (4.10e-2)"	"unprognostic (7.17e-2)"		"unprognostic (1.58e-2)"	"unprognostic (8.86e-2)"		"unprognostic (1.87e-1)"			
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7677088-7679829	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"bone marrow: 81.0;lung: 85.3;lymphoid tissue: 34.3"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 73.0;Kupffer cells: 31.6;Langerhans cells: 20.3;Macrophages: 114.3;monocytes: 29.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Lung Adenocarcinoma (TCGA): 8.3"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 6.2;pons: 2.8;thalamus: 2.9"	"Group enriched"	"Detected in many"	5	"classical monocyte: 124.0;neutrophil: 57.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 57.5;monocytes: 124.0"	"Cancer enriched"	"Detected in some"	6	"Leukemia: 17.5"	"Adipose visceral - Neutrophils, Adrenal gland - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Pituitary gland - Neutrophils, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Thyroid gland - Neutrophils"	"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			HPA014731	Enhanced		Supported	"Plasma membrane"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	9	"Plasma membrane"		"HPA014731: AB_1845619"					"unprognostic (2.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-3)"									"unprognostic (6.58e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-5)"	"unprognostic (3.08e-2)"			"unprognostic (1.76e-2)"								"unprognostic (1.63e-2)"	
RTKN2	"bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1"	ENSG00000182010	"Rhotekin 2"	Q8IZC4	10	62183035-62268844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lung: 75.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 106.0;Early spermatids: 496.0;Late spermatids: 166.0"	"Cell type enhanced"	"Detected in many"		"committed oligodendrocyte precursor: 33.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"T-reg: 16.7"	"Lineage enriched"	"Detected in single"	73	"T-cells: 16.7"	"Low cancer specificity"	"Detected in all"			"Adipose visceral - T-cells, Adrenal gland - Mitotic cells (Adrenal gland), Lung - Alveolar cells type 1, Pituitary gland - Somatotropes, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037946, HPA038446"	Enhanced		Approved	Nucleoplasm,Mitochondria			NA	NA			"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 57: Lung - Lung function"	"Cluster 53: Neurons - Mixed function"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 21: Early spermatids - Spermatogenesis"	2	Nucleoplasm	Mitochondria	"HPA037946: AB_10795398, HPA038446: AB_10796218"	"unprognostic (1.50e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.44e-1)"							"unprognostic (3.16e-2)"	"unprognostic (6.84e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.47e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.19e-2)"		"unprognostic (1.77e-1)"
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"intestine: 39.2;lung: 27.9;placenta: 17.8"	"Group enriched"	"Detected in many"	10	"Cytotrophoblasts: 119.5;Proximal enterocytes: 100.4;Syncytiotrophoblasts: 95.7"	"Cell type enhanced"	"Detected in many"		"splatter: 6.2"	"Cancer enhanced"	"Detected in some"		"Breast Invasive Carcinoma (TCGA): 3.8"	"Group enriched"	"Detected in many"	11	"midbrain: 507.8;pons: 183.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"colorectal cancer: 2.5;liver cancer: 1.4"	"Pancreas - Alpha cells"	"Region enriched"	"Detected in some"	4	"midbrain: 58.4"	"Group enriched"	"Detected in some"	8	"midbrain: 51.2;pons: 38.2"	"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"			NA	NA				"Cluster 25: Small intestine - Absorption"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 24: Cytotrophoblasts - Mitochondria"	8	"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"		"unprognostic (1.35e-1)"	"unprognostic (1.72e-1)"		"unprognostic (1.81e-1)"	"unprognostic (3.47e-1)"				"unprognostic (6.77e-2)"							"unprognostic (7.90e-4)"								"unprognostic (6.60e-2)"	"unprognostic (3.68e-2)"					
NKX2-1	"BCH, NKX2A, TITF1, TTF-1, TTF1"	ENSG00000136352	"NK2 homeobox 1"	P43699	14	36516392-36521149	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lung: 54.3;thyroid gland: 175.8"	"Group enriched"	"Detected in some"	11	"Alveolar cells type 1: 206.0;Alveolar cells type 2: 319.7"	"Group enriched"	"Detected in some"	6	"LAMP5-LHX6 and Chandelier: 1.3;mammillary body: 2.2"	"Group enriched"	"Detected in some"	16	"Lung Adenocarcinoma (TCGA): 88.3;Thyroid Carcinoma (TCGA): 169.1"	"Group enriched"	"Detected in many"	5	"cerebral cortex: 13.2;hypothalamus: 38.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"lung cancer: 32.3;prostate cancer: 35.1;thyroid cancer: 42.4"	"Lung - Alveolar cells type 2"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.2;hypothalamus: 10.2"	"Group enriched"	"Detected in some"	13	"basal ganglia: 5.6;hypothalamus: 13.6"	"CAB000078, CAB053633, HPA074316"	Enhanced		Uncertain	"Golgi apparatus,Vesicles"			NA	NA				"Cluster 51: Thyroid gland - Unknown function"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 72: Alveolar cells - Lung function"	14	"Golgi apparatus, Vesicles"		"CAB000078: , CAB053633: AB_442138, HPA074316: "				"unprognostic (4.30e-2)"	"unprognostic (5.46e-1)"											"unprognostic (5.31e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.30e-1)"							"unprognostic (3.09e-1)"				"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"
SCGB1A1	"CC10, CC16, CCSP, UGB"	ENSG00000149021	"Secretoglobin family 1A member 1"	P11684	11	62405103-62423195	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Phospholipase A2 inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lung: 2979.8"	"Group enriched"	"Detected in some"	5	"Club cells: 65464.2;Ionocytes: 25176.2"	"Cell type enhanced"	"Detected in some"		"deep-layer near-projecting: 3.7;midbrain-derived inhibitory: 4.4"	"Group enriched"	"Detected in many"	7	"Lung Adenocarcinoma (TCGA): 765.3;Lung Squamous Cell Carcinoma (TCGA): 305.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"Esophageal cancer: 174.9;Gallbladder cancer: 111.1;head and neck cancer: 48.1;pancreatic cancer: 75.7"	"Lung - Respiratory ciliated cells, Prostate - Urothelial cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025686, HPA031828"	Enhanced				"Secreted in other tissues"	"Enzyme inhibitor"	NA	NA		8900000		"Cluster 57: Lung - Lung function"	"Cluster 16: Non-specific - Transcription"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 35: Respiratory epithelial cells - Unknown function"	8			"CAB025686: , HPA031828: AB_2674061"	"unprognostic (5.52e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.13e-2)"					"unprognostic (4.86e-2)"					"unprognostic (2.31e-1)"		"unprognostic (6.27e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.85e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.34e-2)"		"unprognostic (3.29e-3)"				"unprognostic (3.95e-2)"	"unprognostic (1.47e-1)"		"unprognostic (1.23e-1)"
FCN3	"FCNH, HAKA1"	ENSG00000142748	"Ficolin 3"	O75636	1	27369110-27374824	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"liver: 270.1;lung: 702.7"	"Group enriched"	"Detected in some"	5	"Endothelial cells: 509.8;Fibroblasts: 450.4;Kupffer cells: 220.6"	"Cell type enhanced"	"Detected in single"		"endothelial cell: 2.4"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 33.9"	"Region enriched"	"Detected in all"	8	"choroid plexus: 20.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Sinusoid Endothelial cells, Testis - Endothelial cells"									CAB025945	Approved				"Secreted to blood"	Immunity	NA	NA	22800000000	8700000000		"Cluster 11: Liver - Plasma proteins"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	2			"CAB025945: "	"unprognostic (2.73e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.30e-3)"	"unprognostic (5.15e-2)"		"unprognostic (3.22e-4)"		"unprognostic (2.01e-1)"	"unprognostic (3.32e-3)"	"unprognostic (5.87e-6)"	"unprognostic (6.09e-6)"	"unprognostic (3.05e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.86e-3)"	"unprognostic (3.21e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.04e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.28e-2)"			"unprognostic (3.91e-2)"		"unprognostic (9.24e-4)"	"unprognostic (2.51e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.95e-2)"
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lung: 729.3"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 672.8;Alveolar cells type 2: 1668.8"	"Cell type enriched"	"Detected in single"	19	"choroid plexus epithelial cell: 8.7"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 621.2;Thyroid Carcinoma (TCGA): 820.3"	"Group enriched"	"Detected in many"	6	"cerebellum: 5.4;choroid plexus: 15.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 53.2;ovarian cancer: 115.1;pancreatic cancer: 54.6;Uterine cancer: 52.8"	"Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells, Skin - Eccrine sweat gland cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA				"Cluster 57: Lung - Lung function"	"Cluster 5: Non-specific - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 72: Alveolar cells - Lung function"	1	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.01e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-3)"			"unprognostic (2.76e-1)"		"unprognostic (1.53e-1)"		"unprognostic (2.28e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.65e-6)"	"unprognostic (2.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.68e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.63e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.47e-2)"	"unprognostic (8.62e-2)"				"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.16e-2)"
SPN	"CD43, GPL115, LEU-22, LSN"	ENSG00000197471	Sialophorin	P16150	16	29662979-29670876	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 70.9;lung: 27.3;lymphoid tissue: 49.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 218.9;Erythroid cells: 123.5;monocytes: 499.5;NK-cells: 248.7;T-cells: 98.0"	"Cell type enhanced"	"Detected in single"		"leukocyte: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 218.5"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 185.3;Myeloma: 49.9"	"Pituitary gland - T-cells, Prostate - T-cells, Skin - Langerhans cells, Spleen - T-cells, Stomach - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002666, HPA055244"	Enhanced		Approved	"Plasma membrane"			NA	NA		130000	"Cluster 33: Non-specific - ATP binding"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 6: Non-specific - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 19: NK-cells - Adaptive immune response"	31	"Plasma membrane"		"CAB002666: , HPA055244: AB_2682756"	"unprognostic (1.25e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.68e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.40e-1)"		"unprognostic (1.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.84e-4)"	"unprognostic (5.51e-2)"	"unprognostic (8.03e-2)"			"unprognostic (2.02e-3)"	"unprognostic (6.62e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.64e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.34e-3)"	"unprognostic (8.57e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.78e-2)"
ENSG00000269711		ENSG00000269711	"Novel protein"		19	7678501-7682854	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	7	"bone marrow: 21.8;intestine: 7.5;lung: 17.8;lymphoid tissue: 11.9"	"Not detected"	"Not detected"							"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 7.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 192.8;neutrophil: 82.3"	"Low lineage specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	5	"Leukemia: 4.8"																	NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 32: Cerebral cortex - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"									"unprognostic (5.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.34e-4)"		"unprognostic (8.15e-4)"		"unprognostic (7.16e-2)"	"unprognostic (1.12e-1)"				"unprognostic (5.76e-3)"		"unprognostic (3.71e-3)"				"unprognostic (9.24e-3)"			"unprognostic (4.87e-2)"	"unprognostic (8.25e-2)"		"unprognostic (3.39e-2)"		"unprognostic (1.31e-2)"	
FCN1	FCNM	ENSG00000085265	"Ficolin 1"	O00602	9	134903232-134917912	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 157.1;lung: 41.8;lymphoid tissue: 86.0"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 754.4;Kupffer cells: 531.0;Macrophages: 490.5;monocytes: 1059.1"	"Cell type enriched"	"Detected in single"	606	"leukocyte: 101.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 1694.0;intermediate monocyte: 1189.2"	"Lineage enhanced"	"Detected in all"		"monocytes: 1694.0"	"Cancer enriched"	"Detected in single"	7	"Leukemia: 1.1"	"Adipose visceral - Neutrophils, Lung - Neutrophil_2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000685, HPA001295, CAB016760"	Enhanced				"Secreted to blood"	Immunity	NA	NA	1060000000	27000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	13			"CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842"			"unprognostic (1.07e-2)"			"unprognostic (1.37e-1)"					"unprognostic (1.56e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.66e-2)"		"unprognostic (1.44e-1)"	"unprognostic (1.03e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.05e-1)"		"unprognostic (3.04e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.40e-1)"			"unprognostic (2.59e-1)"	"unprognostic (3.04e-1)"		"unprognostic (1.57e-2)"		
LAMP3	"CD208, DC-LAMP, DCLAMP, LAMP, TSC403"	ENSG00000078081	"Lysosomal associated membrane protein 3"	Q9UQV4	3	183122215-183163839	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lung: 212.8"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 454.3"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 40.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 5.6"	"Group enriched"	"Detected in many"	9	"granulocytes: 5.6;T-cells: 4.8"	"Low cancer specificity"	"Detected in many"			"Lung - Alveolar cells type 2, Minor Salivary Gland - Mitotic cells (Minor salivary gland), Testis - Early spermatids"									"CAB025133, HPA051467"	Enhanced		Enhanced	Vesicles			NA	NA		40000	"Cluster 3: Non-specific - Nuclear processes"	"Cluster 57: Lung - Lung function"	"Cluster 15: Non-specific - Transcription"	"Cluster 55: Lymphoma - Immune response"	"Cluster 72: Alveolar cells - Lung function"	32	Vesicles		"CAB025133: , HPA051467: AB_2681495"	"unprognostic (1.35e-4)"	"unprognostic (8.57e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.57e-2)"			"unprognostic (2.12e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.89e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.08e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.52e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.71e-3)"	"unprognostic (4.74e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.79e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-2)"	"unprognostic (5.03e-3)"
ARHGAP45	"HA-1, HMHA1, KIAA0223"	ENSG00000180448	"Rho GTPase activating protein 45"	Q92619	19	1065923-1086628	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 67.4;intestine: 51.7;lung: 38.3;lymphoid tissue: 103.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 73.4;monocytes: 93.9;NK-cells: 79.8;Oocytes: 147.8;Syncytiotrophoblasts: 73.6;T-cells: 90.7"	"Group enriched"	"Detected in some"	65	"central nervous system macrophage: 70.6;leukocyte: 106.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Leukemia: 93.4;lymphoma: 73.9;Myeloma: 97.1"	"Colon - T-cells, Liver - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019816, HPA079252"	Enhanced		Supported	"Plasma membrane,Cytosol"			NA	NA		590000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 19: NK-cells - Adaptive immune response"	8	"Plasma membrane, Cytosol"		"HPA019816: AB_1853923, HPA079252: "	"unprognostic (8.51e-3)"	"unprognostic (1.79e-1)"		"unprognostic (8.53e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.47e-4)"	"unprognostic (2.68e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.58e-2)"		"unprognostic (4.73e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.61e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-1)"
CD300LF	"CD300f, CLM1, IGSF13, IREM1, NKIR"	ENSG00000186074	"CD300 molecule like family member f"	Q8TDQ1	17	74694311-74712978	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 26.7;lung: 17.1;lymphoid tissue: 28.2"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 41.0;Kupffer cells: 27.4;Macrophages: 37.8;monocytes: 59.2"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 24.1;lower rhombic lip: 20.3;upper rhombic lip: 24.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 234.8"	"Group enriched"	"Detected in many"	43	"dendritic cells: 63.8;granulocytes: 234.8;monocytes: 193.8"	"Cancer enriched"	"Detected in single"	78	"Leukemia: 19.2"	"Adrenal gland - Macrophages, Lung - Macrophages"									HPA013712	Supported						NA	NA			"Cluster 25: Non-specific - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 25: Non-specific - Transcription"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	1			"HPA013712: AB_2668874"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.66e-3)"		"unprognostic (8.16e-2)"	"unprognostic (6.86e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.17e-1)"		"unprognostic (6.23e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.62e-1)"
DTHD1	FLJ16686	ENSG00000197057	"Death domain containing 1"	Q6ZMT9	4	36281616-36347511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 13.3;lung: 3.4;lymphoid tissue: 3.9"	"Cell type enhanced"	"Detected in some"		"Ciliated cells: 174.8;Early spermatids: 119.9;NK-cells: 66.1;T-cells: 30.1"	"Cell type enriched"	"Detected in some"	7	"ependymal cell: 1239.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.4"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Heart muscle - T-cells, Kidney - T-cells, Lung - Respiratory ciliated cells, Minor Salivary Gland - T-cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"midbrain: 46.9"								NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 59: Fallopian tube - Tissue development"	"Cluster 46: Brainstem - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 42: Ciliated cells - Cilium assembly"							"unprognostic (1.64e-2)"			"unprognostic (3.20e-2)"		"unprognostic (1.99e-1)"									"unprognostic (2.58e-1)"		"unprognostic (2.63e-1)"												
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635185	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 205.7;lung: 83.9;lymphoid tissue: 137.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 117.4;Kupffer cells: 202.5;Langerhans cells: 79.5;Macrophages: 138.9;monocytes: 398.9;NK-cells: 135.9"	"Group enriched"	"Detected in some"	12	"endothelial cell: 71.5;leukocyte: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"Leukemia: 21.4;lymphoma: 33.4;Myeloma: 17.9"	"Adipose subcutaneous - Macrophages, Adrenal gland - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages, Skin - Macrophages, Spleen - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"			NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 55: Lymphoma - Immune response"	"Cluster 29: Monocytes - Innate immune response"	16	"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.10e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-5)"	"unprognostic (4.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.05e-2)"	"unprognostic (9.62e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.28e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.19e-3)"	"unprognostic (3.82e-2)"	"unprognostic (5.32e-4)"	"unprognostic (9.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.64e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.55e-2)"
HTR3C		ENSG00000178084	"5-hydroxytryptamine receptor 3C"	Q8WXA8	3	184053047-184060673	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"lung: 2.4"	"Cell type enhanced"	"Detected in some"		"Lymphatic endothelial cells: 3.6;Oocytes: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Not detected"	"Not detected"										NA	NA				"Cluster 57: Lung - Lung function"		"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	1																																		
ICAM4	"CD242, LW"	ENSG00000105371	"Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)"	Q14773	19	10286955-10288522	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Blood group antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 13.2;lung: 9.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 25.1;Alveolar cells type 2: 83.9;Endothelial cells: 21.3;Erythroid cells: 33.2;monocytes: 31.0"	"Cell type enhanced"	"Detected in single"		"leukocyte: 1.8"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 13.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"non-classical monocyte: 216.1"	"Lineage enriched"	"Detected in many"	7	"monocytes: 216.1"	"Cancer enriched"	"Detected in many"	5	"Leukemia: 35.5"		"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Intracellular and membrane"	"Cell adhesion"	NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"					"unprognostic (1.12e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.48e-3)"		"unprognostic (7.50e-2)"			"unprognostic (1.20e-3)"	"unprognostic (6.20e-2)"				"unprognostic (1.81e-4)"		"unprognostic (1.63e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.12e-2)"				"unprognostic (9.98e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.63e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.69e-1)"
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378547	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, RNA-binding"	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 331.3;lung: 97.9;lymphoid tissue: 168.6"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 484.1;Kupffer cells: 311.1;Langerhans cells: 611.3;Macrophages: 436.9;monocytes: 544.2"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 118.3;leukocyte: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 180.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 180.0"	"Group enriched"	"Detected in some"	15	"Leukemia: 134.6;lymphoma: 69.7"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Langerhans cells, Spleen - Neutrophils, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm			NA	NA			"Cluster 19: Eosinophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	25	Nucleoplasm		"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (1.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.30e-1)"	"unprognostic (8.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.92e-1)"
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510525-76516522	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 116.7;esophagus: 63.0;lung: 48.4;urinary bladder: 40.9"	"Cell type enriched"	"Detected in some"	12	"Mesothelial cells: 1046.6"	"Cell type enriched"	"Detected in some"	4	"choroid plexus epithelial cell: 6.4"	"Group enriched"	"Detected in many"	11	"Bladder Urothelial Carcinoma (TCGA): 41.8;Ovary Serous Cystadenocarcinoma (TCGA): 43.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 49.5"	"Adipose visceral - Mesothelial cells, Lung - Alveolar cells type 1, Minor Salivary Gland - Minor salivary gland basal cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA010506	Approved						NA	NA				"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 72: Alveolar cells - Lung function"				"HPA010506: AB_1080479"	"unprognostic (1.18e-3)"		"unprognostic (2.74e-1)"	"unprognostic (1.45e-2)"					"unprognostic (4.77e-2)"			"unprognostic (5.84e-3)"	"unprognostic (2.27e-1)"		"unprognostic (2.61e-2)"	"unprognostic (1.49e-1)"		"unprognostic (4.64e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.92e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.74e-2)"					"unprognostic (4.47e-2)"			"unprognostic (3.09e-2)"
APOBR	"APOB100R, APOB48R"	ENSG00000184730	"Apolipoprotein B receptor"	Q0VD83	16	28494643-28498964	"Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Receptor	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 34.2;intestine: 22.1;lung: 11.0;lymphoid tissue: 21.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 123.8;Hofbauer cells: 40.9;Intestinal goblet cells: 45.0;Langerhans cells: 44.0;Macrophages: 36.5;NK-cells: 40.4;Paneth cells: 68.7"	"Group enriched"	"Detected in some"	24	"central nervous system macrophage: 10.5;leukocyte: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enriched"	"Detected in some"	7	"Leukemia: 27.3"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Skin - Langerhans cells, Spleen - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041667, HPA042093, HPA079642"	Enhanced		Supported	"Plasma membrane,Centrosome"			NA	NA		360000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 5: Enterocytes - Absorption"		"Plasma membrane"	Centrosome	"HPA041667: AB_10793972, HPA042093: AB_10795393, HPA079642: "	"unprognostic (3.66e-2)"	"unprognostic (3.22e-1)"		"unprognostic (3.28e-2)"	"unprognostic (5.21e-2)"	"unprognostic (6.55e-3)"	"unprognostic (7.54e-2)"		"unprognostic (7.86e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.71e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.85e-4)"	"unprognostic (3.05e-3)"	"unprognostic (9.10e-2)"	"unprognostic (4.73e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.08e-1)"
CCL18	"AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18"	ENSG00000275385	"C-C motif chemokine ligand 18"	P55774	17	36064272-36072032	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lung: 47.3"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 168.1;Macrophages: 205.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adrenal gland - Neutrophils, Breast - Macrophages, Lung - Macrophages, Spleen - Macrophages, Testis - Early spermatids, Testis - Late spermatids"														"Secreted to blood"	Chemokine	NA	NA	55500000	1900000		"Cluster 57: Lung - Lung function"		"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 58: Macrophages - Innate immune response"	1						"unprognostic (1.63e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.78e-2)"			"unprognostic (1.63e-1)"		"unprognostic (6.64e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.48e-3)"		"unprognostic (4.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.94e-1)"			"unprognostic (1.27e-2)"			"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.39e-2)"	"unprognostic (9.55e-3)"	
CLEC7A	"CD369, CLECSF12, DECTIN-1, hDectin-1, SCARE2"	ENSG00000172243	"C-type lectin domain containing 7A"	Q9BXN2	12	10116777-10130258	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 82.8;lung: 30.0;lymphoid tissue: 43.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 185.8;Kupffer cells: 344.2;Langerhans cells: 334.7;Macrophages: 238.2;monocytes: 818.0;Schwann cells: 228.1"	"Cell type enriched"	"Detected in some"	6	"central nervous system macrophage: 297.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 251.5"	"Low lineage specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	11	"Myeloma: 62.2"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Colon - Macrophages, Kidney - Macrophages, Pancreas - Macrophages, Skeletal muscle - Macrophages, Skin - T-cells, Spleen - Neutrophils, Stomach - Macrophages, Testis - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 29: Monocytes - Innate immune response"	12				"unprognostic (5.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.31e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.78e-1)"	"unprognostic (9.85e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.66e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.03e-2)"	"unprognostic (3.77e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.05e-2)"
FFAR4	"GPR120, GPR129, O3FAR1, PGR4"	ENSG00000186188	"Free fatty acid receptor 4"	Q5NUL3	10	93566665-93604480	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Differentiation, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adipose tissue: 3.9;intestine: 11.0;lung: 3.4;pituitary gland: 10.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 30.4;Intestinal goblet cells: 81.8;Late spermatids: 19.1;Pancreatic endocrine cells: 22.1;Paneth cells: 12.9"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 36.7"	"Cancer enhanced"	"Detected in some"		"Colon Adenocarcinoma (TCGA): 6.1;Rectum Adenocarcinoma (TCGA): 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.3"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Macrophages, Breast - Adipocytes (Breast), Colon - Colon enterocytes, Pituitary gland - Corticotropes, Testis - Late spermatids, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042563			Supported	"Vesicles,Plasma membrane,Basal body"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 45: Intestine - Digestion"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 16: Intestinal goblet cells - Mucin production"		"Plasma membrane"	"Vesicles, Basal body"	"HPA042563: AB_10794762"					"unprognostic (8.43e-2)"	"unprognostic (1.98e-3)"						"unprognostic (2.38e-1)"	"unprognostic (4.83e-2)"			"unprognostic (7.43e-3)"	"unprognostic (1.14e-1)"					"unprognostic (2.21e-1)"			"unprognostic (1.29e-1)"	"unprognostic (2.82e-2)"		"unprognostic (7.80e-2)"			
IGHJ6		ENSG00000211900	"Immunoglobulin heavy joining 6"		14	105863198-105863258	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"cervix: 132.5;intestine: 38.7;lung: 43.7;lymphoid tissue: 61.3;testis: 147.9"	"Cell type enriched"	"Detected in single"	59	"Plasma cells: 27.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	14	"memory B-cell: 323.3;naive B-cell: 111.0"	"Lineage enriched"	"Detected in many"	22	"B-cells: 323.3"	"Cancer enriched"	"Detected in some"	7	"lymphoma: 42.7"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"																NA	NA			"Cluster 23: B-cells - Immunoglobulins"		"Cluster 32: Cerebral cortex - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 23: Plasma cells - Humoral immune response"					"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"		"unprognostic (7.62e-2)"	"unprognostic (7.30e-2)"				"unprognostic (1.77e-1)"		"unprognostic (4.77e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.40e-1)"		"unprognostic (1.34e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.61e-2)"	"unprognostic (5.14e-1)"		"unprognostic (1.07e-1)"		"unprognostic (3.11e-1)"	"unprognostic (1.07e-2)"			"unprognostic (2.85e-1)"	"unprognostic (9.19e-3)"	"unprognostic (3.43e-1)"	"unprognostic (7.07e-1)"
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"choroid plexus: 59.9;kidney: 122.8;lung: 157.1;placenta: 193.2"	"Cell type enriched"	"Detected in many"	6	"granulocytes: 1024.3"	"Cell type enhanced"	"Detected in single"		"endothelial cell: 1.1"	"Cancer enhanced"	"Detected in many"		"Thyroid Carcinoma (TCGA): 14.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	64	"basophil: 38.4;eosinophil: 29.4"	"Lineage enriched"	"Detected in single"	73	"granulocytes: 38.4"	"Cancer enhanced"	"Detected in many"		"Esophageal cancer: 24.0;pancreatic cancer: 13.6"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	Receptor	NA	NA	19100000	4500000	"Cluster 41: Basophils - Unknown function"	"Cluster 57: Lung - Lung function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 30: Granulocytes - Unknown function"	2	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"			"unprognostic (7.84e-2)"			"unprognostic (1.37e-2)"			"unprognostic (6.64e-3)"		"unprognostic (5.89e-6)"	"unprognostic (5.69e-3)"	"unprognostic (1.25e-1)"			"unprognostic (6.01e-2)"	"unprognostic (5.11e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.55e-1)"			"unprognostic (1.06e-1)"	"unprognostic (1.10e-1)"			"unprognostic (2.22e-4)"		"unprognostic (9.05e-3)"		"unprognostic (7.18e-2)"	
LILRB2	"CD85d, ILT4, LIR-2, LIR2, MIR-10, MIR10"	ENSG00000131042	"Leukocyte immunoglobulin like receptor B2"	Q8N423	19	54273812-54281184	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 34.7;lung: 14.5;lymphoid tissue: 50.0"	"Cell type enriched"	"Detected in some"	4	"monocytes: 926.9"	"Group enriched"	"Detected in some"	144	"central nervous system macrophage: 17.8;leukocyte: 50.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 61.3;intermediate monocyte: 131.4;neutrophil: 63.2;non-classical monocyte: 152.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 63.2;monocytes: 152.2"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Breast - Macrophages, Kidney - Macrophages, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Stomach - Macrophages"																NA	NA		140000000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	6						"unprognostic (6.53e-3)"			"unprognostic (8.63e-2)"						"unprognostic (2.49e-1)"			"unprognostic (3.33e-2)"		"unprognostic (3.12e-2)"		"unprognostic (4.69e-1)"		"unprognostic (3.68e-2)"		"unprognostic (1.86e-1)"			"unprognostic (8.20e-2)"					
LRRK2	"DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2"	ENSG00000188906	"Leucine rich repeat kinase 2"	Q5S007	12	40196744-40369285	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Differentiation"	"GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lung: 50.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 767.5;monocytes: 185.4;Oligodendrocyte precursor cells: 241.0;Skeletal myocytes: 246.9"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte precursor cell: 470.3"	"Group enriched"	"Detected in many"	6	"Kidney Renal Clear Cell Carcinoma (TCGA): 18.6;Kidney Renal Papillary Cell Carcinoma (TCGA): 32.9;Lung Adenocarcinoma (TCGA): 10.2;Thyroid Carcinoma (TCGA): 27.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"neutrophil: 58.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 58.3"	"Cancer enhanced"	"Detected in some"		"Kidney cancer: 3.3;lymphoma: 3.2;skin cancer: 3.4"	"Adrenal gland - Adrenal cortex cells, Breast - Fibroblasts, Liver - Hepatocytes, Lung - Alveolar cells type 2, Prostate - Fibroblasts, Spleen - Neutrophils"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014293, CAB037160"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Basal body,Cytosol"			NA	NA			"Cluster 28: Neutrophils - Unknown function"	"Cluster 57: Lung - Lung function"	"Cluster 53: Neurons - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 72: Alveolar cells - Lung function"	212	"Vesicles, Basal body"	"Nucleoplasm, Nuclear membrane, Cytosol"	"CAB037160: AB_1840989, HPA014293: AB_1853353"		"unprognostic (1.02e-1)"	"unprognostic (3.94e-1)"				"unprognostic (3.17e-2)"	"unprognostic (2.05e-2)"		"unprognostic (1.08e-1)"	"unprognostic (9.57e-12)"	"unprognostic (1.03e-2)"	"unprognostic (1.48e-1)"		"unprognostic (1.28e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.04e-1)"			"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"				"unprognostic (3.35e-1)"			"unprognostic (1.90e-2)"	
MYO1F		ENSG00000142347	"Myosin IF"	O00160	19	8520778-8577577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 94.9;lung: 28.4;lymphoid tissue: 90.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 118.1;Kupffer cells: 200.2;Macrophages: 124.3;monocytes: 149.6;NK-cells: 353.5;T-cells: 85.1"	"Group enriched"	"Detected in many"	27	"central nervous system macrophage: 374.7;leukocyte: 391.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 263.8"	"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	8	"Leukemia: 51.2"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages, Spleen - Neutrophils, Testis - Macrophages, Thyroid gland - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055242, HPA056036"	Enhanced		Enhanced	Cytosol			NA	NA		22000	"Cluster 28: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 19: NK-cells - Adaptive immune response"	12	Cytosol		"HPA055242: AB_2682754, HPA056036: "	"unprognostic (2.20e-2)"	"unprognostic (6.33e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.49e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.86e-3)"	"unprognostic (2.99e-1)"	"unprognostic (5.11e-3)"	"unprognostic (3.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.68e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.40e-1)"
OSCAR		ENSG00000170909	"Osteoclast associated Ig-like receptor"	Q8IYS5	19	54094668-54102692	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 13.2;lung: 27.5;lymphoid tissue: 29.0"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 49.4;Kupffer cells: 23.7;Langerhans cells: 16.0;Macrophages: 41.3;monocytes: 33.6"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 23.9;leukocyte: 11.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	35	"classical monocyte: 41.9;eosinophil: 26.4;intermediate monocyte: 28.1;myeloid DC: 19.6;neutrophil: 38.8;non-classical monocyte: 26.7"	"Group enriched"	"Detected in many"	77	"dendritic cells: 19.6;granulocytes: 38.8;monocytes: 41.9"	"Group enriched"	"Detected in some"	4	"Leukemia: 8.2;ovarian cancer: 2.5;thyroid cancer: 5.9"	"Adipose subcutaneous - Macrophages, Kidney - Macrophages, Spleen - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA073996			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	Receptor	NA	NA		49000000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 53: Neurons - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"		"Nucleoplasm, Plasma membrane, Cytosol"		"HPA073996: "		"unprognostic (3.52e-1)"	"unprognostic (1.23e-1)"			"unprognostic (5.15e-2)"	"unprognostic (8.76e-3)"		"unprognostic (2.51e-1)"		"unprognostic (1.93e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.39e-1)"		"unprognostic (1.15e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.95e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.81e-1)"					"unprognostic (1.82e-1)"	"unprognostic (4.79e-2)"		
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602759	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease variant, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.1;lung: 16.0;lymphoid tissue: 48.3"	"Cell type enriched"	"Detected in some"	4	"NK-cells: 1101.9"	"Cell type enriched"	"Detected in some"	233	"leukocyte: 262.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 900.8;MAIT T-cell: 628.8;memory CD8 T-cell: 498.2;naive CD8 T-cell: 313.2;NK-cell: 657.0"	"Group enriched"	"Detected in all"	50	"NK-cells: 657.0;T-cells: 900.8"	"Cancer enriched"	"Detected in some"	7	"lymphoma: 61.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Lung - NK-cells (Lung), Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	Other	NA	NA		8900000	"Cluster 15: NK-cells - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 19: NK-cells - Adaptive immune response"	32	Cytosol		"CAB002436: AB_563955, HPA037940: AB_2675747"	"unprognostic (6.33e-2)"	"unprognostic (6.91e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"		"unprognostic (2.80e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.18e-2)"	"unprognostic (6.31e-3)"	"unprognostic (2.16e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.53e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.40e-1)"
SFTA2	"SFTPG, SP-G"	ENSG00000196260	"Surfactant associated 2"	Q6UW10	6	30931353-30955636	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 47.7;lung: 173.7"	"Group enriched"	"Detected in many"	10	"Alveolar cells type 1: 1168.2;Alveolar cells type 2: 1665.0"	"Cell type enhanced"	"Detected in single"		"ependymal cell: 2.0"	"Cancer enriched"	"Detected in many"	13	"Lung Adenocarcinoma (TCGA): 175.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bile duct cancer: 4.1;breast cancer: 3.0;lung cancer: 2.5"	"Lung - Alveolar cells type 2"					"Not detected"	"Not detected"								"Secreted in other tissues"	"No annotated function"	NA	NA				"Cluster 57: Lung - Lung function"		"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 72: Alveolar cells - Lung function"					"unprognostic (1.86e-1)"		"unprognostic (5.63e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.05e-2)"		"unprognostic (2.24e-3)"						"unprognostic (4.13e-2)"		"unprognostic (3.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.73e-2)"	"unprognostic (5.33e-2)"	"unprognostic (5.04e-2)"		"unprognostic (3.32e-2)"	"unprognostic (2.32e-3)"	"unprognostic (8.95e-2)"		"unprognostic (2.03e-1)"				"unprognostic (2.38e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.46e-2)"
TBX21	"T-bet, TBLYM"	ENSG00000073861	"T-box transcription factor 21"	Q9UL17	17	47733236-47746122	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Asthma, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.0;lung: 3.2;lymphoid tissue: 11.4"	"Group enriched"	"Detected in some"	11	"NK-cells: 125.9;T-cells: 42.0"	"Cell type enriched"	"Detected in single"	88	"leukocyte: 70.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 15.7;NK-cell: 14.3"	"Group enriched"	"Detected in many"	7	"NK-cells: 14.3;T-cells: 15.7"	"Group enriched"	"Detected in some"	15	"Leukemia: 2.8;lymphoma: 6.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Testis - Spermatogonia, Thyroid gland - T-cells"	"Region enriched"	"Detected in single"	27	"olfactory bulb: 22.1"	"Region enriched"	"Detected in some"	4	"olfactory bulb: 5.6"	"CAB009524, CAB030043"	Enhanced						NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"		"Cluster 55: Lymphoma - Immune response"	"Cluster 19: NK-cells - Adaptive immune response"	4			"CAB009524: AB_2200557, CAB030043: AB_1595503"			"unprognostic (1.25e-2)"								"unprognostic (3.41e-2)"	"unprognostic (4.29e-2)"				"unprognostic (7.49e-2)"	"unprognostic (1.41e-1)"		"unprognostic (3.27e-1)"										"unprognostic (1.58e-1)"		
ULBP1	RAET1I	ENSG00000111981	"UL16 binding protein 1"	Q9BZM6	6	149963943-149973715	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.6;lung: 1.6;testis: 3.3"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 3.9;Granulosa cells: 1.5;monocytes: 2.0;Sertoli cells: 2.7;Squamous epithelial cells: 2.8"	"Cell type enhanced"	"Detected in some"		"hippocampal CA4: 2.7;hippocampal dentate gyrus: 1.7;upper rhombic lip: 1.1"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 10.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"												"HPA007547, HPA071005"	Enhanced		Supported	"Plasma membrane,Cytosol"			NA	NA				"Cluster 78: Testis - Transcription"	"Cluster 35: Non-specific - DNA binding"	"Cluster 13: Non-specific - Mixed function"	"Cluster 80: Non-specific - Transcription"	1	"Plasma membrane, Cytosol"		"HPA007547: AB_1079430, HPA071005: AB_2686332"			"unprognostic (9.76e-2)"	"unprognostic (1.66e-1)"					"unprognostic (1.31e-2)"								"unprognostic (1.30e-1)"	"unprognostic (6.59e-2)"	"unprognostic (6.13e-2)"											"unprognostic (1.11e-1)"	
ALOX5AP	FLAP	ENSG00000132965	"Arachidonate 5-lipoxygenase activating protein"	P20292	13	30713478-30764426	"Disease related genes, Predicted membrane proteins"	"Leukotriene biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 482.0;lung: 177.5;lymphoid tissue: 135.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 1294.1;granulocytes: 863.6;Hofbauer cells: 495.3;Langerhans cells: 417.5;Macrophages: 607.8;NK-cells: 339.5;T-cells: 313.8"	"Group enriched"	"Detected in some"	43	"central nervous system macrophage: 118.7;leukocyte: 85.5"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 145.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 9738.9;eosinophil: 4044.4;neutrophil: 4992.0;plasmacytoid DC: 3563.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 3563.5;granulocytes: 9738.9"	"Cancer enhanced"	"Detected in many"		"Leukemia: 124.7;lymphoma: 190.4"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Neutrophils, Pancreas - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Neutrophils, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026592	Enhanced						NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	6			"HPA026592: AB_10601115"	"unprognostic (2.12e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.57e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.16e-4)"	"unprognostic (2.13e-3)"	"unprognostic (9.85e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.73e-2)"	"unprognostic (9.12e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.09e-2)"	"unprognostic (6.12e-3)"
AQP4	"AQP-4, hAQP4, MIWC"	ENSG00000171885	"Aquaporin 4"	P55087	18	26852043-26865771	"Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 367.2;lung: 111.3"	"Group enriched"	"Detected in many"	11	"Alveolar cells type 1: 422.7;Alveolar cells type 2: 333.2;Astrocytes: 462.6;Muller glia cells: 197.3"	"Cell type enhanced"	"Detected in many"		"astrocyte: 951.4;bergmann glia: 217.4;ependymal cell: 376.8"	"Cancer enriched"	"Detected in some"	16	"Glioblastoma Multiforme (TCGA): 327.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Brain cancer: 2.5;Rhabdoid: 1.7"	"Skeletal muscle - Skeletal myocytes, Skin - Sebaceous gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005079, HPA014784, CAB058689"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions"			NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 72: Alveolar cells - Lung function"	3	"Plasma membrane"	"Cell Junctions"	"CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967"			"unprognostic (3.85e-1)"				"unprognostic (2.80e-1)"	"unprognostic (6.75e-2)"		"unprognostic (1.84e-1)"	"unprognostic (5.75e-7)"	"unprognostic (1.31e-3)"				"unprognostic (9.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.68e-1)"											"unprognostic (1.05e-1)"	
CXCL17	"Dcip1, DMC, UNQ473, VCC1"	ENSG00000189377	"C-X-C motif chemokine ligand 17"	Q6UXB2	19	42428278-42442946	"Predicted secreted proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 117.2;lung: 144.3;salivary gland: 141.3;stomach 1: 348.8"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 626.0;Basal respiratory cells: 1184.3;Club cells: 1204.1;Ionocytes: 2433.8"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 240.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 17.2;Gastric cancer: 8.7;lung cancer: 8.6"	"Lung - Alveolar cells type 2, Prostate - Urothelial cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"	"Developmental protein"	NA	NA	400000000	80000		"Cluster 38: Salivary gland - Salivary secretion"	"Cluster 34: Non-specific - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 35: Respiratory epithelial cells - Unknown function"	3				"unprognostic (8.32e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.64e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.88e-2)"			"unprognostic (5.51e-3)"					"unprognostic (2.88e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.04e-6)"	"unprognostic (5.13e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.49e-4)"	"unprognostic (7.40e-3)"	"unprognostic (8.97e-2)"	"unprognostic (5.88e-1)"	"unprognostic (4.13e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.99e-2)"
DNAH12	"DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19"	ENSG00000174844	"Dynein axonemal heavy chain 12"	Q6ZR08	3	57293699-57544344	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"choroid plexus: 9.0;fallopian tube: 9.9;lung: 3.4;testis: 8.6"	"Group enriched"	"Detected in some"	4	"Ciliated cells: 191.2;Early spermatids: 60.4;Oocytes: 55.1"	"Group enriched"	"Detected in all"	31	"choroid plexus epithelial cell: 367.3;ependymal cell: 1354.1"	"Cancer enhanced"	"Detected in single"		"Uterine Corpus Endometrial Carcinoma (TCGA): 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Lung - Respiratory ciliated cells, Testis - Early spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037493, HPA058203, HPA061365"	Enhanced		Approved	"Centrosome,Cytosol,Mid piece,Principal piece"			NA	NA				"Cluster 8: Ciliated cells - Cilium organization"	"Cluster 3: Choroid plexus - Cilium"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 42: Ciliated cells - Cilium assembly"		"Centrosome, Mid piece, Principal piece"	Cytosol	"HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493"			"unprognostic (1.06e-1)"																												"unprognostic (1.24e-2)"
DOCK2	KIAA0209	ENSG00000134516	"Dedicator of cytokinesis 2"	Q92608	5	169637268-170083382	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 52.5;lung: 15.1;lymphoid tissue: 48.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 96.7;granulocytes: 65.0;Kupffer cells: 92.7;Macrophages: 87.9;Microglial cells: 165.5;monocytes: 244.8;NK-cells: 63.0"	"Group enriched"	"Detected in all"	15	"central nervous system macrophage: 1056.9;leukocyte: 741.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Kidney cancer: 30.7;Leukemia: 85.2;lymphoma: 97.1;Myeloma: 38.0"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Skeletal muscle - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036469	Enhanced						NA	NA		8700	"Cluster 40: Monocytes - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 29: Monocytes - Innate immune response"	37			"HPA036469: AB_2675140"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.69e-3)"		"unprognostic (1.29e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.41e-3)"		"unprognostic (1.25e-3)"	"unprognostic (2.15e-1)"	"unprognostic (4.23e-2)"		"unprognostic (6.44e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.66e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.20e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (9.58e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.66e-1)"	
GPSM3	"AGS4, C6orf9, G18, G18.1a, G18.1b, G18.2, NG1"	ENSG00000213654	"G protein signaling modulator 3"	Q9Y4H4	6	32190766-32195523	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 158.8;intestine: 65.8;lung: 61.0;lymphoid tissue: 223.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 242.2;dendritic cells: 189.8;Hofbauer cells: 381.2;Kupffer cells: 314.6;Langerhans cells: 238.6;Macrophages: 220.0;monocytes: 349.7;NK-cells: 269.6;T-cells: 248.2"	"Group enriched"	"Detected in some"	4	"central nervous system macrophage: 39.6;leukocyte: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 59.2;lymphoma: 49.8"	"Adrenal gland - Macrophages, Lung - Neutrophil_2, Prostate - T-cells, Skin - T-cells, Spleen - Neutrophils, Stomach - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA		16000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 19: NK-cells - Adaptive immune response"	48				"unprognostic (3.70e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.39e-3)"	"unprognostic (7.64e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.59e-2)"	"unprognostic (4.52e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.84e-1)"
HS3ST2	3OST2	ENSG00000122254	"Heparan sulfate-glucosamine 3-sulfotransferase 2"	Q9Y278	16	22814162-22916338	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.5;lung: 5.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 96.4;Inhibitory neurons: 24.8"	"Cell type enhanced"	"Detected in many"		"deep-layer corticothalamic and 6b: 296.1;deep-layer intratelencephalic: 225.6;midbrain-derived inhibitory: 229.3"	"Cancer enhanced"	"Detected in some"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Bone cancer: 4.0;Neuroblastoma: 2.6;thyroid cancer: 1.9"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017736	Approved						NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 53: Neurons - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 34: Neurons - Neuronal signaling"				"HPA017736: AB_1851095"			"unprognostic (8.32e-2)"				"unprognostic (2.29e-4)"					"unprognostic (3.98e-2)"	"unprognostic (9.39e-4)"		"unprognostic (1.86e-3)"	"unprognostic (2.87e-3)"	"unprognostic (3.97e-2)"														
IGHV1-46		ENSG00000211962	"Immunoglobulin heavy variable 1-46"	P01743	14	106511117-106511856	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 43.3;lung: 11.1;salivary gland: 20.2"	"Cell type enriched"	"Detected in some"	27	"Plasma cells: 7343.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	17	"Myeloma: 18.8"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA		5700000000				"Cluster 55: Lymphoma - Immune response"	"Cluster 61: Plasma cells - Immunoglobulins & histones"					"unprognostic (2.05e-2)"	"unprognostic (5.14e-3)"		"unprognostic (1.52e-2)"	"unprognostic (8.79e-3)"	"unprognostic (5.17e-2)"			"unprognostic (9.98e-2)"		"unprognostic (1.30e-2)"		"unprognostic (1.73e-3)"	"unprognostic (1.96e-1)"		"unprognostic (3.09e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.40e-1)"
LRRN4	"C20orf75, dJ1056H1.1, NLRR4"	ENSG00000125872	"Leucine rich repeat neuronal 4"	Q8WUT4	20	6040546-6054060	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 8.0;lung: 10.1"	"Group enriched"	"Detected in some"	11	"Alveolar cells type 1: 26.4;Mesothelial cells: 51.4"	"Cell type enhanced"	"Detected in some"		"medium spiny neuron: 1.9"	"Group enriched"	"Detected in some"	6	"Kidney Renal Papillary Cell Carcinoma (TCGA): 36.7;Lung Adenocarcinoma (TCGA): 9.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 49.3"	"Adipose visceral - Mesothelial cells, Pancreas - Ductal cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA075974			Uncertain	"Nucleoli,Nucleoli rim,Mitotic chromosome"			Yes	No		35000		"Cluster 57: Lung - Lung function"	"Cluster 33: Neurons - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 72: Alveolar cells - Lung function"	5	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA075974: AB_2686770"			"unprognostic (4.32e-2)"								"unprognostic (1.04e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.87e-4)"			"unprognostic (6.21e-2)"	"unprognostic (1.68e-1)"		"unprognostic (1.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.58e-1)"										"unprognostic (4.53e-2)"
MSR1	"CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII"	ENSG00000038945	"Macrophage scavenger receptor 1"	P21757	8	16107878-16567490	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lung: 116.4"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 122.6;Kupffer cells: 261.4;Langerhans cells: 97.4;Macrophages: 191.1;monocytes: 231.3"	"Group enriched"	"Detected in many"	7	"central nervous system macrophage: 282.4;upper rhombic lip: 274.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 16.8"	"Lineage enriched"	"Detected in many"	5	"monocytes: 16.8"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA000272, CAB032491"	Enhanced						NA	NA		46000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 57: Lung - Lung function"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 58: Macrophages - Innate immune response"	9			"CAB032491: AB_672722, HPA000272: AB_1846269"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.55e-4)"	"unprognostic (5.74e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (6.81e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.51e-2)"	"unprognostic (8.96e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.03e-4)"	"unprognostic (8.31e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"
RASAL3	FLJ21438	ENSG00000105122	"RAS protein activator like 3"	Q86YV0	19	15451624-15464544	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 23.2;intestine: 19.3;lung: 10.3;lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 38.9;dendritic cells: 22.3;granulocytes: 28.7;monocytes: 31.4;NK-cells: 89.3;T-cells: 75.5"	"Group enriched"	"Detected in some"	115	"central nervous system macrophage: 70.8;leukocyte: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"Leukemia: 25.6;lymphoma: 20.9;Myeloma: 29.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Kidney - T-cells, Liver - T-cells, Minor Salivary Gland - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043417	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			NA	NA			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 19: NK-cells - Adaptive immune response"	15	"Nucleoplasm, Plasma membrane"		"HPA043417: AB_2678473"	"unprognostic (9.30e-3)"	"unprognostic (2.63e-2)"	"unprognostic (6.19e-4)"	"unprognostic (1.15e-3)"	"unprognostic (9.04e-2)"	"unprognostic (5.03e-2)"	"unprognostic (6.86e-2)"		"unprognostic (7.34e-4)"	"unprognostic (5.72e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.04e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.06e-1)"
SCGB3A1	"HIN-1, HIN1, LU105, PnSP-2, UGRP2"	ENSG00000161055	"Secretoglobin family 3A member 1"	Q96QR1	5	180590105-180591499	"Plasma proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 259.9;lung: 492.9;salivary gland: 724.7"	"Group enriched"	"Detected in many"	4	"Club cells: 32504.6;Ionocytes: 15631.2"	"Cell type enhanced"	"Detected in some"		"choroid plexus epithelial cell: 2.6;splatter: 1.8"	"Cancer enriched"	"Detected in many"	4	"Lung Adenocarcinoma (TCGA): 1565.1"	"Group enriched"	"Detected in many"	7	"choroid plexus: 24.2;hypothalamus: 11.7"	"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 52.0"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"Gallbladder cancer: 1.0"	"Breast - Breast glandular cells (progenitors), Lung - Respiratory ciliated cells, Minor Salivary Gland - Minor salivary glandular cells, Pancreas - Ductal cells, Pituitary gland - Gonadotropes, Prostate - Urothelial cells, Skin - Eccrine sweat gland cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted to blood"	Cytokine	NA	NA		5500000	"Cluster 25: Non-specific - Unknown function"	"Cluster 38: Salivary gland - Salivary secretion"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 35: Respiratory epithelial cells - Unknown function"					"unprognostic (4.67e-2)"	"unprognostic (3.42e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.06e-3)"					"unprognostic (1.15e-2)"		"unprognostic (3.53e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.65e-2)"		"unprognostic (1.82e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.11e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.90e-2)"				"unprognostic (7.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.28e-1)"
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149337-41154347	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 8.1;brain: 2.9;choroid plexus: 2.2;lung: 2.0;lymphoid tissue: 7.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 1.4;dendritic cells: 1.8;Hofbauer cells: 3.5;Langerhans cells: 2.3;Macrophages: 1.7;Microglial cells: 6.3;NK-cells: 2.2"	"Cell type enriched"	"Detected in single"	42	"central nervous system macrophage: 32.8"	"Cancer enhanced"	"Detected in single"		"Glioblastoma Multiforme (TCGA): 2.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 91.2"	"Lineage enriched"	"Detected in many"	51	"granulocytes: 91.2"	"Not detected"	"Not detected"			"Spleen - Platelets"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced		Uncertain	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"			NA	NA		53000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 57: Platelets - Hemostasis"	4	"Nuclear speckles, Cytosol"	"Golgi apparatus, Plasma membrane"	"HPA016700: AB_1858262, HPA017860: AB_1858261"			"unprognostic (3.09e-2)"				"unprognostic (6.40e-2)"	"unprognostic (3.64e-2)"									"unprognostic (3.73e-3)"														
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1212.9;lung: 1626.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1247.2;Cardiomyocytes: 393.1;Endothelial cells: 861.7;Hepatocytes: 654.0;Microglial cells: 339.1;Smooth muscle cells: 471.0"	"Group enriched"	"Detected in all"	10	"central nervous system macrophage: 1008.7;endothelial cell: 1846.2;pericyte: 487.5;vascular associated smooth muscle cell: 635.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.5"	"Cancer enhanced"	"Detected in many"		"Brain cancer: 48.1;liver cancer: 106.6;skin cancer: 72.1"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Adrenal gland - Fibroblasts, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Macrophages, Kidney - Fibroblasts, Liver - Hepatocytes, Lung - Fibroblast_1, Prostate - Fibroblasts, Skeletal muscle - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	"Enzyme inhibitor"	NA	NA	1630000000000	270000000000	"Cluster 1: T-cells - Unknown function"	"Cluster 11: Liver - Plasma proteins"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	70			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.69e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.01e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.71e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.70e-7)"	"unprognostic (2.04e-4)"	"unprognostic (4.09e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.22e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.78e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.90e-2)"	"unprognostic (6.54e-2)"	"unprognostic (3.73e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.41e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.78e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.46e-1)"
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.2;lung: 88.4"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 220.8;Alveolar cells type 2: 553.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007884, HPA008426"	Enhanced		Supported	Nucleoplasm,Vesicles			NA	NA				"Cluster 34: Non-specific - Mixed function"	"Cluster 24: Neurons - Mixed function"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 72: Alveolar cells - Lung function"	2	"Nucleoplasm, Vesicles"		"HPA007884: AB_1078077, HPA008426: "	"unprognostic (3.19e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.86e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.65e-2)"	"unprognostic (4.74e-2)"		"unprognostic (1.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.50e-4)"	"unprognostic (5.98e-3)"	"unprognostic (1.71e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.10e-2)"
ACOXL	FLJ11042	ENSG00000153093	"Acyl-CoA oxidase like"	Q9NUZ1	2	110732539-111118548	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"epididymis: 7.0;lung: 8.9;urinary bladder: 4.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 33.0;Granulosa cells: 15.7;Late spermatids: 9.3;Plasma cells: 20.1"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Myeloma: 6.4"	"Lung - Alveolar cells type 2, Prostate - Prostate glandular cells, Spleen - Plasma cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035392, HPA035393"			Supported	Nucleoli,Cytosol			NA	NA				"Cluster 53: Non-specific - Glycosylation"	"Cluster 9: Non-specific - Receptor signaling"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 61: Plasma cells - Immunoglobulins & histones"		Cytosol	Nucleoli	"HPA035392: AB_2674604, HPA035393: AB_2674605"	"unprognostic (8.13e-7)"		"unprognostic (2.75e-1)"	"unprognostic (1.36e-1)"		"unprognostic (4.41e-2)"				"unprognostic (1.26e-2)"			"unprognostic (2.67e-4)"			"unprognostic (4.52e-4)"	"unprognostic (2.37e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.18e-1)"		"unprognostic (2.19e-2)"		"unprognostic (1.13e-1)"		"unprognostic (2.85e-2)"			"unprognostic (2.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.94e-2)"
ACP5	"HPAP, TRAcP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574653-11579993	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 159.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 391.8;Macrophages: 293.4;Proximal tubular cells: 109.7"	"Group enriched"	"Detected in some"	4	"fibroblast: 5.2;leukocyte: 9.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 27.0"	"Immune cell enhanced"	"Detected in many"		"memory B-cell: 172.5"	"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	7	"skin cancer: 80.1"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Kidney - Proximal tubular cells, Liver - Sinusoid Endothelial cells, Lung - Macrophages, Skeletal muscle - Macrophages"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002584, HPA057655, HPA059463"	Enhanced		Uncertain	Cytosol	"Intracellular and membrane"	Enzyme	NA	NA		3100000	"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 47: Spleen - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 58: Macrophages - Innate immune response"	2	Cytosol		"CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028"	"unprognostic (1.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.55e-5)"	"unprognostic (5.04e-2)"	"unprognostic (9.06e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.59e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.23e-2)"
ACVRL1	"ACVRLK1, ALK1, HHT, HHT2, ORW2"	ENSG00000139567	"Activin A receptor like type 1"	P37023	12	51906908-51923361	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 93.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 98.8;Distal enterocytes: 137.5;Endothelial cells: 95.6;Extravillous trophoblasts: 44.0;Fibroblasts: 58.0;Lymphatic endothelial cells: 72.0"	"Cell type enriched"	"Detected in some"	6	"endothelial cell: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"classical monocyte: 1.5;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	19	"dendritic cells: 2.1;monocytes: 1.5"	"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 8.0"	"Heart muscle - Endothelial cells, Kidney - Endothelial cells, Pituitary gland - Endothelial cells, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007041	Approved				"Intracellular and membrane"	Receptor	NA	NA			"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 57: Lung - Lung function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	8			"HPA007041: AB_1078097"	"unprognostic (1.51e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.03e-7)"	"unprognostic (8.83e-5)"	"unprognostic (4.02e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.35e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.77e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.12e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.28e-4)"	"unprognostic (6.58e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.21e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.22e-2)"
ADAMTS8	"ADAM-TS8, FLJ41712, METH2"	ENSG00000134917	"ADAM metallopeptidase with thrombospondin type 1 motif 8"	Q9UP79	11	130404923-130428609	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 26.7"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 32.0;Fibroblasts: 18.0;Glandular and luminal cells: 27.0;Schwann cells: 9.6;Smooth muscle cells: 11.9"	"Cell type enhanced"	"Detected in many"		"fibroblast: 55.0;hippocampal dentate gyrus: 37.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"Adrenocortical cancer: 6.7"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066349	Approved				"Secreted to extracellular matrix"	Enzyme	NA	NA		48000000		"Cluster 57: Lung - Lung function"	"Cluster 51: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 37: Glandular & Luminal cells - Unknown function"				"HPA066349: AB_2685662"			"unprognostic (1.86e-2)"				"unprognostic (1.83e-1)"									"unprognostic (5.13e-3)"						"unprognostic (8.39e-2)"		"unprognostic (1.65e-1)"		"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.65e-1)"		"unprognostic (2.48e-3)"
ADGRF5	"DKFZp564O1923, GPR116, KIAA0758"	ENSG00000069122	"Adhesion G protein-coupled receptor F5"	Q8IZF2	6	46852522-46954943	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 102.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 393.9;Alveolar cells type 1: 205.3;Alveolar cells type 2: 303.0;Endothelial cells: 214.3;Microglial cells: 99.3"	"Group enriched"	"Detected in many"	6	"endothelial cell: 767.0;pericyte: 289.3"	"Group enriched"	"Detected in all"	4	"Kidney Chromophobe (TCGA): 85.3;Kidney Renal Clear Cell Carcinoma (TCGA): 48.8;Lung Adenocarcinoma (TCGA): 50.0;Thyroid Carcinoma (TCGA): 23.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lung cancer: 11.7;pancreatic cancer: 6.7;Sarcoma: 6.2"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Liver - Vascular Endothelial cells, Minor Salivary Gland - Endothelial cells, Pancreas - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Spleen - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA		53000000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	1				"unprognostic (2.77e-1)"	"unprognostic (4.99e-2)"		"unprognostic (9.69e-2)"	"unprognostic (5.84e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.59e-10)"	"unprognostic (2.41e-4)"	"unprognostic (6.00e-4)"	"unprognostic (8.47e-2)"		"unprognostic (3.58e-3)"	"unprognostic (2.74e-1)"	"unprognostic (6.67e-3)"	"unprognostic (5.59e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.98e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.72e-2)"
ADRB1	ADRB1R	ENSG00000043591	"Adrenoceptor beta 1"	P08588	10	114043866-114046904	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 22.9;lung: 12.7;placenta: 28.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 24.6;Cardiomyocytes: 74.7;Cytotrophoblasts: 79.8;Sertoli cells: 24.5;Syncytiotrophoblasts: 34.7"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Kidney Chromophobe (TCGA): 4.1;Prostate Adenocarcinoma (TCGA): 13.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"Bone cancer: 7.9"	"Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Prostate - Prostate glandular cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067972	Enhanced						NA	NA				"Cluster 34: Non-specific - Mixed function"	"Cluster 53: Neurons - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 24: Cytotrophoblasts - Mitochondria"	7			"HPA067972: AB_2685936"	"unprognostic (6.91e-3)"		"unprognostic (1.45e-3)"			"unprognostic (2.36e-4)"	"unprognostic (2.14e-1)"			"unprognostic (9.96e-3)"						"unprognostic (3.26e-3)"	"unprognostic (1.07e-1)"							"unprognostic (7.89e-2)"				"unprognostic (6.14e-2)"			
AGR3	"BCMP11, hAG-3, HAG3, PDIA18"	ENSG00000173467	"Anterior gradient 3, protein disulphide isomerase family member"	Q8TD06	7	16859412-16881987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 217.5;intestine: 230.7;lung: 147.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 316.3;Ciliated cells: 1021.0;Distal enterocytes: 365.9;Enteroendocrine cells: 327.6;Intestinal goblet cells: 689.4;Ionocytes: 347.5;Paneth cells: 692.8;Proximal enterocytes: 1057.5;Undifferentiated cells: 404.6"	"Cell type enriched"	"Detected in single"	72	"ependymal cell: 23.6"	"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 327.0"	"Region enhanced"	"Detected in some"		"midbrain: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"breast cancer: 51.8;colorectal cancer: 65.3;Gastric cancer: 151.5"	"Breast - Breast glandular cells, Colon - Colon enterocytes, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells, Stomach - Gastric mucous cells"	"Region enriched"	"Detected in some"	5	"olfactory bulb: 4.6"					HPA053942	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	"No annotated function"	NA	NA		94000		"Cluster 45: Intestine - Digestion"	"Cluster 46: Brainstem - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 22: Proximal enterocytes - Digestion"	21	"Endoplasmic reticulum"	Vesicles	"HPA053942: AB_2682317"	"unprognostic (5.81e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.77e-4)"		"unprognostic (1.45e-2)"				"unprognostic (3.06e-2)"		"unprognostic (7.93e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.49e-4)"	"unprognostic (1.33e-1)"	"unprognostic (7.37e-2)"	"unprognostic (5.61e-3)"		"unprognostic (2.28e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.28e-1)"
AGTR2	"AT2, MRX88"	ENSG00000180772	"Angiotensin II receptor type 2"	P50052	X	116170744-116174974	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 8.5;lung: 8.6;smooth muscle: 12.7"	"Cell type enriched"	"Detected in some"	6	"Alveolar cells type 2: 14.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"Lung Adenocarcinoma (TCGA): 3.0;Lung Squamous Cell Carcinoma (TCGA): 1.3;Uterine Corpus Endometrial Carcinoma (TCGA): 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	17	"Sarcoma: 1.6"	"Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"cerebellum: 2.6"								NA	NA				"Cluster 62: Connective tissue - ECM organization"		"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 72: Alveolar cells - Lung function"	4						"unprognostic (3.82e-1)"													"unprognostic (8.46e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"												"unprognostic (2.73e-1)"
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 70.6;lymphoid tissue: 91.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 61.6;granulocytes: 184.4;Hofbauer cells: 91.7;Kupffer cells: 98.1;Macrophages: 93.5;monocytes: 70.2"	"Cell type enriched"	"Detected in many"	6	"central nervous system macrophage: 355.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"lymphoma: 26.3;pancreatic cancer: 12.6"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Breast - Breast glandular cells, Colon - Macrophages, Liver - Neutrophils, Pituitary gland - Macrophages, Skeletal muscle - Macrophages, Spleen - Neutrophils, Thyroid gland - Macrophages"	"Region enriched"	"Detected in single"	4	"white matter: 2.9"	"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm			NA	NA			"Cluster 20: Non-specific - DNA binding"	"Cluster 47: Spleen - Immune response"	"Cluster 25: Non-specific - Transcription"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 58: Macrophages - Innate immune response"	21	Nucleoplasm		"HPA071285: AB_2686379"	"unprognostic (6.42e-3)"	"unprognostic (6.20e-3)"	"unprognostic (7.96e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.22e-1)"	"unprognostic (1.76e-1)"		"unprognostic (1.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.28e-4)"	"unprognostic (4.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.17e-1)"		"unprognostic (1.21e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.03e-2)"	"unprognostic (9.98e-2)"
ANOS1	"ADMLX, KAL, KAL1, KALIG-1, WFDC19"	ENSG00000011201	"Anosmin 1"	P23352	X	8528874-8732137	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 41.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 107.0;Astrocytes: 62.2;Inhibitory neurons: 26.9;Microglial cells: 25.9;Oligodendrocyte precursor cells: 35.8"	"Cell type enhanced"	"Detected in many"		"astrocyte: 259.9;central nervous system macrophage: 234.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"cervical cancer: 15.1"	"Colon - Enteric glia cells, Lung - Alveolar cells type 1, Skin - Outer root sheath cells, Spleen - Macrophages, Thyroid gland - Thyroid glandular cells"					"Low region specificity"	"Detected in all"								"Secreted in brain"	"Cell adhesion"	NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 22: Non-specific - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 25: Bipolar cells - Visual perception"	5				"unprognostic (8.28e-2)"	"unprognostic (3.53e-1)"		"unprognostic (9.72e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.81e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.16e-5)"	"unprognostic (8.70e-3)"	"unprognostic (3.86e-2)"			"unprognostic (3.69e-3)"	"unprognostic (5.22e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.43e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.19e-2)"		"unprognostic (2.91e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.24e-1)"
BMP3		ENSG00000152785	"Bone morphogenetic protein 3"	P12645	4	81030708-81057627	"Plasma proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.0;lung: 5.3;ovary: 5.2;urinary bladder: 9.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 18.1;Club cells: 13.3;Distal enterocytes: 39.7;Mucus glandular cells: 15.7;Paneth cells: 37.3;Proximal enterocytes: 25.0;Salivary duct cells: 15.2;Undifferentiated cells: 14.7"	"Cell type enhanced"	"Detected in many"		"ependymal cell: 44.1"	"Cancer enhanced"	"Detected in some"		"Bladder Urothelial Carcinoma (TCGA): 7.9;Lung Adenocarcinoma (TCGA): 5.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bladder cancer: 2.9;lymphoma: 6.6"	"Lung - Alveolar cells type 2, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	Cytokine	NA	NA				"Cluster 45: Intestine - Digestion"	"Cluster 17: Choroid plexus - Cilium"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 5: Enterocytes - Absorption"					"unprognostic (2.84e-3)"		"unprognostic (2.57e-2)"	"unprognostic (3.35e-4)"		"unprognostic (2.73e-1)"										"unprognostic (1.61e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.41e-2)"									"unprognostic (6.87e-3)"			"unprognostic (3.63e-2)"
BPIFA1	"bA49G10.5, LUNX, PLUNC, SPLUNC1"	ENSG00000198183	"BPI fold containing family A member 1"	Q9NP55	20	33235995-33243311	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 6.0;lung: 17.7;pituitary gland: 11.8"	"Group enriched"	"Detected in some"	5	"Club cells: 960.0;Ionocytes: 617.4;Serous glandular cells: 535.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	14	"Lung Adenocarcinoma (TCGA): 611.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	28	"pancreatic cancer: 28.5"	"Lung - Respiratory ciliated cells"	"Region enriched"	"Detected in single"	10	"cerebellum: 2.0"	"Not detected"	"Not detected"			CAB025669	Supported				"Secreted in other tissues"	Immunity	NA	NA		730000		"Cluster 57: Lung - Lung function"		"Cluster 7: Liver cancer - Metabolism"	"Cluster 35: Respiratory epithelial cells - Unknown function"	48			"CAB025669: "	"unprognostic (1.27e-3)"	"unprognostic (2.17e-1)"		"unprognostic (2.11e-1)"					"unprognostic (2.13e-1)"					"unprognostic (3.37e-1)"		"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"unprognostic (4.64e-2)"	"unprognostic (5.57e-2)"									"unprognostic (1.79e-1)"			
C16orf89	MGC45438	ENSG00000153446	"Chromosome 16 open reading frame 89"	Q6UX73	16	5044122-5066110	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 104.9;thyroid gland: 221.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 268.4;Club cells: 65.2;Distal tubular cells: 76.8;Fibroblasts: 33.6"	"Group enriched"	"Detected in many"	4	"astrocyte: 31.8;bergmann glia: 24.1;fibroblast: 69.4;pericyte: 31.2"	"Group enriched"	"Detected in many"	13	"Kidney Chromophobe (TCGA): 71.3;Lung Adenocarcinoma (TCGA): 205.3;Thyroid Carcinoma (TCGA): 250.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	10	"thyroid cancer: 14.2"	"Colon - Fibroblasts, Lung - Alveolar cells type 2, Prostate - Fibroblasts, Stomach - Chief cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA013613, HPA016934"	Enhanced				"Secreted to blood"	"No annotated function"	NA	NA		4300000		"Cluster 51: Thyroid gland - Unknown function"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 72: Alveolar cells - Lung function"				"HPA013613: AB_1845584, HPA016934: AB_2732417"		"unprognostic (2.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.31e-2)"			"unprognostic (1.47e-3)"	"unprognostic (1.16e-2)"		"unprognostic (1.57e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.99e-6)"			"unprognostic (1.12e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.68e-2)"	"unprognostic (6.72e-4)"	"unprognostic (4.52e-2)"			"unprognostic (2.58e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.13e-2)"
C1orf116	"FLJ36507, MGC2742, MGC4309, SARG"	ENSG00000182795	"Chromosome 1 open reading frame 116"	Q9BW04	1	207018522-207032756	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 99.2;lung: 70.7;stomach 1: 57.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 177.1;Alveolar cells type 2: 95.6;Club cells: 46.8;Prostatic glandular cells: 49.6;Suprabasal keratinocytes: 51.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Prostate Adenocarcinoma (TCGA): 97.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"prostate cancer: 57.3"	"Colon - Colon enterocytes, Liver - Cholangiocyte, Minor Salivary Gland - Minor salivary gland basal cells, Pituitary gland - Corticotropes, Prostate - Prostate glandular cells, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011888, HPA011889"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			NA	NA		63000		"Cluster 27: Squamous epithelium - Keratinization"		"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 72: Alveolar cells - Lung function"	4	"Plasma membrane, Cytosol"		"HPA011888: AB_1853872, HPA011889: AB_1853873"	"unprognostic (4.78e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.27e-4)"			"unprognostic (8.29e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.16e-3)"		"unprognostic (1.83e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.03e-4)"	"unprognostic (6.80e-4)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.17e-1)"
CACNA2D2	"alpha2delta-2, KIAA0558"	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362613-50504244	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 47.6"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 39.5;Alveolar cells type 2: 127.4;Horizontal cells: 60.4;Inhibitory neurons: 34.6;Oocytes: 53.7"	"Cell type enhanced"	"Detected in many"		"cerebellar inhibitory: 112.6"	"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 19.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 26.8;thyroid cancer: 13.2"	"Breast - Breast glandular cells, Colon - Colon enteroendocrine cells, Lung - Alveolar cells type 2, Pancreas - Alpha cells, Pancreas - Beta cells, Pituitary gland - Corticotropes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034771	Enhanced		Approved	"Plasma membrane,Cytosol,Flagellar centriole,Mid piece"			NA	NA		6500000	"Cluster 11: T-cells - Unknown function"	"Cluster 28: Neuronal - Transcription"	"Cluster 1: Neurons - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 72: Alveolar cells - Lung function"	1	Cytosol	"Plasma membrane, Flagellar centriole, Mid piece"	"HPA034771: AB_10603555"		"unprognostic (3.38e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.05e-1)"			"unprognostic (1.15e-2)"						"unprognostic (1.86e-4)"	"unprognostic (2.36e-3)"	"unprognostic (7.22e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.42e-4)"		"unprognostic (3.11e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.54e-2)"			"unprognostic (4.88e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.68e-3)"
CALCRL	"CGRPR, CRLR"	ENSG00000064989	"Calcitonin receptor like receptor"	Q16602	2	187341964-187448460	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 68.3;lung: 74.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 131.7;Endometrial stromal cells: 98.4;Endothelial cells: 262.9;Lymphatic endothelial cells: 297.8;Oligodendrocyte precursor cells: 275.0"	"Cell type enhanced"	"Detected in many"		"bergmann glia: 365.9;endothelial cell: 403.4;oligodendrocyte precursor cell: 468.1"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 34.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.6;myeloid DC: 9.2;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 9.2;monocytes: 2.6"	"Cancer enhanced"	"Detected in many"		"Rhabdoid: 12.7;Sarcoma: 23.1"	"Adrenal gland - Endothelial cells, Colon - Endothelial cells, Prostate - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008070, HPA046515"	Uncertain		Supported	"Plasma membrane"			NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	5	"Plasma membrane"		"HPA008070: AB_1845912, HPA046515: AB_2679681"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.38e-5)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.49e-10)"	"unprognostic (8.04e-4)"	"unprognostic (4.98e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.25e-3)"	"unprognostic (9.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.47e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.86e-1)"
CASS4	"C20orf32, HEFL, HEPL"	ENSG00000087589	"Cas scaffold protein family member 4"	Q9NQ75	20	56412112-56460387	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 11.8;lymphoid tissue: 9.4"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 11.0;Langerhans cells: 19.5;Macrophages: 14.0;Microglial cells: 27.7;monocytes: 7.8;NK-cells: 8.0;T-cells: 17.4"	"Group enriched"	"Detected in many"	13	"central nervous system macrophage: 91.6;endothelial cell: 82.4;leukocyte: 31.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 23.1;neutrophil: 69.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 69.1"	"Group enriched"	"Detected in some"	7	"Leukemia: 4.6;Sarcoma: 2.2"	"Adrenal gland - Macrophages, Minor Salivary Gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB034217	Approved						NA	NA		320000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 44: Non-specific - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"				"CAB034217: AB_2071598"			"unprognostic (1.34e-1)"			"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"				"unprognostic (1.12e-2)"	"unprognostic (7.22e-2)"				"unprognostic (2.09e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.91e-1)"							"unprognostic (8.40e-2)"			"unprognostic (5.94e-2)"		
CCDC190	"C1orf110, MGC48998"	ENSG00000185860	"Coiled-coil domain containing 190"	Q86UF4	1	162824458-162868761	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"esophagus: 2.5;lung: 1.7"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 35.6"	"Group enriched"	"Detected in some"	5	"astrocyte: 30.8;ependymal cell: 41.6"	"Cancer enhanced"	"Detected in many"		"Head and Neck Squamous Cell Carcinoma (TCGA): 6.1;Lung Squamous Cell Carcinoma (TCGA): 8.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Lung - Respiratory ciliated cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028579, HPA028584, HPA028592"	Uncertain		Approved	"Actin filaments,Cytosol"			NA	NA				"Cluster 29: Squamous epithelium - Innate immune response"	"Cluster 46: Brainstem - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 42: Ciliated cells - Cilium assembly"		"Actin filaments, Cytosol"		"HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001"	"unprognostic (4.64e-1)"			"unprognostic (6.07e-2)"					"unprognostic (2.51e-2)"							"unprognostic (1.46e-2)"		"unprognostic (7.34e-3)"	"unprognostic (5.40e-2)"			"unprognostic (5.25e-2)"						"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"		
CCL3	"G0S19-1, LD78ALPHA, MIP-1-alpha, SCYA3"	ENSG00000277632	"C-C motif chemokine ligand 3"	P10147	17	36088256-36090169	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 76.2;lung: 34.7;lymphoid tissue: 48.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3179.9;Kupffer cells: 565.1;Langerhans cells: 883.9;Macrophages: 1607.3;monocytes: 1380.4;NK-cells: 543.5"	"Group enriched"	"Detected in some"	82	"central nervous system macrophage: 29.7;leukocyte: 43.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"basal ganglia: 1.5;cerebral cortex: 2.7;medulla oblongata: 1.4;thalamus: 1.0;white matter: 2.7"	"Immune cell enhanced"	"Detected in many"		"gdT-cell: 23.7"	"Group enriched"	"Detected in many"	4	"B-cells: 10.4;granulocytes: 10.8;T-cells: 23.7"	"Cancer enriched"	"Detected in some"	5	"Myeloma: 218.9"	"Breast - T-cells, Liver - NK-cells (Liver), Thyroid gland - T-cells"														"Secreted to blood"	Chemokine	NA	NA	138000		"Cluster 14: Non-specific - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 34: Non-specific - Mixed function"	"Cluster 20: Myeloma - Immune response"	"Cluster 58: Macrophages - Innate immune response"	3					"unprognostic (2.08e-1)"	"unprognostic (1.39e-1)"		"unprognostic (1.98e-1)"				"unprognostic (2.23e-1)"		"unprognostic (2.30e-1)"	"unprognostic (3.56e-2)"			"unprognostic (4.72e-3)"	"unprognostic (1.74e-1)"		"unprognostic (2.45e-2)"		"unprognostic (6.98e-2)"							"unprognostic (9.49e-5)"	"unprognostic (2.49e-1)"			
CCL3L1	"CCL3L3, D17S1718, G0S19-2, LD78BETA, MGC12815, SCYA3L, SCYA3L1"	ENSG00000276085	"C-C motif chemokine ligand 3 like 1"	P16619	17	36194869-36196758	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.0;lung: 4.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 796.8;Kupffer cells: 154.6;Langerhans cells: 385.1;Macrophages: 500.2;monocytes: 206.0"	"Cell type enriched"	"Detected in some"	4	"central nervous system macrophage: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"eosinophil: 4.2;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.2"	"Group enriched"	"Detected in some"	11	"lymphoma: 2.3;Myeloma: 9.1"															"Secreted to blood"	Chemokine	NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"		"Cluster 20: Myeloma - Immune response"	"Cluster 58: Macrophages - Innate immune response"	5						"unprognostic (7.63e-3)"									"unprognostic (1.52e-1)"																			
CD101	"IGSF2, V7"	ENSG00000134256	"CD101 molecule"	Q93033	1	117001750-117036552	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;intestine: 6.1;lung: 6.5"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 5.9;Langerhans cells: 4.7;Macrophages: 7.8;monocytes: 24.7;T-cells: 6.0"	"Cell type enhanced"	"Detected in many"		"leukocyte: 18.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 97.1"	"Group enriched"	"Detected in many"	18	"dendritic cells: 33.8;granulocytes: 97.1;monocytes: 53.4"	"Low cancer specificity"	"Detected in some"				"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049527, HPA057763"	Approved		Uncertain	Mitochondria			NA	NA		5600000	"Cluster 25: Non-specific - Unknown function"	"Cluster 25: Small intestine - Absorption"	"Cluster 53: Neurons - Mixed function"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	1	Mitochondria		"HPA049527: , HPA057763: AB_2683519"			"unprognostic (4.26e-2)"	"unprognostic (1.15e-1)"		"unprognostic (2.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.54e-1)"							"unprognostic (2.45e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.54e-1)"							"unprognostic (2.28e-2)"					
CD274	"B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1"	ENSG00000120217	"CD274 molecule"	Q9NZQ7	9	5450503-5470566	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.3"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 31.3;granulocytes: 43.8;Langerhans cells: 62.7;Syncytiotrophoblasts: 54.7"	"Cell type enriched"	"Detected in many"	5	"central nervous system macrophage: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.7"	"Low cancer specificity"	"Detected in many"			"Kidney - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003528, CAB076385, CAB080537"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"	"Secreted - unknown location"	Receptor	NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 14: Langerhans cells - Innate immune response"	54	"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB076385: AB_2687655, CAB080537: , HPA003528: "	"unprognostic (1.57e-1)"	"unprognostic (6.55e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.36e-2)"	"unprognostic (7.77e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.50e-4)"	"unprognostic (9.06e-2)"	"unprognostic (9.75e-2)"		"unprognostic (3.05e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.58e-1)"		"unprognostic (1.26e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.99e-2)"		"unprognostic (3.46e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.81e-1)"	
CD300C	"CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR"	ENSG00000167850	"CD300c molecule"	Q08708	17	74541073-74546115	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.6;lung: 8.1;lymphoid tissue: 7.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 42.5;Kupffer cells: 17.8;Langerhans cells: 16.1;Macrophages: 28.0;monocytes: 31.4"	"Group enriched"	"Detected in some"	8	"central nervous system macrophage: 4.9;leukocyte: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 228.5;non-classical monocyte: 243.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Leukemia: 5.2;lymphoma: 5.0;thyroid cancer: 1.5"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages, Stomach - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA014523, HPA060349"	Approved		Uncertain	"Golgi apparatus,Vesicles,Mitochondria"			NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 29: Monocytes - Innate immune response"	10	"Golgi apparatus"	"Vesicles, Mitochondria"	"HPA014523: AB_1846293, HPA060349: "	"unprognostic (2.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.73e-2)"		"unprognostic (1.83e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-1)"			"unprognostic (1.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.21e-1)"				"unprognostic (1.35e-2)"		"unprognostic (8.70e-2)"	"unprognostic (4.96e-3)"	"unprognostic (3.28e-4)"	
CD68	"DKFZp686M18236, GP110, LAMP4, SCARD1"	ENSG00000129226	"CD68 molecule"	P34810	17	7579491-7582111	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 346.5;lymphoid tissue: 360.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 223.6;Kupffer cells: 258.2;Langerhans cells: 80.9;Macrophages: 190.0;Proximal enterocytes: 193.1"	"Cell type enriched"	"Detected in some"	5	"central nervous system macrophage: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3264.9;intermediate monocyte: 3664.2;non-classical monocyte: 3764.8"	"Group enriched"	"Detected in all"	11	"dendritic cells: 1382.0;monocytes: 3764.8"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Lung - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"					"Low region specificity"	"Detected in all"			"CAB000051, CAB000066, HPA048982, CAB072861, CAB072862"	Enhanced		Supported	"Golgi apparatus,Vesicles"			NA	NA		11000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	11	"Golgi apparatus, Vesicles"		"CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.71e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.80e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.24e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.14e-1)"
CD80	"B7-1, B7.1, CD28LG, CD28LG1"	ENSG00000121594	"CD80 molecule"	P33681	3	119524293-119559614	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 2.9;lymphoid tissue: 6.6"	"Group enriched"	"Detected in some"	4	"B-cells: 9.1;Langerhans cells: 21.3;Macrophages: 7.2;monocytes: 19.3"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.4;T-reg: 1.3"	"Low lineage specificity"	"Detected in many"			"Cancer enriched"	"Detected in some"	5	"lymphoma: 19.6"	"Liver - Kupffer cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB025368, HPA050092"	Enhanced				"Intracellular and membrane"	Receptor	NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 8: Immune cells - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 14: Langerhans cells - Innate immune response"	6			"CAB025368: , HPA050092: AB_2681012"			"unprognostic (7.63e-2)"			"unprognostic (3.57e-2)"						"unprognostic (1.86e-1)"				"unprognostic (3.52e-3)"	"unprognostic (3.40e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.13e-1)"				"unprognostic (1.01e-3)"			"unprognostic (3.69e-3)"		"unprognostic (3.16e-1)"	"unprognostic (1.25e-2)"		
CEACAM6	"CD66c, NCA"	ENSG00000086548	"CEA cell adhesion molecule 6"	P40199	19	41750977-41772211	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 179.4;esophagus: 189.8;intestine: 213.5;lung: 277.7;salivary gland: 172.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 1478.7;Alveolar cells type 2: 210.1;Club cells: 252.8;Distal enterocytes: 438.9;Paneth cells: 364.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 854.2;Rectum Adenocarcinoma (TCGA): 879.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 386.8"	"Colon - Colon enterocytes, Prostate - Urothelial cells, Skin - Eccrine sweat gland cells, Spleen - Hematopoietic stem cells"									"CAB008370, HPA011041"	Enhanced						NA	NA		41000000		"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 34: Non-specific - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	25			"CAB008370: AB_592067, HPA011041: AB_1078481"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.24e-3)"			"unprognostic (1.32e-2)"				"unprognostic (3.22e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.99e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.32e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.18e-2)"
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 49.2;lung: 35.3;lymphoid tissue: 21.2"	"Cell type enhanced"	"Detected in some"		"Club cells: 44.1;granulocytes: 15.1;Hofbauer cells: 35.1;Macrophages: 71.9"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"Testicular Germ Cell Tumor (TCGA): 103.2"	"Region enhanced"	"Detected in some"		"white matter: 4.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Enhanced				"Secreted to blood"	Enzyme	NA	NA	26400000	30000000		"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 30: White matter - Myelination"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 58: Macrophages - Innate immune response"	1			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.01e-3)"	"unprognostic (5.35e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.26e-2)"		"unprognostic (1.06e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.51e-5)"	"unprognostic (7.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.00e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.99e-2)"		"unprognostic (2.51e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.08e-2)"
CLDN5	"AWAL, BEC1, CPETRL1, TMVCF"	ENSG00000184113	"Claudin 5"	O00501	22	19523024-19527545	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 425.6;breast: 407.2;choroid plexus: 418.8;lung: 386.5"	"Group enriched"	"Detected in many"	12	"Adipocytes: 2773.0;Endothelial cells: 835.9;Lymphatic endothelial cells: 1261.5"	"Cell type enriched"	"Detected in many"	8	"endothelial cell: 1608.8"	"Cancer enriched"	"Detected in all"	4	"Glioblastoma Multiforme (TCGA): 108.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"basophil: 19.0;naive CD4 T-cell: 4.8;neutrophil: 5.9"	"Group enriched"	"Detected in many"	29	"granulocytes: 19.0;T-cells: 4.8"	"Cancer enhanced"	"Detected in some"		"Bone cancer: 6.4;cervical cancer: 13.7"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Minor Salivary Gland - Endothelial cells, Prostate - Endothelial cells, Testis - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002607	Approved						NA	NA		210000	"Cluster 4: Neutrophils - Degranulation"	"Cluster 34: Non-specific - Mixed function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	33			"CAB002607: "	"unprognostic (4.25e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.01e-4)"	"unprognostic (3.25e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.51e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.83e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.10e-1)"	"unprognostic (2.68e-5)"	"unprognostic (2.30e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.98e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.03e-1)"
CLEC6A	"CLECSF10, dectin-2, hDECTIN-2"	ENSG00000205846	"C-type lectin domain containing 6A"	Q6EIG7	12	8455962-8478330	"Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 1.0;lymphoid tissue: 1.1"	"Cell type enhanced"	"Detected in single"		"Distal tubular cells: 3.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"Testicular Germ Cell Tumor (TCGA): 1.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 5.4;myeloid DC: 2.2"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.2;monocytes: 5.4"	"Not detected"	"Not detected"				"Not detected"	"Not detected"														NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 34: Testis cancer - Unknown function"	"Cluster 58: Macrophages - Innate immune response"							"unprognostic (4.43e-1)"																										"unprognostic (4.04e-1)"		
COL6A5	"COL29A1, FLJ35880, VWA4"	ENSG00000172752	"Collagen type VI alpha 5 chain"		3	130345516-130484846	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"lung: 5.5;skin 1: 4.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 6.0;Erythroid cells: 3.4;Fibroblasts: 4.4;Langerhans cells: 2.2;Late spermatids: 2.9;Oocytes: 2.2;Plasma cells: 1.3"	"Cell type enriched"	"Detected in single"	29	"thalamic excitatory: 27.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"midbrain: 3.3;thalamus: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	7	"lymphoma: 4.3"	"Testis - Early spermatids"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA043138	Uncertain				"Secreted in other tissues"		NA	NA				"Cluster 13: Skin - Cornification"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 49: Non-specific - Transcription"	1			"HPA043138: AB_10796687"																	"unprognostic (5.24e-2)"														
COX4I2	"COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2"	ENSG00000131055	"Cytochrome c oxidase subunit 4I2"	Q96KJ9	20	31637912-31645006	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 47.6;placenta: 111.5"	"Group enriched"	"Detected in some"	8	"Adipocytes: 49.5;Oocytes: 56.6;Sertoli cells: 155.0;Smooth muscle cells: 186.2"	"Group enriched"	"Detected in some"	33	"pericyte: 62.7;vascular associated smooth muscle cell: 64.6"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 27.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"lymphoma: 2.0;Neuroblastoma: 1.7"	"Adipose subcutaneous - Endothelial cells, Breast - Endothelial cells, Minor Salivary Gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 55: Lymphoma - Immune response"	"Cluster 48: Smooth muscle cells - Signal transduction"	1				"unprognostic (3.28e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.87e-4)"	"unprognostic (3.93e-3)"		"unprognostic (2.51e-1)"		"unprognostic (1.77e-5)"	"unprognostic (1.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (2.44e-6)"	"unprognostic (6.03e-5)"	"unprognostic (6.14e-2)"	"unprognostic (4.58e-2)"	"unprognostic (7.86e-5)"	"unprognostic (2.19e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.67e-2)"	"unprognostic (8.32e-3)"		"unprognostic (2.96e-2)"	"unprognostic (5.91e-3)"		"unprognostic (1.47e-1)"	"unprognostic (2.56e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.47e-3)"
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865296-148897203	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 108.3;lung: 83.7"	"Cell type enriched"	"Detected in some"	180	"granulocytes: 4512.3"	"Cell type enhanced"	"Detected in single"		"leukocyte: 1.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	1540	"basophil: 1120.0"	"Lineage enriched"	"Detected in single"	5543	"granulocytes: 1120.0"	"Cancer enriched"	"Detected in some"	12	"Leukemia: 15.3"	"Adipose subcutaneous - Mast cells, Adipose visceral - Mast cells, Breast - Fibroblasts, Colon - Mast cells, Lung - Mast cells, Minor Salivary Gland - Mast cells, Skeletal muscle - Macrophages"	"Not detected"	"Not detected"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	Enzyme	NA	NA	7520000	1300000	"Cluster 46: Basophils - Proteolysis"	"Cluster 75: Epithelium - Extracellular exosomes"		"Cluster 47: Leukemia - Hemostasis"	"Cluster 30: Granulocytes - Unknown function"	1	"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.50e-2)"			"unprognostic (3.88e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.14e-6)"	"unprognostic (2.92e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.96e-1)"			"unprognostic (2.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.43e-3)"		"unprognostic (1.49e-1)"	"unprognostic (1.94e-2)"
CRTAC1	"ASPIC1, CEP-68, FLJ10320"	ENSG00000095713	"Cartilage acidic protein 1"	Q9NQ79	10	97865000-98030828	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 37.0;lung: 48.4;seminal vesicle: 32.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 125.1;Basal prostatic cells: 67.9;Inhibitory neurons: 61.2;Oligodendrocyte precursor cells: 51.4;Secretory cells: 94.3"	"Cell type enhanced"	"Detected in all"		"LAMP5-LHX6 and Chandelier: 152.1"	"Group enriched"	"Detected in many"	8	"Kidney Chromophobe (TCGA): 265.9;Skin Cuteneous Melanoma (TCGA): 79.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Kidney cancer: 6.0;skin cancer: 4.9"	"Colon - Enteric glia cells, Liver - Vascular Endothelial cells, Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008175	Enhanced				"Secreted to extracellular matrix"	"No annotated function"	NA	NA		570000000		"Cluster 64: Neuronal - Transcription"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 72: Alveolar cells - Lung function"	6			"HPA008175: AB_1847254"	"unprognostic (2.75e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.61e-1)"			"unprognostic (1.00e-1)"	"unprognostic (3.79e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.81e-1)"			"unprognostic (2.95e-4)"	"unprognostic (5.87e-3)"	"unprognostic (2.22e-3)"	"unprognostic (4.01e-1)"	"unprognostic (2.45e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.07e-1)"			"unprognostic (4.60e-3)"		"unprognostic (6.21e-3)"	"unprognostic (5.55e-3)"	"unprognostic (1.45e-2)"
CSF2	"GM-CSF, GMCSF"	ENSG00000164400	"Colony stimulating factor 2"	P04141	5	132073789-132076170	"Cancer-related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lung: 2.0"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 16.3;Basal respiratory cells: 7.5;Ductal cells: 11.0;granulocytes: 13.5;NK-cells: 21.0;T-cells: 23.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Head and Neck Squamous Cell Carcinoma (TCGA): 6.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"NK-cell: 6.3"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 6.3"	"Cancer enhanced"	"Detected in many"		"Bile duct cancer: 27.2;Kidney cancer: 31.4"	"Lung - Alveolar cells type 2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA057404, HPA062006"			Enhanced	Vesicles	"Secreted to blood"	Cytokine	NA	NA	23900		"Cluster 15: NK-cells - Unknown function"	"Cluster 57: Lung - Lung function"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	4	Vesicles		"HPA057404: AB_2683428, HPA062006: AB_2684654"	"unprognostic (1.05e-3)"		"unprognostic (6.29e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-1)"			"unprognostic (2.06e-3)"							"unprognostic (1.51e-3)"	"unprognostic (2.03e-1)"	"unprognostic (6.54e-3)"	"unprognostic (5.74e-3)"			"unprognostic (4.25e-3)"			"unprognostic (1.11e-2)"	"unprognostic (1.19e-1)"		"unprognostic (3.18e-2)"		"unprognostic (6.94e-2)"	
CSF3	"C17orf33, G-CSF, GCSF, MGC45931"	ENSG00000108342	"Colony stimulating factor 3"	P09919	17	40015361-40017813	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 119.2;urinary bladder: 55.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 62.7;Alveolar cells type 2: 52.0;Basal respiratory cells: 187.5;Endothelial cells: 129.4;Ionocytes: 208.4"	"Cell type enhanced"	"Detected in single"		"endothelial cell: 3.2"	"Cancer enhanced"	"Detected in many"		"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 9.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Bladder cancer: 35.5;Sarcoma: 52.0"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	Cytokine	NA	NA	6170			"Cluster 57: Lung - Lung function"	"Cluster 44: Non-specific - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"					"unprognostic (7.43e-2)"		"unprognostic (7.75e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (9.98e-2)"	"unprognostic (7.42e-2)"		"unprognostic (4.67e-2)"							"unprognostic (5.12e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.94e-1)"					"unprognostic (6.68e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.23e-2)"		"unprognostic (1.18e-1)"			"unprognostic (2.82e-1)"
CSF3R	"CD114, GCSFR"	ENSG00000119535	"Colony stimulating factor 3 receptor"	Q99062	1	36466043-36483278	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.3;lung: 132.6;lymphoid tissue: 366.7"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 395.7;Syncytiotrophoblasts: 1355.6"	"Cell type enriched"	"Detected in some"	13	"central nervous system macrophage: 410.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 1924.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 1924.2"	"Cancer enriched"	"Detected in some"	25	"Leukemia: 32.2"	"Adipose subcutaneous - Macrophages, Adipose visceral - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Thyroid gland - Neutrophils"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017116, HPA048086"	Enhanced				"Intracellular and membrane"	Receptor	NA	NA		4100000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	7			"CAB017116: , HPA048086: AB_2680257"	"unprognostic (1.23e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.60e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.62e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.06e-4)"	"unprognostic (4.22e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.79e-1)"
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 338.6"	"Cell type enriched"	"Detected in all"	5	"Alveolar cells type 2: 1759.4"	"Cell type enhanced"	"Detected in all"		"astrocyte: 68.3;bergmann glia: 78.6;central nervous system macrophage: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 209.6;intermediate monocyte: 138.1;memory B-cell: 83.8;myeloid DC: 184.0;naive B-cell: 56.3;non-classical monocyte: 95.3"	"Group enriched"	"Detected in all"	5	"B-cells: 83.8;dendritic cells: 184.0;monocytes: 209.6"	"Low cancer specificity"	"Detected in all"			"Breast - Fibroblasts, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skin - Keratinocyte (granular)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"	Enzyme	NA	NA		10000000	"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 47: Spleen - Immune response"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 72: Alveolar cells - Lung function"	23	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (5.52e-4)"	"unprognostic (7.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.98e-2)"	"unprognostic (7.35e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.69e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.58e-1)"
CYP2F1	CYP2F	ENSG00000197446	"Cytochrome P450 family 2 subfamily F member 1"	P24903	19	41114432-41128381	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 1.3;salivary gland: 1.0;testis: 2.0"	"Group enriched"	"Detected in some"	8	"Club cells: 97.7;Ionocytes: 76.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Lung - Respiratory ciliated cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	Enzyme	NA	NA				"Cluster 21: Testis - Unknown function"		"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 35: Respiratory epithelial cells - Unknown function"							"unprognostic (3.53e-1)"															"unprognostic (8.09e-2)"			"unprognostic (3.43e-2)"								"unprognostic (1.81e-1)"		
CYP4B1		ENSG00000142973	"Cytochrome P450 family 4 subfamily B member 1"	P13584	1	46757838-46819413	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 233.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 148.6;Basal prostatic cells: 121.3;Basal respiratory cells: 107.2;Ciliated cells: 433.5;Club cells: 368.1;Ionocytes: 260.3"	"Group enriched"	"Detected in some"	4	"endothelial cell: 7.0;ependymal cell: 1.8;fibroblast: 6.4"	"Cancer enhanced"	"Detected in many"		"Bladder Urothelial Carcinoma (TCGA): 67.4;Lung Adenocarcinoma (TCGA): 56.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Bladder cancer: 12.1;breast cancer: 28.8"	"Lung - Alveolar cells type 1, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA004331	Approved		Supported	Vesicles			NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 35: Respiratory epithelial cells - Unknown function"		Vesicles		"HPA004331: AB_1078616"	"unprognostic (1.20e-2)"	"unprognostic (5.12e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-2)"					"unprognostic (4.00e-1)"	"unprognostic (1.28e-1)"			"unprognostic (5.20e-1)"			"unprognostic (6.81e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.79e-4)"	"unprognostic (7.24e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.85e-1)"						"unprognostic (1.36e-2)"	"unprognostic (6.54e-2)"
DCSTAMP	"DC-STAMP, FIND, TM7SF4"	ENSG00000164935	"Dendrocyte expressed seven transmembrane protein"	Q9H295	8	104339087-104356689	"Predicted membrane proteins, Transporters"	"Differentiation, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.9;lung: 3.7"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 6.4;Macrophages: 9.8"	"Group enriched"	"Detected in some"	6	"amygdala excitatory: 13.4;deep-layer intratelencephalic: 4.9;hippocampal CA4: 8.1;thalamic excitatory: 5.2"	"Cancer enriched"	"Detected in single"	57	"Thyroid Carcinoma (TCGA): 53.8"	"Region enhanced"	"Detected in many"		"amygdala: 9.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"skin cancer: 1.6;thyroid cancer: 3.1"	"Kidney - Proximal tubular cells"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"										NA	NA				"Cluster 53: Non-specific - Glycosylation"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 58: Macrophages - Innate immune response"	1																				"unprognostic (2.72e-2)"													"unprognostic (1.45e-1)"	
DEFA1B		ENSG00000240247	"Defensin alpha 1B"	P59665	8	6996766-6999198	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Antiviral defense, Host-virus interaction"	"Antibiotic, Antimicrobial, Defensin, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.3;lung: 50.5;lymphoid tissue: 146.9"	"Cell type enriched"	"Detected in single"	4	"Kupffer cells: 1.7"					"Cancer enhanced"	"Detected in single"		"Glioblastoma Multiforme (TCGA): 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Lung - Neutrophil_1, Spleen - Hematopoietic stem cells"									HPA052517	Supported				"Secreted to blood"	Defense	NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"		"Cluster 72: Neuronal - Signal transduction"	"Cluster 74: Neutrophils - Degranulation"	4			"HPA052517: AB_2681860"			"unprognostic (2.39e-1)"				"unprognostic (7.50e-1)"																								
DOK2	"Dok-2, p56dok-2"	ENSG00000147443	"Docking protein 2"	O60496	8	21908873-21913690	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 24.8;lymphoid tissue: 40.0"	"Group enriched"	"Detected in many"	8	"Hofbauer cells: 158.0;Kupffer cells: 125.5;Langerhans cells: 366.0;Macrophages: 127.6;monocytes: 92.6;NK-cells: 229.7;T-cells: 132.9"	"Cell type enriched"	"Detected in single"	75	"leukocyte: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1568.8"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	49	"Leukemia: 36.3;lymphoma: 9.8;Myeloma: 11.1"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Liver - Kupffer cells, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Skeletal muscle - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002862, CAB004379, HPA066571, HPA069121"	Enhanced		Enhanced	"Plasma membrane"			NA	NA		120000	"Cluster 25: Non-specific - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 19: NK-cells - Adaptive immune response"	17	"Plasma membrane"		"CAB004379: AB_627449, HPA002862: , HPA066571: AB_2732749, HPA069121: "	"unprognostic (1.51e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.72e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.08e-2)"	"unprognostic (5.19e-5)"		"unprognostic (4.47e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.44e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.72e-1)"
DRAM1	"DRAM, FLJ11259"	ENSG00000136048	"DNA damage regulated autophagy modulator 1"	Q8N682	12	101877580-102012130	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 91.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 187.5;Early spermatids: 142.4;Late spermatids: 98.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 57: Lung - Lung function"	"Cluster 31: Non-specific - Transcription"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 72: Alveolar cells - Lung function"	6				"unprognostic (1.09e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-5)"	"unprognostic (5.14e-3)"	"unprognostic (3.92e-1)"	"unprognostic (8.92e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.09e-3)"	"unprognostic (4.79e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.87e-1)"	"unprognostic (4.17e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.19e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.35e-1)"
EFCC1	"C3orf73, CCDC48, FLJ12057"	ENSG00000114654	"EF-hand and coiled-coil domain containing 1"	Q9HA90	3	129001304-129040742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 5.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.0;Endothelial cells: 8.7;Lymphatic endothelial cells: 29.3;Microglial cells: 8.9;Ovarian stromal cells: 8.4;Peritubular cells: 6.8"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 25.3;ependymal cell: 21.1;fibroblast: 51.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.6"	"Liver - Hepatic stellate cells"	"Low region specificity"	"Detected in many"							"HPA042798, HPA050888, HPA076069"	Uncertain		Approved	Nucleoplasm,Cytosol			NA	NA				"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 24: Neurons - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"		Nucleoplasm	Cytosol	"HPA042798: AB_2678173, HPA050888: AB_2681263, HPA076069: "						"unprognostic (8.52e-3)"						"unprognostic (4.67e-3)"								"unprognostic (1.72e-1)"	"unprognostic (8.61e-2)"			"unprognostic (1.03e-2)"		"unprognostic (1.27e-2)"		"unprognostic (2.95e-1)"			
ELAPOR2	"EIG121L, FLJ31340, KIAA1324L"	ENSG00000164659	"Endosome-lysosome associated apoptosis and autophagy regulator family member 2"	A8MWY0	7	86876906-87059654	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 21.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 73.1;Early spermatids: 94.5;Excitatory neurons: 55.4;Inhibitory neurons: 104.5;Late spermatids: 97.3;Oligodendrocytes: 358.0"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte: 511.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.9;NK-cells: 2.3;T-cells: 2.7"	"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044527, HPA076093"	Uncertain		Approved	"Endoplasmic reticulum"			NA	NA			"Cluster 30: Non-specific - DNA binding"	"Cluster 34: Non-specific - Mixed function"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 56: Non-specific - Sensory perception"	"Cluster 65: Neurons - Synaptic function"	3	"Endoplasmic reticulum"		"HPA044527: AB_10963793, HPA076093: AB_2686776"	"unprognostic (6.07e-2)"	"unprognostic (1.91e-1)"		"unprognostic (3.02e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.53e-3)"			"unprognostic (2.86e-2)"	"unprognostic (7.37e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.22e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.74e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.34e-3)"	"unprognostic (4.44e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.20e-3)"
EMP2	XMP	ENSG00000213853	"Epithelial membrane protein 2"	P54851	16	10528422-10580632	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 223.6"	"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 1: 3419.6"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 251.9;pericyte: 119.1;vascular associated smooth muscle cell: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Endothelial cells, Liver - Hepatocytes, Lung - Alveolar cells type 1, Skeletal muscle - Endothelial cells, Skin - Keratinocyte (other), Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014711, HPA070816"	Approved		Approved	Nucleoplasm,Cytosol			No	Yes				"Cluster 27: Squamous epithelium - Keratinization"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 72: Alveolar cells - Lung function"		Nucleoplasm	Cytosol	"HPA014711: AB_1848147, HPA070816: "	"unprognostic (4.10e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.34e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.01e-4)"	"unprognostic (3.33e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.69e-4)"	"unprognostic (3.87e-3)"	"unprognostic (4.01e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.79e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.79e-2)"
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386697	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 399.3;placenta: 430.9"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 795.3;Endothelial cells: 626.4;Extravillous trophoblasts: 336.1;Syncytiotrophoblasts: 365.0"	"Group enriched"	"Detected in all"	4	"endothelial cell: 1673.4;pericyte: 727.1;vascular associated smooth muscle cell: 610.1"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 190.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 20.7;eosinophil: 8.4"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 20.7"	"Low cancer specificity"	"Detected in all"			"Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Stomach - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	"Nucleoplasm,Actin filaments,Cytokinetic bridge,Cytosol"			Yes	NA			"Cluster 46: Basophils - Proteolysis"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	41	Nucleoplasm	"Actin filaments, Cytokinetic bridge, Cytosol"	"HPA031200: AB_2673785, HPA069697: AB_2732139"	"unprognostic (1.69e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.61e-3)"	"unprognostic (9.03e-2)"	"unprognostic (2.50e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.70e-10)"	"unprognostic (3.35e-4)"	"unprognostic (6.75e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.80e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.42e-1)"
F2RL3	PAR4	ENSG00000127533	"F2R like thrombin or trypsin receptor 3"	Q96RI0	19	16888999-16892606	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.4;lung: 32.4;thyroid gland: 18.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 105.5;Endothelial cells: 24.6;Lymphatic endothelial cells: 28.7"	"Cell type enhanced"	"Detected in single"		"endothelial cell: 1.1"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 12.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Leukemia: 10.6"	"Testis - Sertoli cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031401, HPA042340"			Supported	"Plasma membrane"			NA	NA			"Cluster 20: Non-specific - DNA binding"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 48: Non-specific - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 57: Platelets - Hemostasis"		"Plasma membrane"		"HPA031401: , HPA042340: "	"unprognostic (2.51e-1)"	"unprognostic (3.66e-1)"	"unprognostic (6.10e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.36e-1)"			"unprognostic (1.56e-2)"	"unprognostic (4.22e-1)"	"unprognostic (7.79e-8)"	"unprognostic (2.50e-6)"	"unprognostic (4.35e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.61e-2)"	"unprognostic (8.28e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.03e-1)"		"unprognostic (5.08e-2)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.72e-4)"		"unprognostic (6.43e-3)"		"unprognostic (3.86e-1)"	"unprognostic (5.02e-2)"
FCAR	"CD89, FcalphaR, FcalphaRI"	ENSG00000186431	"Fc alpha receptor"	P24071	19	54874235-54891420	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		"IgA-binding protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 25.9;lung: 10.2;lymphoid tissue: 13.1"	"Group enriched"	"Detected in some"	5	"Kupffer cells: 13.9;Macrophages: 20.4;monocytes: 47.3"	"Group enriched"	"Detected in some"	4	"central nervous system macrophage: 5.4;leukocyte: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.3;neutrophil: 4.1"	"Group enriched"	"Detected in many"	27	"granulocytes: 4.1;monocytes: 1.3"	"Not detected"	"Not detected"			"Adipose visceral - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Minor Salivary Gland - Neutrophils, Pituitary gland - Neutrophils, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Thyroid gland - Neutrophils"					"Not detected"	"Not detected"			HPA014050	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"		"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	1	"Plasma membrane"		"HPA014050: AB_1846338"			"unprognostic (1.28e-1)"																												
FCGR3A	"CD16, CD16a, FCG3, FcgammaRIIIa, FCGR3, FcGRIIIA"	ENSG00000203747	"Fc gamma receptor IIIa"	P08637	1	161541759-161550968	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 202.0;lymphoid tissue: 294.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 240.5;Kupffer cells: 656.2;Macrophages: 303.8;monocytes: 1050.2;NK-cells: 597.4"	"Group enriched"	"Detected in some"	73	"central nervous system macrophage: 8.0;leukocyte: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"intermediate monocyte: 1806.3;non-classical monocyte: 4107.1"	"Lineage enriched"	"Detected in all"	6	"monocytes: 4107.1"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"									"CAB032435, HPA055431"	Supported				"Secreted to blood"	Receptor	NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	4			"CAB032435: AB_626925, HPA055431: AB_2682815"	"unprognostic (1.04e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.66e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.14e-2)"
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086905-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 80.5;lung: 63.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 61.1;Enteroendocrine cells: 17.0;Hepatocytes: 23.4;Proximal tubular cells: 17.0;Undifferentiated cells: 32.0"	"Cell type enriched"	"Detected in some"	7	"fibroblast: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"liver cancer: 117.0"	"Liver - Hepatocytes, Lung - Fibroblast_1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	Receptor	NA	NA		4600000		"Cluster 47: Spleen - Immune response"	"Cluster 15: Non-specific - Transcription"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 2: Skeletal myocytes - Muscle contraction"	28			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (1.02e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.72e-1)"		"unprognostic (2.78e-3)"		"unprognostic (9.14e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.08e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.54e-1)"		"unprognostic (3.08e-1)"
FMO2		ENSG00000094963	"Flavin containing dimethylaniline monoxygenase 2"	Q99518	1	171185249-171212686	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 67.2;lung: 91.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 188.1;Alveolar cells type 1: 115.7;Breast myoepithelial cells: 84.3;Club cells: 74.4;Endothelial cells: 92.7;Fibroblasts: 115.3;Mucus glandular cells: 80.6;Salivary duct cells: 108.3"	"Cell type enriched"	"Detected in some"	16	"fibroblast: 361.2"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 11.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Lung - Fibroblast_1, Pancreas - Fibroblasts, Spleen - Fibroblast_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028261	Approved						NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"				"HPA028261: AB_10601012"		"unprognostic (3.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"					"unprognostic (4.92e-2)"		"unprognostic (2.14e-5)"	"unprognostic (4.06e-3)"	"unprognostic (1.12e-2)"			"unprognostic (4.78e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.94e-4)"	"unprognostic (7.73e-4)"	"unprognostic (2.59e-1)"	"unprognostic (9.61e-2)"	"unprognostic (3.82e-1)"				"unprognostic (7.84e-4)"			
FPR3	"FMLPY, FPRH1, FPRL2, RMLP-R-I"	ENSG00000187474	"Formyl peptide receptor 3"	P25089	19	51795157-51826190	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.3"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 63.3;Kupffer cells: 91.7;Langerhans cells: 297.8;Macrophages: 97.4"	"Cell type enriched"	"Detected in some"	5	"central nervous system macrophage: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	20	"classical monocyte: 2.3;intermediate monocyte: 6.7;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	46	"dendritic cells: 2.4;monocytes: 6.7"	"Cancer enriched"	"Detected in some"	5	"Gastric cancer: 6.7"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"																NA	NA			"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 11: Liver - Plasma proteins"	"Cluster 12: Non-specific - Vasculature"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 58: Macrophages - Innate immune response"					"unprognostic (1.34e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.54e-2)"	"unprognostic (9.18e-3)"	"unprognostic (4.23e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (6.28e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.63e-4)"	"unprognostic (2.63e-1)"	"unprognostic (2.05e-2)"
GALNT5	GalNAc-T5	ENSG00000136542	"Polypeptide N-acetylgalactosaminyltransferase 5"	Q7Z7M9	2	157257705-157318491	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.1;lung: 9.9;stomach 1: 12.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 134.2;Alveolar cells type 2: 37.4;Distal enterocytes: 60.2;Intestinal goblet cells: 150.5;Salivary duct cells: 72.7"	"Group enriched"	"Detected in some"	11	"choroid plexus epithelial cell: 69.9;upper rhombic lip: 75.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"cerebellum: 8.9;choroid plexus: 11.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 40.6"	"Colon - Colon enterocytes, Heart muscle - Fibroblasts, Skeletal muscle - Fibroblasts, Stomach - Gastric mucous cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA008963, HPA009035"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles,Cytosol"			NA	NA		1700000		"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 5: Non-specific - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 16: Intestinal goblet cells - Mucin production"	9	"Golgi apparatus, Cytosol"	"Nucleoli, Vesicles"	"HPA008963: AB_1078942, HPA009035: AB_1078943"	"unprognostic (2.43e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.61e-2)"		"unprognostic (6.91e-4)"	"unprognostic (3.52e-2)"			"unprognostic (5.73e-2)"	"unprognostic (9.02e-3)"			"unprognostic (1.77e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.57e-2)"			"unprognostic (1.19e-2)"	"unprognostic (2.23e-3)"		"unprognostic (1.38e-2)"	"unprognostic (1.79e-2)"		"unprognostic (4.88e-2)"			
GDF10	BMP-3b	ENSG00000266524	"Growth differentiation factor 10"	P55107	10	47300197-47313577	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 19.0;retina: 17.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 19.0;Cone photoreceptor cells: 10.2;Fibroblasts: 25.6;Horizontal cells: 7.6;Lymphatic endothelial cells: 8.4;Rod photoreceptor cells: 27.4"	"Cell type enhanced"	"Detected in many"		"bergmann glia: 44.6;midbrain-derived inhibitory: 15.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	24	"Bone cancer: 13.5"	"Breast - Fibroblasts, Skin - Fibroblast_2, Testis - Sertoli cells, Thyroid gland - Fibroblasts"	"Region enriched"	"Detected in all"	8	"cerebellum: 42.5"	"Low region specificity"	"Detected in all"			HPA015498	Uncertain		Approved	Vesicles	"Secreted in other tissues"	Cytokine	NA	NA				"Cluster 39: Retina & Testis - Cilium"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 53: Fibroblasts - ECM organization"		Vesicles		"HPA015498: AB_1849584"			"unprognostic (1.18e-1)"													"unprognostic (1.33e-4)"	"unprognostic (1.71e-2)"								"unprognostic (3.68e-1)"				"unprognostic (2.40e-1)"	"unprognostic (1.66e-3)"	
GP9	"CD42a, GPIX"	ENSG00000169704	"Glycoprotein IX platelet"	P14770	3	129060779-129062406	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.0;lung: 3.1;lymphoid tissue: 8.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 8.3;Late spermatids: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"choroid plexus: 1.3"	"Group enriched"	"Detected in some"	7	"basophil: 29.4;neutrophil: 14.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 29.4"	"Cancer enriched"	"Detected in single"	97	"Leukemia: 9.6"	"Spleen - Platelets, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063182	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA		4300000	"Cluster 4: Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 57: Platelets - Hemostasis"	57	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA063182: AB_2684956"			"unprognostic (1.10e-1)"																												
GPRC5A	"PEIG-1, RAI3, RAIG1, TIG1"	ENSG00000013588	"G protein-coupled receptor class C group 5 member A"	Q8NFJ5	12	12891559-12917937	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 195.6;urinary bladder: 125.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 1849.7;Alveolar cells type 2: 586.6;Club cells: 431.6;Distal enterocytes: 306.0"	"Cell type enhanced"	"Detected in some"		"endothelial cell: 18.0;fibroblast: 11.7;vascular associated smooth muscle cell: 53.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"basophil: 3.6"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 3.6"	"Low cancer specificity"	"Detected in many"			"Lung - Alveolar cells type 1, Prostate - Urothelial cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA007928, HPA046526"	Enhanced		Enhanced	"Vesicles,Plasma membrane"			NA	Yes				"Cluster 57: Lung - Lung function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 72: Alveolar cells - Lung function"	6	"Vesicles, Plasma membrane"		"HPA007928: AB_1849318, HPA046526: AB_2679685"	"unprognostic (2.66e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.19e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.83e-10)"	"unprognostic (1.65e-3)"	"unprognostic (4.02e-5)"		"unprognostic (2.24e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.56e-4)"	"unprognostic (1.04e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.83e-1)"	"unprognostic (9.31e-5)"	"unprognostic (1.72e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.36e-2)"
GPRIN2	"KIAA0514, MGC15171"	ENSG00000204175	"G protein regulated inducer of neurite outgrowth 2"	O60269	10	46541736-46556658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 10.2;skin 1: 16.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.7;Distal enterocytes: 17.6;Intestinal goblet cells: 47.8;Late spermatids: 20.3;Proximal enterocytes: 19.7"	"Cell type enhanced"	"Detected in many"		"deep-layer near-projecting: 6.0;lower rhombic lip: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 6.0;prostate cancer: 8.1"	"Adipose visceral - Mesothelial cells, Colon - Colon enterocytes, Lung - Alveolar cells type 2, Pancreas - Ductal cells, Skin - Keratinocyte (granular), Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"							"HPA038129, HPA070760"	Approved		Approved	"Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle"			Yes	NA				"Cluster 45: Intestine - Digestion"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 16: Intestinal goblet cells - Mucin production"	7	"Plasma membrane, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA038129: AB_2675846, HPA070760: "	"unprognostic (4.92e-3)"	"unprognostic (3.13e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-1)"			"unprognostic (6.85e-4)"		"unprognostic (2.93e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.39e-3)"			"unprognostic (1.33e-3)"	"unprognostic (4.70e-2)"	"unprognostic (8.45e-2)"		"unprognostic (7.22e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.07e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.04e-3)"		"unprognostic (3.74e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.71e-2)"	
GRP		ENSG00000134443	"Gastrin releasing peptide"	P07492	18	59220158-59230774	"Predicted intracellular proteins, Predicted secreted proteins"	"Mast cell degranulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.7;lung: 8.7;stomach 1: 11.9"	"Group enriched"	"Detected in some"	4	"Breast myoepithelial cells: 32.1;Early spermatids: 19.5;Late spermatids: 12.1;Smooth muscle cells: 9.6"	"Group enriched"	"Detected in many"	4	"endothelial cell: 40.7;hippocampal dentate gyrus: 75.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"midbrain: 56.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	26	"Bone cancer: 180.1;lung cancer: 47.9;thyroid cancer: 71.6"	"Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Parafollicular cells"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 33.2"						"Secreted in other tissues"	Other	NA	NA				"Cluster 32: Endocrine & Neural - Unknown function"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 48: Smooth muscle cells - Signal transduction"	1				"unprognostic (4.06e-1)"	"unprognostic (8.71e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.94e-4)"	"unprognostic (3.35e-2)"			"unprognostic (1.55e-2)"							"unprognostic (1.87e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.56e-2)"			"unprognostic (5.84e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.15e-3)"
HHIP	"FLJ20992, HIP"	ENSG00000164161	"Hedgehog interacting protein"	Q96QV1	4	144646156-144745271	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.1;lung: 15.7"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 2: 291.5;Leydig cells: 142.1;Oligodendrocytes: 384.5"	"Cell type enhanced"	"Detected in all"		"committed oligodendrocyte precursor: 281.6;oligodendrocyte: 731.0"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"Rhabdoid: 115.1"	"Adipose visceral - Mesothelial cells, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Lung - Alveolar cells type 2, Minor Salivary Gland - Fibroblasts, Skeletal muscle - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012616	Uncertain		Uncertain	Nucleoplasm	"Secreted in other tissues"	"No annotated function"	NA	NA		320000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 11: White matter - Signal transduction"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 72: Alveolar cells - Lung function"	1	Nucleoplasm		"HPA012616: AB_1850687"			"unprognostic (1.93e-2)"			"unprognostic (2.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.38e-1)"				"unprognostic (3.74e-2)"				"unprognostic (8.92e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.68e-2)"			"unprognostic (2.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.83e-2)"			"unprognostic (1.17e-1)"		"unprognostic (2.01e-1)"
HLA-DPA1	HLA-DP1A	ENSG00000231389	"Major histocompatibility complex, class II, DP alpha 1"	P20036	6	33064569-33080775	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 531.2;lymphoid tissue: 593.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 2146.0;dendritic cells: 1539.0;Langerhans cells: 8980.3;Macrophages: 2779.5;monocytes: 2073.0;Schwann cells: 6090.4"	"Cell type enriched"	"Detected in many"	4	"central nervous system macrophage: 359.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 473.9;intermediate monocyte: 1069.2;memory B-cell: 818.4;myeloid DC: 1726.4;naive B-cell: 800.1;non-classical monocyte: 725.0;plasmacytoid DC: 542.7"	"Group enriched"	"Detected in all"	9	"B-cells: 818.4;dendritic cells: 1726.4;monocytes: 1069.2"	"Cancer enhanced"	"Detected in many"		"lymphoma: 299.8;Myeloma: 115.4;skin cancer: 120.3"	"Adipose visceral - T-cells, Testis - Macrophages, Thyroid gland - T-cells"									HPA017967	Enhanced		Supported	Vesicles			NA	NA		270000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 22: Non-specific - Mixed function"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	14	Vesicles		"HPA017967: AB_1853929"	"unprognostic (1.91e-1)"	"unprognostic (1.28e-1)"		"unprognostic (5.19e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-4)"	"unprognostic (1.12e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.87e-1)"		"unprognostic (2.02e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.06e-2)"
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075990-33089696	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 270.1;lymphoid tissue: 399.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 2780.2;Langerhans cells: 13649.0;Macrophages: 2457.5;Schwann cells: 5697.0"	"Group enriched"	"Detected in many"	5	"central nervous system macrophage: 263.9;leukocyte: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 286.9"	"Group enriched"	"Detected in all"	10	"B-cells: 229.7;dendritic cells: 286.9;monocytes: 138.3"	"Group enriched"	"Detected in some"	6	"Leukemia: 4.4;lymphoma: 14.2;skin cancer: 3.7"	"Adipose visceral - T-cells, Testis - Macrophages, Thyroid gland - T-cells"									"HPA011078, HPA058509"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"			NA	NA		610000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 25: Non-specific - Transcription"	"Cluster 55: Lymphoma - Immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	2	"Cell Junctions"	Nucleoplasm	"HPA011078: AB_1079378, HPA058509: AB_2683737"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"		"unprognostic (6.37e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.31e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.90e-4)"		"unprognostic (2.10e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.52e-2)"
HLA-DQA1	"CELIAC1, HLA-DQA"	ENSG00000196735	"Major histocompatibility complex, class II, DQ alpha 1"	P01909	6	32628179-32647062	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 323.1;lymphoid tissue: 327.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 1044.9;dendritic cells: 627.3;Langerhans cells: 4525.8;Macrophages: 865.2;Schwann cells: 1859.3"	"Cell type enriched"	"Detected in some"	4	"central nervous system macrophage: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 667.5"	"Group enriched"	"Detected in all"	19	"B-cells: 288.5;dendritic cells: 667.5;monocytes: 257.5"	"Cancer enhanced"	"Detected in some"		"lymphoma: 195.2;skin cancer: 49.0"	"Adipose visceral - T-cells, Heart muscle - T-cells, Skin - Langerhans cells, Thyroid gland - T-cells"									HPA012315	Enhanced						NA	NA		350000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 21: Non-specific - Metabolism"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	3			"HPA012315: AB_1853930"	"unprognostic (7.81e-2)"	"unprognostic (3.14e-2)"		"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.87e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.85e-2)"		"unprognostic (4.70e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.04e-2)"
HLA-DQA2	HLA-DXA	ENSG00000237541	"Major histocompatibility complex, class II, DQ alpha 2"	P01906	6	32741391-32747198	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.2;lymphoid tissue: 26.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 189.6;dendritic cells: 339.0;Langerhans cells: 688.5;Macrophages: 240.8;Schwann cells: 384.4"	"Cell type enriched"	"Detected in single"	10	"central nervous system macrophage: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Skin - Langerhans cells"																NA	NA				"Cluster 47: Spleen - Immune response"		"Cluster 27: Breast cancer - Unknown function"	"Cluster 28: Dendritic cells - Antigen presentation"	1											"unprognostic (9.28e-2)"													"unprognostic (1.58e-1)"		"unprognostic (2.70e-1)"								
HLA-DQB1	"CELIAC1, HLA-DQB, IDDM1"	ENSG00000179344	"Major histocompatibility complex, class II, DQ beta 1"		6	32659467-32668383	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"lung: 177.8;lymphoid tissue: 302.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 1196.0;dendritic cells: 876.0;Langerhans cells: 4977.2;Macrophages: 1143.6;Schwann cells: 2128.2"	"Group enriched"	"Detected in many"	8	"central nervous system macrophage: 120.7;leukocyte: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 149.8;intermediate monocyte: 141.0;memory B-cell: 161.5;myeloid DC: 392.1;naive B-cell: 171.4;plasmacytoid DC: 114.8"	"Group enriched"	"Detected in all"	6	"B-cells: 171.4;dendritic cells: 392.1;monocytes: 149.8"	"Cancer enhanced"	"Detected in many"		"lymphoma: 101.7;skin cancer: 45.4"	"Thyroid gland - T-cells"					"Low region specificity"	"Detected in all"			HPA013667	Enhanced		Supported	"Golgi apparatus,Rods & Rings"			NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 22: Non-specific - Mixed function"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	1	"Rods & Rings"	"Golgi apparatus"	"HPA013667: AB_1853932"	"unprognostic (3.32e-2)"	"unprognostic (1.87e-3)"		"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.31e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.47e-2)"		"unprognostic (9.39e-4)"	"unprognostic (1.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.94e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.67e-3)"
HLA-DRA	HLA-DRA1	ENSG00000204287	"Major histocompatibility complex, class II, DR alpha"	P01903	6	32439878-32445046	"Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 911.4;lymphoid tissue: 1247.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 6087.4;Langerhans cells: 28943.5;Macrophages: 6606.3;monocytes: 4953.5;Schwann cells: 10203.4"	"Cell type enriched"	"Detected in many"	5	"central nervous system macrophage: 734.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 209.9;intermediate monocyte: 408.5;memory B-cell: 380.1;naive B-cell: 419.5;non-classical monocyte: 255.4;plasmacytoid DC: 231.2"	"Group enriched"	"Detected in all"	5	"B-cells: 419.5;dendritic cells: 231.2;monocytes: 408.5"	"Group enriched"	"Detected in many"	14	"Leukemia: 103.6;lymphoma: 328.5;Myeloma: 126.2;skin cancer: 86.9"	"Adipose visceral - T-cells, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002798, CAB015402, HPA050162, HPA053176"	Enhanced						NA	NA		1600000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	63			"CAB002798: , CAB015402: AB_629980, HPA050162: AB_2681037, HPA053176: AB_2682070"	"unprognostic (8.95e-2)"	"unprognostic (2.59e-4)"		"unprognostic (3.29e-1)"	"unprognostic (4.88e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.35e-2)"		"unprognostic (4.69e-3)"	"unprognostic (3.36e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.19e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.92e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.02e-2)"	"unprognostic (8.48e-3)"
HLA-DRB1	HLA-DR1B	ENSG00000196126	"Major histocompatibility complex, class II, DR beta 1"	P01911	6	32577902-32589848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 563.4;lymphoid tissue: 597.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 2371.0;Langerhans cells: 11433.9;Macrophages: 3225.5;Schwann cells: 4924.9"	"Cell type enriched"	"Detected in many"	4	"central nervous system macrophage: 523.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 655.8"	"Group enriched"	"Detected in all"	9	"B-cells: 209.8;dendritic cells: 655.8;monocytes: 313.1"	"Cancer enhanced"	"Detected in many"		"lymphoma: 168.4;skin cancer: 100.3"	"Thyroid gland - T-cells"									"CAB015400, CAB034021, HPA043151"	Enhanced						NA	NA		1400000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 21: Non-specific - Metabolism"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	59			"CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342"	"unprognostic (6.86e-2)"	"unprognostic (2.45e-2)"		"unprognostic (2.33e-1)"	"unprognostic (3.50e-1)"	"unprognostic (6.89e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.54e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.94e-2)"		"unprognostic (1.01e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.43e-1)"	"unprognostic (7.15e-2)"
HLA-DRB5		ENSG00000198502	"Major histocompatibility complex, class II, DR beta 5"	Q30154	6	32517353-32530287	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 344.6;lymphoid tissue: 413.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 669.7;Langerhans cells: 2064.3;Macrophages: 825.9;Proximal enterocytes: 707.4;Schwann cells: 1302.8"	"Cell type enriched"	"Detected in some"	4	"central nervous system macrophage: 203.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 62.3"	"Group enriched"	"Detected in all"	10	"B-cells: 26.2;dendritic cells: 62.3;monocytes: 35.2"	"Cancer enhanced"	"Detected in many"		"lymphoma: 116.2;skin cancer: 63.3"										HPA043151	Supported						NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	11			"HPA043151: AB_2678342"	"unprognostic (7.35e-2)"	"unprognostic (1.93e-3)"		"unprognostic (1.54e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.05e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.51e-3)"	"unprognostic (6.34e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.46e-2)"		"unprognostic (1.21e-2)"	"unprognostic (4.39e-1)"	"unprognostic (9.37e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.08e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.50e-2)"
HMCN1	"ARMD1, FBLN6, FIBL-6, FIBL6"	ENSG00000143341	"Hemicentin 1"	Q96RW7	1	185734391-186190949	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Cell division, Sensory transduction, Vision"		"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 19.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 37.7;Endothelial cells: 22.1;Fibroblasts: 22.5;Lymphatic endothelial cells: 35.5;Microglial cells: 42.9;Oocytes: 16.9;Salivary duct cells: 17.1;Schwann cells: 22.2"	"Cell type enriched"	"Detected in many"	5	"endothelial cell: 397.0"	"Cancer enriched"	"Detected in many"	7	"Skin Cuteneous Melanoma (TCGA): 62.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Bone cancer: 64.8;skin cancer: 50.9"	"Breast - Fibroblasts, Colon - Enteric glia cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Fibroblasts"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"olfactory bulb: 13.2"	"HPA008220, HPA051677"	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Secreted to extracellular matrix"	Other	NA	NA		9800000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 53: Fibroblasts - ECM organization"	1	"Golgi apparatus, Cytosol"		"HPA008220: , HPA051677: AB_2681572"	"unprognostic (1.46e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.07e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.34e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.15e-9)"	"unprognostic (5.77e-4)"		"unprognostic (2.29e-1)"	"unprognostic (6.80e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.41e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.83e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.06e-2)"
HSPA6	HSP70B'	ENSG00000173110	"Heat shock protein family A (Hsp70) member 6"	P17066	1	161524540-161526894	"Plasma proteins, Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 234.5;Granulosa cells: 404.1;Langerhans cells: 572.4;Ovarian stromal cells: 246.5"	"Group enriched"	"Detected in some"	5	"central nervous system macrophage: 20.5;endothelial cell: 8.6;leukocyte: 23.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 125.6"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 319.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 319.0"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Macrophages, Spleen - Neutrophils"					"Low region specificity"	"Detected in all"			"CAB017452, HPA028549, HPA052504"	Approved		Approved	"Vesicles,Perinuclear theca,Calyx,Flagellar centriole,Annulus"			NA	NA		39000000	"Cluster 28: Neutrophils - Unknown function"	"Cluster 34: Non-specific - Mixed function"	"Cluster 12: Non-specific - Vasculature"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 80: Non-specific - Transcription"	48	"Vesicles, Flagellar centriole, Annulus"	"Perinuclear theca, Calyx"	"CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854"	"unprognostic (9.28e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.99e-1)"	"unprognostic (4.39e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.99e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.48e-4)"	"unprognostic (9.89e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.30e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-4)"	"unprognostic (9.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.59e-4)"	"unprognostic (5.18e-2)"
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10271093-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 212.5;urinary bladder: 207.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 518.0;Alveolar cells type 2: 276.8;Endothelial cells: 318.0;Langerhans cells: 216.7;Macrophages: 230.4;monocytes: 345.6"	"Cell type enriched"	"Detected in some"	8	"endothelial cell: 105.4"	"Cancer enhanced"	"Detected in all"		"Lung Adenocarcinoma (TCGA): 198.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002126, CAB002142, HPA004877"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"			NA	NA		1200000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	35	"Plasma membrane"	"Vesicles, Cytosol"	"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"unprognostic (6.29e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.90e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.44e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.73e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.83e-2)"
IFI30	"GILT, IFI-30, IP-30, IP30, MGC32056"	ENSG00000216490	"IFI30 lysosomal thiol reductase"	P13284	19	18173162-18178117	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 554.6;lymphoid tissue: 688.9"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 205.3;Kupffer cells: 132.8;Langerhans cells: 136.5;Macrophages: 255.7;monocytes: 168.5"	"Group enriched"	"Detected in some"	5	"central nervous system macrophage: 45.3;leukocyte: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 9529.3;eosinophil: 3901.6;intermediate monocyte: 14264.3;myeloid DC: 5706.8;non-classical monocyte: 9916.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 5706.8;granulocytes: 3901.6;monocytes: 14264.3"	"Cancer enhanced"	"Detected in all"		"lymphoma: 572.2"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Lung - Macrophages, Pituitary gland - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026650	Enhanced		Supported	Vesicles,Cytosol	"Intracellular and membrane"	Immunity	NA	NA		140000	"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 55: Lymphoma - Immune response"	"Cluster 29: Monocytes - Innate immune response"	20	"Vesicles, Cytosol"		"HPA026650: AB_10602237"	"unprognostic (7.32e-2)"	"unprognostic (7.00e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.09e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.42e-3)"		"unprognostic (1.15e-1)"	"unprognostic (6.73e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.23e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.38e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.05e-3)"	"unprognostic (6.43e-2)"	"unprognostic (5.80e-2)"
IGKV1D-12		ENSG00000278857	"Immunoglobulin kappa variable 1D-12"	P01611	2	90159840-90160335	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.8;lung: 11.2;lymphoid tissue: 27.3"	"Cell type enriched"	"Detected in single"	166	"Plasma cells: 113.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Rectum Adenocarcinoma (TCGA): 22.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"memory B-cell: 13.0;naive B-cell: 12.3"	"Lineage enriched"	"Detected in single"	34	"B-cells: 13.0"	"Not detected"	"Not detected"			"Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"									HPA048721	Approved				"Immunoglobulin genes"	Immunity	NA	NA		17000000000	"Cluster 23: B-cells - Immunoglobulins"			"Cluster 55: Lymphoma - Immune response"	"Cluster 77: Plasma cells - Protein processing"				"HPA048721: "		"unprognostic (9.24e-3)"		"unprognostic (4.05e-1)"		"unprognostic (1.61e-1)"			"unprognostic (1.01e-3)"							"unprognostic (1.12e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.80e-1)"			"unprognostic (3.94e-1)"			"unprognostic (4.10e-1)"	"unprognostic (1.53e-2)"		"unprognostic (7.58e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.78e-1)"	
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398777	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 23.5;lymphoid tissue: 18.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 37.8;dendritic cells: 55.4;granulocytes: 126.7;Langerhans cells: 32.8;NK-cells: 47.0;Schwann cells: 26.2;T-cells: 36.2"	"Group enriched"	"Detected in some"	6	"endothelial cell: 71.4;leukocyte: 89.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 45.8"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Liver - Neutrophils, Spleen - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007615	Approved		Approved	Mitochondria			Yes	No			"Cluster 15: NK-cells - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 55: Lymphoma - Immune response"	"Cluster 74: Neutrophils - Degranulation"	1	Mitochondria		"HPA007615: AB_1851675"			"unprognostic (4.22e-4)"			"unprognostic (2.68e-1)"					"unprognostic (5.16e-7)"	"unprognostic (5.56e-2)"	"unprognostic (3.99e-3)"		"unprognostic (5.38e-2)"		"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.46e-3)"		"unprognostic (4.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.88e-1)"			"unprognostic (1.04e-2)"		"unprognostic (1.28e-1)"		"unprognostic (3.53e-2)"	
INMT		ENSG00000241644	"Indolethylamine N-methyltransferase"	O95050	7	30697985-30757602	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Detoxification	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 199.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 88.0;Leydig cells: 277.1;Mesothelial cells: 163.1;Peritubular cells: 439.3;Smooth muscle cells: 89.1"	"Cell type enhanced"	"Detected in some"		"choroid plexus epithelial cell: 20.7;endothelial cell: 7.3"	"Cancer enhanced"	"Detected in many"		"Thyroid Carcinoma (TCGA): 33.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in single"			"Adipose visceral - Mesothelial cells, Adrenal gland - Fibroblasts, Minor Salivary Gland - Fibroblasts, Pituitary gland - Fibroblasts, Prostate - Smooth muscle cells, Spleen - Fibroblast_2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"spinal cord: 35.6"	HPA061343			Approved	"Golgi apparatus,Vesicles"			NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 31: Non-specific - Transcription"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	2	"Golgi apparatus, Vesicles"		"HPA061343: AB_2684483"	"unprognostic (1.26e-2)"	"unprognostic (5.75e-2)"	"unprognostic (5.20e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.52e-4)"	"unprognostic (2.61e-1)"	"unprognostic (1.80e-5)"	"unprognostic (1.18e-2)"	"unprognostic (4.56e-4)"	"unprognostic (1.36e-3)"	"unprognostic (8.39e-6)"	"unprognostic (6.75e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.75e-5)"	"unprognostic (6.31e-2)"	"unprognostic (6.04e-2)"	"unprognostic (5.50e-2)"		"unprognostic (4.78e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.36e-2)"
ITGAE	"CD103, HUMINAE"	ENSG00000083457	"Integrin subunit alpha E"	P38570	17	3714628-3801188	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.4;intestine: 5.7;lung: 6.4"	"Low cell type specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"leukocyte: 73.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.7"	"Group enriched"	"Detected in some"	11	"Leukemia: 1.7;lymphoma: 2.5"	"Spleen - B-cells (Spleen), Testis - Early spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036313, HPA052147"	Enhanced						NA	NA		36000	"Cluster 27: T-cells - Unknown function"	"Cluster 25: Small intestine - Absorption"	"Cluster 33: Neurons - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 7: T-cells - T-cell receptor"				"HPA036313: AB_10795355, HPA052147: "	"unprognostic (1.73e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.22e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.18e-2)"	"unprognostic (5.93e-2)"		"unprognostic (1.56e-2)"	"unprognostic (2.15e-3)"						"unprognostic (6.16e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.70e-1)"		"unprognostic (1.95e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.23e-2)"			"unprognostic (6.09e-2)"		"unprognostic (1.04e-1)"	"unprognostic (4.75e-2)"		"unprognostic (2.95e-1)"
ITGAX	CD11C	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382999	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.5;lung: 56.3;lymphoid tissue: 65.9"	"Cell type enhanced"	"Detected in some"		"granulocytes: 76.6;Hofbauer cells: 70.9;Langerhans cells: 141.8;Macrophages: 125.7;monocytes: 419.8;NK-cells: 63.4"	"Cell type enriched"	"Detected in some"	5	"central nervous system macrophage: 457.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.3"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Leukemia: 7.5;lymphoma: 7.8"	"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Kidney - T-cells, Liver - Neutrophils, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Thyroid gland - T-cells"	"Not detected"	"Not detected"							"CAB004458, HPA004723, CAB072871, CAB080214"	Enhanced		Supported	"Vesicles,Plasma membrane"			NA	NA		45000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	2	"Vesicles, Plasma membrane"		"CAB004458: AB_626859, CAB072871: AB_2665723, CAB080214: , HPA004723: AB_1846231"	"unprognostic (1.92e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.82e-2)"	"unprognostic (8.17e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.17e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.77e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.81e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.12e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.46e-4)"	"unprognostic (4.26e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193725-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 41.9;lymphoid tissue: 66.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 271.2;Hofbauer cells: 104.0;Kupffer cells: 116.2;Langerhans cells: 328.1;Macrophages: 141.9;monocytes: 73.9;T-cells: 86.4"	"Cell type enriched"	"Detected in some"	7	"leukocyte: 106.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 3539.1"	"Group enriched"	"Detected in all"	5	"dendritic cells: 1018.9;granulocytes: 3539.1;monocytes: 1025.5"	"Group enriched"	"Detected in some"	11	"Leukemia: 7.5;lymphoma: 18.0"	"Adipose subcutaneous - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Prostate - T-cells, Spleen - Neutrophils, Stomach - T-cells, Testis - Macrophages, Thyroid gland - T-cells"					"Region enriched"	"Detected in many"	11	"cerebellum: 63.6"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"			NA	NA		930000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 25: Non-specific - Transcription"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 58: Macrophages - Innate immune response"		"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (7.91e-3)"	"unprognostic (3.03e-2)"		"unprognostic (2.59e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.47e-1)"	"unprognostic (3.75e-5)"		"unprognostic (4.74e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.36e-1)"		"unprognostic (1.14e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.15e-1)"	"unprognostic (4.76e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.44e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.14e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.81e-1)"
KCNA3	"HLK3, HPCN3, Kv1.3, MK3"	ENSG00000177272	"Potassium voltage-gated channel subfamily A member 3"	P22001	1	110653560-110674940	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.9;lung: 2.1;lymphoid tissue: 2.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 12.7;Inhibitory neurons: 57.6;Plasma cells: 49.8;T-cells: 24.0"	"Cell type enhanced"	"Detected in some"		"leukocyte: 6.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.6;MAIT T-cell: 5.3;memory CD4 T-cell: 8.5;memory CD8 T-cell: 9.6;naive B-cell: 2.6;naive CD4 T-cell: 5.0;naive CD8 T-cell: 4.6;T-reg: 8.5"	"Group enriched"	"Detected in many"	6	"B-cells: 2.6;T-cells: 9.6"	"Cancer enriched"	"Detected in some"	5	"Myeloma: 5.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Minor Salivary Gland - Plasma cells, Skin - T-cells, Testis - Spermatocytes, Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016625	Approved						NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 1: Neurons - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 7: T-cells - T-cell receptor"	102			"HPA016625: AB_2669407"			"unprognostic (1.37e-1)"			"unprognostic (1.78e-1)"		"unprognostic (8.22e-2)"				"unprognostic (2.23e-2)"				"unprognostic (1.01e-2)"	"unprognostic (1.33e-3)"		"unprognostic (4.17e-1)"							"unprognostic (6.85e-2)"		"unprognostic (3.67e-2)"			
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314461	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 7.5;thyroid gland: 6.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 35.1;Microglial cells: 17.0;Pancreatic endocrine cells: 18.7;Smooth muscle cells: 6.6"	"Cell type enriched"	"Detected in some"	21	"fibroblast: 115.2"	"Cancer enhanced"	"Detected in some"		"Thyroid Carcinoma (TCGA): 3.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 63.9"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 63.9"	"Cancer enhanced"	"Detected in some"		"Leukemia: 5.6;thyroid cancer: 3.4"	"Colon - Colon enteroendocrine cells"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 28: Dendritic cells - Antigen presentation"		"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"		"unprognostic (1.11e-2)"	"unprognostic (2.38e-1)"								"unprognostic (1.19e-4)"	"unprognostic (1.23e-2)"				"unprognostic (4.67e-5)"	"unprognostic (2.58e-1)"		"unprognostic (2.08e-2)"			"unprognostic (1.64e-2)"								"unprognostic (2.00e-1)"	
LAIR1	"CD305, LAIR-1"	ENSG00000167613	"Leukocyte associated immunoglobulin like receptor 1"	Q6GTX8	19	54351384-54370558	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.3;lymphoid tissue: 45.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 144.7;granulocytes: 80.6;Hofbauer cells: 188.9;Kupffer cells: 90.9;Macrophages: 126.2;monocytes: 115.3;NK-cells: 62.9"	"Group enriched"	"Detected in some"	33	"central nervous system macrophage: 108.8;leukocyte: 39.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Leukemia: 4.3;Myeloma: 2.3"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"							HPA011155	Enhanced		Supported	"Plasma membrane"			NA	NA		240000	"Cluster 29: Non-specific - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	6	"Plasma membrane"		"HPA011155: AB_1852685"	"unprognostic (2.16e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.05e-3)"		"unprognostic (8.38e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-1)"			"unprognostic (1.37e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.07e-2)"		"unprognostic (1.04e-1)"	"unprognostic (3.14e-2)"			"unprognostic (1.63e-1)"		"unprognostic (1.84e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.03e-1)"			"unprognostic (3.49e-2)"	"unprognostic (8.76e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.05e-2)"		"unprognostic (2.90e-2)"
LILRA6	"CD85b, ILT8, LILRB6"	ENSG00000244482	"Leukocyte immunoglobulin like receptor A6"	Q6PI73	19	54236592-54242791	"Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 8.7;lymphoid tissue: 16.5"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 19.9;Kupffer cells: 59.9;Macrophages: 28.2;monocytes: 23.2"	"Cell type enriched"	"Detected in some"	6	"leukocyte: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 3.5;intermediate monocyte: 3.9;neutrophil: 8.4"	"Group enriched"	"Detected in many"	27	"granulocytes: 8.4;monocytes: 3.9"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Breast - Macrophages, Kidney - Macrophages, Lung - Neutrophil_2, Skeletal muscle - Macrophages, Spleen - Neutrophils"									HPA026985			Approved	"Plasma membrane,Cytosol"			NA	NA		13000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 47: Spleen - Immune response"		"Cluster 55: Lymphoma - Immune response"	"Cluster 29: Monocytes - Innate immune response"		"Plasma membrane"	Cytosol	"HPA026985: "			"unprognostic (1.84e-1)"																		"unprognostic (9.13e-2)"		"unprognostic (1.56e-1)"								
LILRB3	"CD85a, HL9, ILT5, LIR-3, LIR3, PIR-B, PIRB"	ENSG00000204577	"Leukocyte immunoglobulin like receptor B3"	O75022	19	54216278-54223506	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 26.2;lymphoid tissue: 48.7"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 87.3;Kupffer cells: 93.5;Macrophages: 79.5;monocytes: 166.3"	"Cell type enriched"	"Detected in some"	5	"leukocyte: 26.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 43.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 43.2;monocytes: 15.3"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Breast - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2, Pituitary gland - Macrophages, Skin - Macrophages, Spleen - Neutrophils, Thyroid gland - Neutrophils"									HPA026985			Approved	"Plasma membrane,Cytosol"			NA	NA		10000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 47: Spleen - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 55: Lymphoma - Immune response"	"Cluster 74: Neutrophils - Degranulation"		"Plasma membrane"	Cytosol	"HPA026985: "			"unprognostic (1.04e-2)"			"unprognostic (4.93e-3)"									"unprognostic (9.49e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.65e-4)"	"unprognostic (1.00e-1)"		"unprognostic (6.25e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.16e-2)"			"unprognostic (2.63e-1)"		"unprognostic (1.18e-2)"			
LILRB4	"CD85k, HM18, ILT3, LIR-5, LIR5"	ENSG00000186818	"Leukocyte immunoglobulin like receptor B4"	Q8NHJ6	19	54643889-54670359	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.7;lung: 13.3;lymphoid tissue: 18.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 185.8;Hofbauer cells: 137.3;Kupffer cells: 104.7;Macrophages: 86.8;Plasma cells: 42.4"	"Cell type enriched"	"Detected in some"	20	"central nervous system macrophage: 157.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 37.8"	"Group enriched"	"Detected in many"	43	"dendritic cells: 37.8;monocytes: 11.0"	"Cancer enriched"	"Detected in some"	5	"Myeloma: 28.0"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Skeletal muscle - Macrophages, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"									HPA052807	Approved						NA	NA		190000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 58: Macrophages - Innate immune response"	3			"HPA052807: AB_2681958"		"unprognostic (1.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.89e-2)"		"unprognostic (1.35e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.34e-1)"		"unprognostic (4.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.50e-1)"		"unprognostic (4.24e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.52e-1)"
LPCAT1	"AGPAT10, AGPAT9, AYTL2, FLJ12443, LPLAT8"	ENSG00000153395	"Lysophosphatidylcholine acyltransferase 1"	Q8NF37	5	1456480-1523962	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 55.6;lymphoid tissue: 37.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 510.4;Alveolar cells type 2: 581.2;monocytes: 158.5;Rod photoreceptor cells: 138.2"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 29.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in many"			"Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012501, HPA022268"	Enhanced		Supported	"Endoplasmic reticulum,Lipid droplets"			NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 47: Spleen - Immune response"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 72: Alveolar cells - Lung function"	14	"Endoplasmic reticulum"	"Lipid droplets"	"HPA012501: AB_1845224, HPA022268: AB_1845225"	"unprognostic (3.74e-2)"	"unprognostic (1.49e-3)"	"unprognostic (4.61e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.39e-1)"		"unprognostic (5.25e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.97e-4)"	"unprognostic (9.08e-6)"	"unprognostic (2.52e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.09e-4)"		"unprognostic (3.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (4.37e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.23e-3)"
LTK	TYK1	ENSG00000062524	"Leukocyte receptor tyrosine kinase"	P29376	15	41503637-41513887	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 12.8;lung: 14.6;salivary gland: 11.4"	"Group enriched"	"Detected in some"	4	"dendritic cells: 25.2;Distal enterocytes: 28.1;Gastric mucus-secreting cells: 15.9;Intestinal goblet cells: 9.5;Proximal enterocytes: 16.5"	"Cell type enhanced"	"Detected in some"		"upper-layer intratelencephalic: 6.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 5.7;plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	10	"dendritic cells: 5.0;T-cells: 5.7"	"Low cancer specificity"	"Detected in many"			"Liver - Sinusoid Endothelial cells, Minor Salivary Gland - Minor salivary gland ductal cells"	"Low region specificity"	"Detected in many"							HPA059545			Approved	Vesicles			NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 25: Small intestine - Absorption"	"Cluster 53: Neurons - Mixed function"	"Cluster 35: RS4;11 - Unknown function"	"Cluster 5: Enterocytes - Absorption"	37	Vesicles		"HPA059545: AB_2684057"			"unprognostic (3.07e-1)"	"unprognostic (3.82e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.57e-2)"				"unprognostic (2.75e-1)"						"unprognostic (6.67e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.97e-2)"				"unprognostic (4.46e-2)"			"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.40e-1)"		"unprognostic (1.54e-1)"
MARCO	"SCARA2, SR-A6"	ENSG00000019169	"Macrophage receptor with collagenous structure"	Q9UEW3	2	118942194-118994660	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 92.1;lung: 193.5;lymphoid tissue: 85.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 176.7;Kupffer cells: 768.7;Macrophages: 229.5"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 12.9;leukocyte: 3.8"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 40.2"	"Region enhanced"	"Detected in many"		"thalamus: 28.0"	"Group enriched"	"Detected in some"	4	"classical monocyte: 33.8;intermediate monocyte: 56.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 56.6"	"Cancer enhanced"	"Detected in some"		"Esophageal cancer: 1.2;lymphoma: 1.2"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Macrophages, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063793	Enhanced		Approved	"Golgi apparatus,Vesicles"			NA	NA		20000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 11: Liver - Plasma proteins"	"Cluster 12: Non-specific - Vasculature"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 58: Macrophages - Innate immune response"		"Golgi apparatus"	Vesicles	"HPA063793: AB_2685123"	"unprognostic (8.13e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.27e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.49e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.17e-2)"		"unprognostic (4.95e-3)"	"unprognostic (2.10e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.30e-1)"		"unprognostic (2.84e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.09e-1)"
MATN3	"EDM5, HOA"	ENSG00000132031	"Matrilin 3"	O15232	2	19992052-20012668	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.8;placenta: 10.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 21.8;Breast glandular cells: 4.7;Microglial cells: 4.5;Peritubular cells: 4.8;Sertoli cells: 5.4;Smooth muscle cells: 8.0"	"Group enriched"	"Detected in some"	5	"endothelial cell: 57.3;thalamic excitatory: 23.8"	"Cancer enhanced"	"Detected in many"		"Pancreatic Adenocarcinoma (TCGA): 20.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"liver cancer: 29.3;testis cancer: 24.9"	"Lung - Alveolar cells type 1, Spleen - Fibroblast_2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 2.3"	"HPA051250, HPA074980"			Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	"No annotated function"	NA	NA		650000		"Cluster 34: Non-specific - Mixed function"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 48: Smooth muscle cells - Signal transduction"	5	"Endoplasmic reticulum, Golgi apparatus, Vesicles"		"HPA051250: AB_2681406, HPA074980: "	"unprognostic (1.07e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.41e-3)"	"unprognostic (2.50e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.34e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.84e-5)"		"unprognostic (2.66e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.93e-2)"	"unprognostic (7.95e-3)"	"unprognostic (3.59e-5)"	"unprognostic (2.61e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.26e-5)"	"unprognostic (2.59e-1)"		"unprognostic (2.03e-2)"
MEFV	"FMF, MEF, TRIM20"	ENSG00000103313	"MEFV innate immuity regulator, pyrin"	O15553	16	3242027-3256633	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	Actin-binding	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.4;lung: 3.9;lymphoid tissue: 8.6"	"Cell type enriched"	"Detected in some"	4	"monocytes: 57.5"	"Cell type enriched"	"Detected in some"	4	"leukocyte: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 7.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 7.6;monocytes: 5.6"	"Cancer enhanced"	"Detected in single"		"Leukemia: 1.0"	"Adipose subcutaneous - Macrophages, Adipose visceral - Neutrophils, Adrenal gland - Macrophages, Breast - Macrophages, Heart muscle - Neutrophils, Liver - Neutrophils, Skin - Macrophages, Spleen - Neutrophils, Thyroid gland - Neutrophils"	"Not detected"	"Not detected"							"HPA066867, HPA067626"			Enhanced	"Plasma membrane"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	7	"Plasma membrane"		"HPA066867: , HPA067626: "			"unprognostic (1.78e-1)"			"unprognostic (3.97e-2)"																				"unprognostic (2.27e-1)"					
MRC1	"bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1"	ENSG00000260314	"Mannose receptor C-type 1"	P22897	10	17809348-17911164	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 118.5"	"Group enriched"	"Detected in many"	4	"Breast glandular cells: 124.7;Hofbauer cells: 157.9;Kupffer cells: 348.2;Langerhans cells: 206.5;Lymphatic endothelial cells: 244.1;Macrophages: 414.9"	"Cell type enriched"	"Detected in many"	17	"central nervous system macrophage: 199.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"choroid plexus: 20.4"	"Immune cell enriched"	"Detected in single"	16	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 4.8"	"Cancer enriched"	"Detected in some"	7	"Rhabdoid: 8.4"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004114, HPA045134, CAB068203"	Enhanced						NA	NA		140000000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 57: Lung - Lung function"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 58: Macrophages - Innate immune response"	1			"CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228"	"unprognostic (1.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-2)"		"unprognostic (3.30e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.85e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.48e-2)"		"unprognostic (7.58e-4)"	"unprognostic (3.86e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.96e-3)"		"unprognostic (6.36e-2)"		"unprognostic (3.26e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.62e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.81e-2)"	
MS4A2	"APY, FCER1B, IGER"	ENSG00000149534	"Membrane spanning 4-domains A2"	Q01362	11	60088261-60098467	"FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.2"	"Cell type enriched"	"Detected in some"	29	"granulocytes: 1187.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	873	"basophil: 275.8"	"Lineage enriched"	"Detected in single"	1528	"granulocytes: 275.8"	"Cancer enriched"	"Detected in single"	14	"Leukemia: 1.9"	"Adipose subcutaneous - Mast cells, Adipose visceral - Mast cells, Colon - Mast cells, Kidney - T-cells, Lung - Mast cells, Minor Salivary Gland - Mast cells, Skin - Mast cells"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 20.9"	HPA059967	Enhanced						NA	NA			"Cluster 46: Basophils - Proteolysis"	"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 6: Non-specific - Immune response"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 30: Granulocytes - Unknown function"	1			"HPA059967: AB_2684183"		"unprognostic (6.00e-2)"	"unprognostic (1.55e-1)"			"unprognostic (1.11e-1)"						"unprognostic (7.02e-5)"	"unprognostic (6.45e-2)"			"unprognostic (1.76e-3)"	"unprognostic (2.03e-1)"		"unprognostic (1.84e-1)"			"unprognostic (1.76e-1)"				"unprognostic (3.15e-2)"		"unprognostic (3.33e-2)"			
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183554461-183590905	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 124.7;lung: 63.0;lymphoid tissue: 76.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 260.2;Kupffer cells: 135.3;Langerhans cells: 168.8;Macrophages: 188.7;monocytes: 248.5"	"Group enriched"	"Detected in some"	8	"central nervous system macrophage: 40.2;leukocyte: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 1253.7"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"lymphoma: 37.9"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages, Prostate - Macrophages, Spleen - Neutrophils, Testis - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Cytosol			NA	NA		12000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 55: Lymphoma - Immune response"	"Cluster 58: Macrophages - Innate immune response"	19	Cytosol		"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (1.17e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.79e-3)"	"unprognostic (9.14e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.56e-5)"	"unprognostic (1.71e-1)"	"unprognostic (4.32e-1)"	"unprognostic (5.45e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.22e-4)"	"unprognostic (7.94e-4)"	"unprognostic (3.58e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.69e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.41e-1)"
NCKAP5	"ERIH1, ERIH2, NAP5"	ENSG00000176771	"NCK associated protein 5"	O14513	2	132671788-133568463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 11.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 453.9;Oligodendrocyte precursor cells: 726.8;Oligodendrocytes: 2007.3"	"Cell type enhanced"	"Detected in all"		"bergmann glia: 1724.0;committed oligodendrocyte precursor: 1682.3;oligodendrocyte: 2771.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.5"	"Adipose subcutaneous - Endothelial cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Alveolar cells type 1, Skeletal muscle - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034639, HPA044859"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"			NA	NA				"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 6: Non-specific - Immune response"	"Cluster 65: Non-specific - Unknown function"	"Cluster 51: Oligodendrocytes - Unknown function"	4	Nucleoli	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA034639: AB_10669678, HPA044859: AB_2679114"		"unprognostic (4.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (9.95e-3)"		"unprognostic (1.71e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.97e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.40e-9)"	"unprognostic (3.85e-2)"	"unprognostic (1.57e-3)"			"unprognostic (8.03e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.23e-1)"				"unprognostic (8.55e-3)"	"unprognostic (8.11e-2)"		"unprognostic (4.53e-2)"	"unprognostic (2.11e-2)"				"unprognostic (3.22e-1)"
NDNF	"C4orf31, FLJ23191"	ENSG00000173376	"Neuron derived neurotrophic factor"	Q8TB73	4	121035613-121073021	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Neurogenesis		"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 103.2;placenta: 58.1;retina: 55.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 72.3;Alveolar cells type 2: 44.9;Bipolar cells: 63.3;Early spermatids: 169.7;Late spermatids: 262.5"	"Cell type enhanced"	"Detected in many"		"CGE interneuron: 34.8;choroid plexus epithelial cell: 70.0;fibroblast: 27.8"	"Cancer enriched"	"Detected in many"	5	"Lung Adenocarcinoma (TCGA): 30.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Myeloma: 15.6"	"Adrenal gland - Adrenal cortex cells, Heart muscle - Endothelial cells, Kidney - Podocytes, Liver - Vascular Endothelial cells, Lung - Alveolar cells type 1, Prostate - Fibroblasts, Testis - Early spermatids, Testis - Late spermatids"	"Group enriched"	"Detected in all"	4	"basal ganglia: 11.1;olfactory bulb: 34.0"	"Low region specificity"	"Detected in all"			HPA048881			Supported	Vesicles	"Secreted in other tissues"	Other	NA	NA		100000		"Cluster 57: Lung - Lung function"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 20: Myeloma - Immune response"	"Cluster 11: Late spermatids - Unknown function"		Vesicles		"HPA048881: "		"unprognostic (3.28e-1)"		"unprognostic (2.85e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.90e-1)"			"unprognostic (3.02e-2)"	"unprognostic (4.05e-1)"	"unprognostic (4.85e-4)"			"unprognostic (5.68e-4)"	"unprognostic (8.72e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.17e-2)"			"unprognostic (3.10e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.12e-1)"		"unprognostic (2.68e-3)"			"unprognostic (3.47e-1)"
NKD2	Naked2	ENSG00000145506	"NKD inhibitor of WNT signaling pathway 2"	Q969F2	5	1008802-1038943	"Predicted intracellular proteins"	"Exocytosis, Transport, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 40.8"	"Cell type enriched"	"Detected in many"	8	"Oocytes: 119.8"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 18.6;fibroblast: 42.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 15.0"	"Heart muscle - Fibroblasts, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049463	Uncertain						NA	NA				"Cluster 57: Lung - Lung function"	"Cluster 51: Neurons - Mixed function"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 44: Oocytes - Unknown function"	14			"HPA049463: AB_2680777"	"unprognostic (3.11e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"			"unprognostic (3.13e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.65e-4)"	"unprognostic (2.11e-2)"			"unprognostic (1.58e-4)"	"unprognostic (1.71e-1)"		"unprognostic (6.29e-2)"		"unprognostic (2.62e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.66e-2)"		"unprognostic (6.99e-2)"	"unprognostic (1.67e-1)"		"unprognostic (3.56e-1)"	"unprognostic (3.14e-1)"		"unprognostic (3.03e-1)"
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 132.8;thyroid gland: 227.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 166.3;Alveolar cells type 2: 94.0"	"Cell type enhanced"	"Detected in many"		"medium spiny neuron: 98.7;vascular associated smooth muscle cell: 143.6"	"Cancer enhanced"	"Detected in all"		"Thyroid Carcinoma (TCGA): 279.0"	"Region enhanced"	"Detected in all"		"midbrain: 63.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 71.1"	"Adipose subcutaneous - Smooth muscle cells, Adrenal gland - Adrenal cortex cells, Kidney - Podocytes, Liver - Hepatic stellate cells, Prostate - Smooth muscle cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	"Developmental protein"	NA	NA		330000		"Cluster 51: Thyroid gland - Unknown function"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 72: Alveolar cells - Lung function"	2	"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.19e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.09e-6)"	"unprognostic (1.31e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.03e-1)"	"unprognostic (9.55e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.25e-5)"	"unprognostic (3.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.68e-2)"	"unprognostic (8.18e-2)"
OLR1	"CLEC8A, LOX-1, SCARE1"	ENSG00000173391	"Oxidized low density lipoprotein receptor 1"	P78380	12	10158301-10172138	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 97.0;placenta: 110.6"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 379.7;Hofbauer cells: 215.6;Langerhans cells: 114.6;Macrophages: 201.5;monocytes: 313.5;Syncytiotrophoblasts: 410.4"	"Cell type enriched"	"Detected in many"	35	"central nervous system macrophage: 466.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"cervical cancer: 116.7;head and neck cancer: 80.2"	"Prostate - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050798			Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 58: Placenta - Pregnancy"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 58: Macrophages - Innate immune response"	4	"Nucleoplasm, Plasma membrane"	Vesicles	"HPA050798: AB_2756318"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.63e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.13e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.84e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.55e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.10e-2)"	"unprognostic (8.58e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.07e-3)"	"unprognostic (1.16e-2)"
OVCH1	OVCH	ENSG00000187950	"Ovochymase 1"	Q7RTY7	12	29412474-29497686	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 1.5;testis: 1.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 13.9;Inhibitory neurons: 14.3"	"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Prostate - Endothelial cells, Testis - Early spermatids, Testis - Late spermatids"														"Secreted in other tissues"	Enzyme	NA	NA				"Cluster 44: Testis - Spermatogenesis"	"Cluster 33: Neurons - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 8: Neurons - Neuronal signaling"																																			
PCDH17	"PCDH68, PCH68"	ENSG00000118946	"Protocadherin 17"	O14917	13	57631744-57729311	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.2;lung: 13.6;lymphoid tissue: 24.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 73.1;Early spermatids: 81.7;Endothelial cells: 110.7;Excitatory neurons: 120.7;Granulosa cells: 80.3;Inhibitory neurons: 65.0;Oligodendrocyte precursor cells: 181.1;Oligodendrocytes: 94.1;Spermatocytes: 59.0"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 12.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bone cancer: 11.2;Neuroblastoma: 6.4"	"Adipose visceral - Endothelial cells, Breast - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Lung - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026817	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"			NA	NA		880000		"Cluster 34: Non-specific - Mixed function"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	2	"Vesicles, Cytosol"	"Plasma membrane"	"HPA026817: AB_1855044"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-2)"	"unprognostic (9.58e-2)"		"unprognostic (2.75e-1)"	"unprognostic (4.61e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.41e-7)"	"unprognostic (8.82e-4)"				"unprognostic (1.29e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.80e-1)"		"unprognostic (6.81e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.19e-1)"		"unprognostic (1.28e-2)"	"unprognostic (9.76e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.29e-1)"
PRRT1B	"DSPD2, IFITMD8"	ENSG00000283526	"Proline rich transmembrane protein 1B"	A0A1B0GWB2	9	131545523-131559815	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 7.2;lung: 5.2;pancreas: 4.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"committed oligodendrocyte precursor: 1.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 3.8;liver cancer: 3.6;prostate cancer: 9.3"	"Liver - Hepatocytes, Lung - Alveolar cells type 1, Prostate - Prostate glandular cells, Stomach - Chief cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 48: Stomach - Proteolysis"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 40: Prostatic glandular cells - Transcription"						"unprognostic (1.93e-2)"				"unprognostic (2.14e-4)"								"unprognostic (2.17e-1)"		"unprognostic (3.43e-2)"	"unprognostic (1.81e-2)"					"unprognostic (2.29e-4)"		"unprognostic (4.13e-2)"		"unprognostic (7.15e-2)"		"unprognostic (1.77e-1)"	"unprognostic (7.73e-2)"		"unprognostic (2.59e-1)"
PRX	KIAA1620	ENSG00000105227	Periaxin	Q9BXM0	19	40393766-40414793	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 33.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 21.5;Breast myoepithelial cells: 34.7;Endothelial cells: 18.1;Schwann cells: 41.9;Skeletal myocytes: 36.1"	"Cell type enriched"	"Detected in some"	14	"endothelial cell: 53.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"				"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	8	"spinal cord: 249.7"	HPA001868	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"			NA	NA				"Cluster 57: Lung - Lung function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	3	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA001868: AB_2172440"	"unprognostic (9.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.08e-4)"			"unprognostic (2.73e-1)"		"unprognostic (1.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-7)"	"unprognostic (8.65e-4)"	"unprognostic (5.20e-3)"	"unprognostic (2.78e-2)"		"unprognostic (1.34e-3)"	"unprognostic (5.69e-3)"	"unprognostic (2.15e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.33e-2)"		"unprognostic (4.70e-2)"			"unprognostic (1.52e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.92e-1)"
PTGIR	IP	ENSG00000160013	"Prostaglandin I2 receptor"	P43119	19	46620468-46625089	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 53.8"	"Cell type enriched"	"Detected in some"	6	"Langerhans cells: 239.5"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 5.1;leukocyte: 5.2;vascular associated smooth muscle cell: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	10	"classical monocyte: 28.3;intermediate monocyte: 65.3;myeloid DC: 20.9;non-classical monocyte: 38.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 20.9;monocytes: 65.3"	"Cancer enhanced"	"Detected in some"		"Leukemia: 6.4;Neuroblastoma: 7.7"	"Spleen - Fibroblast_1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 51: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 14: Langerhans cells - Innate immune response"	6				"unprognostic (1.23e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-1)"		"unprognostic (4.67e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.46e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.72e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.90e-4)"	"unprognostic (2.89e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.22e-1)"		"unprognostic (9.10e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.83e-3)"	"unprognostic (7.73e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.67e-1)"
RGCC	"bA157L14.2, C13orf15, RGC-32, RGC32"	ENSG00000102760	"Regulator of cell cycle"	Q9H4X1	13	41457550-41470871	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 409.9;lung: 673.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1212.9;Langerhans cells: 597.4;Schwann cells: 752.9;T-cells: 544.6"	"Cell type enhanced"	"Detected in many"		"bergmann glia: 596.0;endothelial cell: 312.4;oligodendrocyte: 207.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 160.9;T-reg: 91.1"	"Lineage enriched"	"Detected in many"	15	"T-cells: 160.9"	"Cancer enhanced"	"Detected in many"		"lymphoma: 34.0"	"Minor Salivary Gland - Minor salivary glandular cells, Spleen - Fibroblast_2, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035638, HPA063701"	Enhanced		Supported	Nucleoplasm,Nucleoli			No	No		480000	"Cluster 31: T-cells - T-cell receptor"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	3	Nucleoplasm	Nucleoli	"HPA035638: AB_10670152, HPA063701: AB_2685096"	"unprognostic (4.62e-2)"	"unprognostic (1.31e-2)"		"unprognostic (3.54e-1)"	"unprognostic (9.55e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.18e-11)"	"unprognostic (3.68e-4)"	"unprognostic (3.08e-1)"	"unprognostic (2.03e-4)"		"unprognostic (5.98e-3)"	"unprognostic (2.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-4)"	"unprognostic (9.05e-3)"	"unprognostic (9.73e-2)"	"unprognostic (9.54e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.86e-2)"
RHOBTB2	"DBC2, KIAA0717"	ENSG00000008853	"Rho related BTB domain containing 2"	Q9BYZ6	8	22987417-23020509	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 51.3;lung: 49.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 126.9;Alveolar cells type 2: 159.8;Basal prostatic cells: 43.1;Proximal enterocytes: 43.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2, Spleen - B-cells (Spleen)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060938	Approved		Approved	"Plasma membrane"			NA	NA			"Cluster 32: Basophils - Transcription"	"Cluster 61: Brain - Neuronal signaling"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 72: Alveolar cells - Lung function"	7	"Plasma membrane"		"HPA060938: AB_2684391"	"unprognostic (3.30e-3)"	"unprognostic (1.72e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.88e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.03e-7)"	"unprognostic (3.76e-4)"	"unprognostic (1.25e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.53e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.22e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.84e-3)"	"unprognostic (8.08e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.80e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.48e-1)"
RSPO4	"C20orf182, dJ824F16.3"	ENSG00000101282	"R-spondin 4"	Q2I0M5	20	958452-1002311	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.8;lung: 12.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.2;Early spermatids: 5.0;Late spermatids: 7.5;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 6.6"	"Cell type enhanced"	"Detected in all"		"ependymal cell: 70.0"	"Cancer enhanced"	"Detected in many"		"Thyroid Carcinoma (TCGA): 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.8"	"Testis - Early spermatids, Testis - Late spermatids"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"Not detected"	"Not detected"			HPA048887	Uncertain				"Secreted in other tissues"	Other	NA	NA				"Cluster 34: Non-specific - Mixed function"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 24: Non-specific - Unknown function"	"Cluster 76: Oligodendrocyte precursor - Unknown function"	13			"HPA048887: AB_2680545"	"unprognostic (7.36e-2)"		"unprognostic (2.49e-1)"													"unprognostic (1.09e-1)"		"unprognostic (1.70e-2)"		"unprognostic (8.65e-4)"	"unprognostic (4.91e-2)"						"unprognostic (4.42e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.20e-2)"
SDR16C5	"EPHD-2, RDH-E2, RDHE2"	ENSG00000170786	"Short chain dehydrogenase/reductase family 16C member 5"	Q8N3Y7	8	56300005-56320776	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 50.4;lung: 33.4;skin 1: 60.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 213.2;Alveolar cells type 2: 467.7;Basal respiratory cells: 330.7;Ionocytes: 287.9;Suprabasal keratinocytes: 235.7"	"Cell type enhanced"	"Detected in many"		"lower rhombic lip: 21.3"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 29.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"memory B-cell: 4.7;naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	48	"B-cells: 4.7"	"Cancer enhanced"	"Detected in many"		"Bile duct cancer: 15.5"	"Breast - Breast glandular cells, Breast - Breast glandular cells, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary gland basal cells, Prostate - Urothelial cells, Stomach - Gastric mucous cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA025224	Enhanced						NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 27: Squamous epithelium - Keratinization"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 35: Respiratory epithelial cells - Unknown function"	18			"HPA025224: AB_1856163"	"unprognostic (9.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.75e-4)"			"unprognostic (7.39e-4)"							"unprognostic (1.63e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.04e-1)"			"unprognostic (1.19e-3)"	"unprognostic (1.41e-1)"		"unprognostic (5.04e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.11e-1)"			
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1561385-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.7;lung: 18.8;lymphoid tissue: 27.8"	"Group enriched"	"Detected in some"	8	"dendritic cells: 35.5;Hofbauer cells: 29.3;Kupffer cells: 44.1;Macrophages: 30.4;monocytes: 57.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1606.1"	"Group enriched"	"Detected in all"	6	"granulocytes: 1606.1;monocytes: 503.9"	"Cancer enhanced"	"Detected in many"		"Leukemia: 18.6;thyroid cancer: 23.3"	"Adipose subcutaneous - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2, Spleen - Neutrophils"									HPA047463	Uncertain		Uncertain	Vesicles,Centrosome			NA	NA		28000000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 34: Non-specific - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	4	Vesicles	Centrosome	"HPA047463: AB_2680057"	"unprognostic (3.94e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.72e-2)"		"unprognostic (1.09e-1)"		"unprognostic (2.29e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.01e-1)"			"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.90e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.60e-1)"		"unprognostic (2.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.94e-3)"		"unprognostic (9.25e-2)"
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 35.3;lung: 76.2;lymphoid tissue: 45.5"	"Group enriched"	"Detected in many"	9	"Hofbauer cells: 171.8;Kupffer cells: 159.6;Macrophages: 216.8;monocytes: 503.9"	"Group enriched"	"Detected in many"	14	"central nervous system macrophage: 62.7;leukocyte: 52.7"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 9.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 6.1;intermediate monocyte: 4.5;myeloid DC: 1.9;neutrophil: 4.4;non-classical monocyte: 6.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 1.9;granulocytes: 4.4;monocytes: 6.1"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Breast - Macrophages, Colon - Neutrophils, Liver - Neutrophils, Prostate - Macrophages, Skin - Macrophages, Spleen - Neutrophils, Thyroid gland - Neutrophils"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA029590, HPA050378, HPA068540"	Uncertain		Approved	Nucleoli,Mitochondria			NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 57: Lung - Lung function"	"Cluster 12: Non-specific - Vasculature"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 58: Macrophages - Innate immune response"		Mitochondria	Nucleoli	"HPA029590: AB_10794613, HPA050378: , HPA068540: "	"unprognostic (4.80e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.59e-1)"	"unprognostic (5.37e-3)"	"unprognostic (8.53e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.31e-5)"	"unprognostic (7.18e-2)"	"unprognostic (1.88e-2)"		"unprognostic (4.90e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.92e-3)"	"unprognostic (7.75e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.44e-2)"		"unprognostic (4.65e-3)"	"unprognostic (2.57e-3)"
SLC22A31		ENSG00000259803	"Solute carrier family 22 member 31"	A6NKX4	16	89195761-89201651	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 155.6;lung: 39.4;pancreas: 32.0"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 74.4;Alveolar cells type 2: 285.8"	"Cell type enriched"	"Detected in some"	20	"upper rhombic lip: 59.8"	"Group enriched"	"Detected in many"	6	"Lung Adenocarcinoma (TCGA): 60.3;Thyroid Carcinoma (TCGA): 27.4"	"Region enriched"	"Detected in many"	10	"cerebellum: 63.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Myeloma: 11.7"	"Lung - Alveolar cells type 2, Skin - Sebaceous gland cells"																NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 35: Non-specific - DNA binding"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 72: Alveolar cells - Lung function"									"unprognostic (3.23e-3)"									"unprognostic (2.00e-2)"		"unprognostic (2.37e-3)"	"unprognostic (9.07e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"				"unprognostic (1.53e-1)"		"unprognostic (9.83e-2)"		"unprognostic (2.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.90e-2)"
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251080-102431258	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Symport, Transport, Zinc transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 67.8"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 735.2;Alveolar cells type 2: 629.7;Extravillous trophoblasts: 241.4;Mesothelial cells: 581.7"	"Cell type enriched"	"Detected in all"	7	"endothelial cell: 341.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Mesothelial cells, Pituitary gland - Corticotropes, Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038832, HPA038833"	Approved						NA	NA			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 68: Non-specific - Protein processing"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 72: Alveolar cells - Lung function"	2			"HPA038832: AB_2676226, HPA038833: AB_10670910"	"unprognostic (8.99e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.63e-4)"	"unprognostic (4.04e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.52e-2)"	"unprognostic (4.02e-3)"	"unprognostic (9.91e-7)"	"unprognostic (8.45e-3)"	"unprognostic (3.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.97e-1)"
SLC46A2	"Ly110, TSCOT"	ENSG00000119457	"Solute carrier family 46 member 2"	Q9BY10	9	112878920-112890876	"Predicted membrane proteins, Transporters"	"Immunity, Innate immunity, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 15.9;lung: 10.1;lymphoid tissue: 15.6;skin 1: 23.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 25.2;Ciliated cells: 4.1;Club cells: 4.5;Glandular and luminal cells: 6.4;Hofbauer cells: 5.1;Kupffer cells: 8.4;Late spermatids: 5.2;Macrophages: 4.4"	"Cell type enhanced"	"Detected in some"		"upper rhombic lip: 3.6"	"Cancer enriched"	"Detected in single"	5	"Lung Adenocarcinoma (TCGA): 3.7"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 24.7;intermediate monocyte: 12.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 24.7"	"Not detected"	"Not detected"			"Lung - Alveolar cells type 2, Skin - Keratinocyte (granular), Testis - Sertoli cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA020098	Approved						NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 13: Skin - Cornification"	"Cluster 15: Non-specific - Transcription"	"Cluster 56: Non-specific - Sensory perception"	"Cluster 72: Alveolar cells - Lung function"				"HPA020098: AB_2670363"			"unprognostic (2.61e-3)"													"unprognostic (1.95e-2)"	"unprognostic (3.53e-2)"														
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436606-116461458	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 15.6;salivary gland: 20.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 193.3;Basal respiratory cells: 110.0;Club cells: 166.6;Ionocytes: 275.7;Mucus glandular cells: 107.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 22.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 10.1"	"Lung - Alveolar cells type 2, Stomach - Gastric mucous cells"									HPA003193	Uncertain		Approved	"Vesicles,Plasma membrane,Primary cilium,Primary cilium tip,Mitochondria"			NA	NA				"Cluster 48: Stomach - Proteolysis"	"Cluster 48: Non-specific - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 35: Respiratory epithelial cells - Unknown function"		"Vesicles, Primary cilium, Primary cilium tip"	"Plasma membrane, Mitochondria"	"HPA003193: AB_2190122"	"unprognostic (1.03e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"			"unprognostic (1.66e-2)"							"unprognostic (9.30e-4)"	"unprognostic (2.83e-1)"	"unprognostic (2.55e-3)"	"unprognostic (2.20e-1)"			"unprognostic (6.00e-4)"		"unprognostic (6.08e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.89e-2)"			"unprognostic (5.42e-2)"
SLCO2A1	"MATR1, OATP2A1, PGT, SLC21A2"	ENSG00000174640	"Solute carrier organic anion transporter family member 2A1"	Q92959	3	133932701-134052184	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 119.9"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 108.1;Endothelial cells: 123.2"	"Cell type enriched"	"Detected in some"	8	"endothelial cell: 144.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"choroid plexus: 18.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"thyroid cancer: 14.2"	"Adrenal gland - Endothelial cells, Colon - Endothelial cells, Liver - Vascular Endothelial cells, Pituitary gland - Endothelial cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA013742	Enhanced						NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"				"HPA013742: AB_2668877"	"unprognostic (6.62e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.57e-3)"	"unprognostic (8.86e-3)"	"unprognostic (2.46e-10)"	"unprognostic (1.94e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.51e-4)"	"unprognostic (1.03e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.24e-3)"	"unprognostic (8.95e-3)"	"unprognostic (8.15e-2)"	"unprognostic (9.14e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.46e-5)"	"unprognostic (3.29e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.94e-2)"
SLCO4A1	"OATP-E, OATP4A1, SLC21A12"	ENSG00000101187	"Solute carrier organic anion transporter family member 4A1"	Q96BD0	20	62642503-62685785	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 55.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.0;Endothelial cells: 58.9;Extravillous trophoblasts: 269.5;Melanocytes: 72.1"	"Cell type enriched"	"Detected in many"	6	"endothelial cell: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"				"Region enriched"	"Detected in some"	5	"cerebellum: 6.7"	"Low region specificity"	"Detected in all"			"HPA030669, HPA030670"	Uncertain		Supported	"Cell Junctions"			NA	NA			"Cluster 16: Non-specific - Cell proliferation"	"Cluster 30: Heart muscle - Heart development"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	2	"Cell Junctions"		"HPA030669: AB_10601163, HPA030670: AB_10670033"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.29e-4)"		"unprognostic (8.19e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.06e-5)"	"unprognostic (1.92e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.88e-3)"	"unprognostic (4.01e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.49e-3)"	"unprognostic (2.58e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.45e-2)"
SMAD6	"HsT17432, MADH6, MADH7"	ENSG00000137834	"SMAD family member 6"	O43541	15	66702236-66782849	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"		"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.1;lung: 27.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 17.0;Endothelial cells: 34.1;Microglial cells: 54.6"	"Cell type enriched"	"Detected in some"	4	"endothelial cell: 273.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Liver - Vascular Endothelial cells, Minor Salivary Gland - Endothelial cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061917			Approved	"Nucleoplasm,Nuclear bodies,Primary cilium,Basal body,Cytosol"			NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	19	"Nucleoplasm, Nuclear bodies, Basal body"	"Primary cilium, Cytosol"	"HPA061917: AB_2684637"	"unprognostic (2.61e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-1)"			"unprognostic (1.07e-1)"	"unprognostic (1.81e-7)"	"unprognostic (4.70e-4)"	"unprognostic (8.83e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.59e-2)"		"unprognostic (2.56e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.15e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.08e-1)"	"unprognostic (5.33e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.70e-2)"
SMIM41		ENSG00000284791	"Small integral membrane protein 41"	A0A2R8YCJ5	12	52079704-52108255	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lung: 4.0;ovary: 2.7"	"Group enriched"	"Detected in some"	7	"Fibroblasts: 3.7;Leydig cells: 7.4;Peritubular cells: 14.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Stomach Adenocarcinoma (TCGA): 1.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	59	"plasmacytoid DC: 5.8"	"Lineage enriched"	"Detected in single"	59	"dendritic cells: 5.8"	"Not detected"	"Not detected"				"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"										NA	NA			"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"			"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 49: Non-specific - Transcription"																					"unprognostic (1.35e-1)"									"unprognostic (1.64e-1)"		"unprognostic (1.27e-3)"			
ST8SIA6	SIAT8F	ENSG00000148488	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6"	P61647	10	17315421-17454595	"Predicted intracellular proteins"	"Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 5.0;epididymis: 4.5;lung: 5.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 24.5;Erythroid cells: 37.0;granulocytes: 48.8;Microglial cells: 131.5"	"Cell type enriched"	"Detected in many"	5	"endothelial cell: 891.3"	"Cancer enhanced"	"Detected in some"		"Breast Invasive Carcinoma (TCGA): 6.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"breast cancer: 1.9;Leukemia: 7.1;Rhabdoid: 2.7"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Breast - Breast glandular cells, Liver - Vascular Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011635, HPA072708"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	Enzyme	NA	NA			"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 34: Non-specific - Mixed function"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"		"Endoplasmic reticulum"		"HPA011635: AB_2194921, HPA072708: "		"unprognostic (1.17e-2)"	"unprognostic (8.41e-2)"			"unprognostic (1.55e-2)"				"unprognostic (6.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.11e-4)"												"unprognostic (9.36e-2)"		"unprognostic (2.14e-3)"	"unprognostic (1.68e-1)"				
SUSD2	"BK65A6.2, FLJ22778, W5C5"	ENSG00000099994	"Sushi domain containing 2"	Q9UGT4	22	24181487-24189106	"Predicted membrane proteins"		Receptor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 96.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 189.3;Alveolar cells type 2: 142.2;Proximal enterocytes: 134.8"	"Cell type enhanced"	"Detected in some"		"pericyte: 15.0;vascular associated smooth muscle cell: 34.2"	"Cancer enhanced"	"Detected in all"		"Lung Adenocarcinoma (TCGA): 70.9;Testicular Germ Cell Tumor (TCGA): 124.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"breast cancer: 65.6;Rhabdoid: 35.5"	"Adipose subcutaneous - Smooth muscle cells, Adrenal gland - Fibroblasts, Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatic stellate cells, Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	7	"spinal cord: 14.4"	HPA004117	Enhanced		Approved	"Plasma membrane"			NA	NA		4500000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 72: Alveolar cells - Lung function"	14	"Plasma membrane"		"HPA004117: AB_1857674"	"unprognostic (2.51e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.37e-4)"	"unprognostic (2.99e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.76e-2)"		"unprognostic (3.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.05e-5)"	"unprognostic (1.36e-2)"	"unprognostic (4.24e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.40e-2)"	"unprognostic (7.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (3.53e-4)"	"unprognostic (4.88e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.13e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-1)"
SYT15B		ENSG00000277758	"Synaptotagmin 15B"	X6R8R1	10	47744717-47763592	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"lung: 10.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.4;Alveolar cells type 1: 10.8;Alveolar cells type 2: 6.4;Endothelial cells: 4.2;Lymphatic endothelial cells: 7.3"					"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"												"HPA036971, HPA036972, HPA064559"	Approved		Approved	"Golgi apparatus"			NA	NA				"Cluster 34: Non-specific - Mixed function"	"Cluster 51: Neurons - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"		"Golgi apparatus"		"HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286"		"unprognostic (1.39e-1)"														"unprognostic (2.90e-4)"	"unprognostic (5.57e-2)"		"unprognostic (1.55e-1)"												
TBX2		ENSG00000121068	"T-box transcription factor 2"	Q13207	17	61399843-61409466	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 60.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 81.8;Bipolar cells: 112.4;Collecting duct cells: 83.6;Muller glia cells: 124.8;Peritubular cells: 46.6;Sertoli cells: 62.6;Smooth muscle cells: 121.8"	"Group enriched"	"Detected in some"	70	"pericyte: 228.0;vascular associated smooth muscle cell: 320.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"Neuroblastoma: 80.2;Rhabdoid: 81.4;skin cancer: 47.4"	"Breast - Endothelial cells, Liver - Hepatic stellate cells, Minor Salivary Gland - Endothelial cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA008586, CAB013636"	Approved		Approved	Nucleoplasm,Cytosol			NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 48: Smooth muscle cells - Signal transduction"	9	Nucleoplasm	Cytosol	"CAB013636: , HPA008586: AB_1080222"	"unprognostic (7.78e-2)"	"unprognostic (1.73e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.76e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.84e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.36e-2)"
TBX4		ENSG00000121075	"T-box transcription factor 4"	P57082	17	61452404-61485110	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 31.3;placenta: 20.3;prostate: 8.7"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 16.4"	"Cell type enriched"	"Detected in single"	8	"choroid plexus epithelial cell: 2.9"	"Cancer enhanced"	"Detected in some"		"Lung Adenocarcinoma (TCGA): 3.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"Gastric cancer: 4.6"	"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB032413, HPA044457"	Uncertain		Approved	Vesicles			NA	NA				"Cluster 57: Lung - Lung function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 50: Connective tissue cells - ECM organization"		Vesicles		"CAB032413: AB_2200705, HPA044457: AB_2678948"	"unprognostic (2.45e-2)"		"unprognostic (3.89e-2)"												"unprognostic (2.02e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.47e-1)"					"unprognostic (1.60e-1)"					"unprognostic (1.21e-1)"		
TBX5	HOS	ENSG00000089225	"T-box transcription factor 5"	Q99593	12	114353911-114408442	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Atrial fibrillation, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 85.2;lung: 20.2;placenta: 27.7"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 110.2"	"Cell type enhanced"	"Detected in some"		"astrocyte: 2.8;lower rhombic lip: 3.0"	"Cancer enhanced"	"Detected in some"		"Lung Adenocarcinoma (TCGA): 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	7	"Bone cancer: 3.7"	"Heart muscle - Cardiomyocytes, Prostate - Fibroblasts, Skin - Fibroblast_2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA008786, HPA064683"	Uncertain		Approved	Nucleoplasm			NA	NA				"Cluster 30: Heart muscle - Heart development"	"Cluster 29: Forebrain - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 68: Cardiomyocytes - Muscle contraction"	7	Nucleoplasm		"HPA008786: AB_10601720, HPA064683: AB_2685320"		"unprognostic (6.45e-2)"	"unprognostic (1.53e-1)"				"unprognostic (4.81e-2)"									"unprognostic (2.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.17e-1)"										"unprognostic (8.07e-2)"		
TLR8	"CD288, hTLR8"	ENSG00000101916	"Toll like receptor 8"	Q9NR97	X	12906620-12923169	"CD markers, Disease related genes, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 10.3;lymphoid tissue: 16.3"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 47.8;Macrophages: 21.5;monocytes: 51.0"	"Group enriched"	"Detected in some"	17	"central nervous system macrophage: 4.4;leukocyte: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	73	"classical monocyte: 16.7;intermediate monocyte: 14.9;myeloid DC: 8.4;neutrophil: 27.6;non-classical monocyte: 15.7"	"Group enriched"	"Detected in many"	77	"dendritic cells: 8.4;granulocytes: 27.6;monocytes: 16.7"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skin - Macrophages, Spleen - Neutrophils, Stomach - Macrophages, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001608	Enhanced						NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	1			"HPA001608: AB_1080295"			"unprognostic (1.97e-2)"			"unprognostic (9.95e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"			"unprognostic (1.58e-2)"	"unprognostic (2.87e-1)"				"unprognostic (2.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.00e-1)"			"unprognostic (1.34e-1)"	"unprognostic (3.50e-1)"			"unprognostic (1.28e-1)"		"unprognostic (2.23e-1)"	"unprognostic (3.98e-2)"		
TMEM100	"FLJ10970, FLJ37856"	ENSG00000166292	"Transmembrane protein 100"	Q9NV29	17	55719627-55732121	"Predicted membrane proteins, Transporters"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 186.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 49.7;Basal prostatic cells: 47.4;Endothelial cells: 46.4;Fibroblasts: 33.0;Leydig cells: 38.1;Lymphatic endothelial cells: 49.1;Peritubular cells: 55.0"	"Cell type enhanced"	"Detected in some"		"committed oligodendrocyte precursor: 19.4;fibroblast: 20.5;oligodendrocyte precursor cell: 35.4"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 24.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 49.8;Rhabdoid: 19.8"	"Minor Salivary Gland - Fibroblasts, Prostate - Fibroblasts, Skin - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055936	Approved		Uncertain	Nucleoplasm			NA	NA				"Cluster 57: Lung - Lung function"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	32	Nucleoplasm		"HPA055936: AB_2682975"	"unprognostic (2.93e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.59e-2)"			"unprognostic (4.25e-3)"	"unprognostic (7.00e-5)"		"unprognostic (8.96e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.39e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.38e-3)"	"unprognostic (6.66e-4)"	"unprognostic (8.40e-3)"	"unprognostic (2.03e-3)"	"unprognostic (5.93e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.50e-3)"		"unprognostic (1.38e-1)"		"unprognostic (6.65e-3)"	"unprognostic (8.32e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.14e-1)"
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269983-43274002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 73.4;pancreas: 87.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 153.1;Alveolar cells type 2: 178.6;Distal enterocytes: 75.1;Proximal enterocytes: 169.7"	"Cell type enriched"	"Detected in many"	4	"oligodendrocyte: 111.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose visceral - Mesothelial cells, Breast - Breast glandular cells, Colon - Colon enterocytes, Liver - Cholangiocyte, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells, Pituitary gland - Somatotropes, Prostate - Prostate glandular cells, Skin - Keratinocyte (granular), Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015796			Approved	Midbody,Cytosol			Yes	NA				"Cluster 32: Endocrine & Neural - Unknown function"	"Cluster 11: White matter - Signal transduction"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 72: Alveolar cells - Lung function"		"Midbody, Cytosol"		"HPA015796: AB_1858081"	"unprognostic (1.87e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.66e-1)"		"unprognostic (1.05e-1)"	"unprognostic (3.30e-4)"	"unprognostic (6.85e-11)"	"unprognostic (2.24e-5)"	"unprognostic (8.36e-5)"	"unprognostic (2.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.13e-6)"	"unprognostic (6.80e-2)"	"unprognostic (3.04e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.08e-2)"	"unprognostic (7.25e-2)"	"unprognostic (6.02e-4)"	"unprognostic (5.34e-2)"	"unprognostic (8.44e-2)"	"unprognostic (6.57e-2)"		"unprognostic (6.58e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.70e-1)"
TMEM74B	"C20orf46, FLJ11190"	ENSG00000125895	"Transmembrane protein 74B"	Q9NUR3	20	1180561-1185415	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.6;lung: 26.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 20.6;Enteroendocrine cells: 15.0;Horizontal cells: 23.9;Inhibitory neurons: 15.6;Intestinal goblet cells: 20.5;Paneth cells: 16.5;Proximal enterocytes: 19.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045213	Approved		Approved	"Nucleoplasm,Golgi apparatus"			NA	NA				"Cluster 25: Small intestine - Absorption"	"Cluster 24: Neurons - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 65: Neurons - Synaptic function"		"Nucleoplasm, Golgi apparatus"		"HPA045213: AB_10961999"	"unprognostic (2.81e-2)"	"unprognostic (1.01e-1)"		"unprognostic (3.36e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.85e-2)"		"unprognostic (9.65e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.87e-5)"	"unprognostic (3.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.97e-2)"		"unprognostic (1.63e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-4)"		"unprognostic (1.09e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.34e-2)"		"unprognostic (7.83e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.18e-2)"
TNFRSF6B	"DcR3, M68, TR6"	ENSG00000243509	"TNF receptor superfamily member 6b"	O95407	20	63696652-63698684	"Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 49.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 21.6"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 21.6"	"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 144.8;pancreatic cancer: 170.2"										HPA047154	Approved				"Secreted to blood"	Receptor	NA	NA	406000		"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 34: Non-specific - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 15: Kidney cancer - Membrane components"		25			"HPA047154: AB_2679959"	"unprognostic (5.63e-3)"	"unprognostic (4.15e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.34e-2)"		"unprognostic (1.09e-2)"		"unprognostic (1.37e-5)"	"unprognostic (6.93e-3)"	"unprognostic (7.32e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.12e-3)"		"unprognostic (1.27e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.10e-1)"
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286682	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 95.0;lung: 63.3;lymphoid tissue: 42.9"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 121.6;Macrophages: 117.6;monocytes: 389.2"	"Cell type enriched"	"Detected in some"	4	"leukocyte: 5.3"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 48.5"	"Region enhanced"	"Detected in many"		"cerebral cortex: 16.3"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 616.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 616.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.7"	"Adipose visceral - Neutrophils, Colon - Neutrophils, Spleen - Neutrophils, Stomach - Neutrophils, Thyroid gland - Neutrophils"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005563, HPA053612"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	Receptor	NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 58: Macrophages - Innate immune response"	4	"Golgi apparatus"		"HPA005563: AB_1858259, HPA053612: "	"unprognostic (1.07e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.48e-4)"	"unprognostic (4.72e-2)"	"unprognostic (3.48e-2)"		"unprognostic (8.30e-5)"	"unprognostic (9.64e-2)"	"unprognostic (1.63e-2)"		"unprognostic (6.00e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.28e-2)"	"unprognostic (7.01e-4)"	"unprognostic (4.26e-1)"	"unprognostic (6.90e-4)"	"unprognostic (9.39e-2)"		"unprognostic (1.21e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.21e-2)"	"unprognostic (8.17e-2)"	"unprognostic (7.29e-2)"
TRGJP2	"JP2, TCRGJP2"	ENSG00000211688	"T cell receptor gamma joining P2"		7	38256337-38256396	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 64.2;lung: 25.8;lymphoid tissue: 29.5;prostate: 31.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	11	"Prostate Adenocarcinoma (TCGA): 26.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 367.8"	"Group enriched"	"Detected in many"	84	"NK-cells: 187.8;T-cells: 367.8"	"Cancer enriched"	"Detected in some"	4	"Leukemia: 40.1"																	NA	NA			"Cluster 15: NK-cells - Unknown function"		"Cluster 47: Endothelial cells - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"											"unprognostic (1.94e-1)"						"unprognostic (3.51e-1)"				"unprognostic (3.48e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"					"unprognostic (6.16e-2)"		"unprognostic (1.98e-1)"					
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.9;placenta: 20.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.6;Inhibitory neurons: 45.0;Microglial cells: 11.6;Smooth muscle cells: 21.1"	"Cell type enhanced"	"Detected in many"		"ependymal cell: 250.7"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 5.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.4;testis cancer: 1.9"	"Adipose subcutaneous - Endothelial cells, Minor Salivary Gland - Endothelial cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045098	Approved						NA	NA			"Cluster 25: Non-specific - Unknown function"	"Cluster 58: Placenta - Pregnancy"	"Cluster 17: Choroid plexus - Cilium"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 69: Neurons - Neuronal signaling"	6			"HPA045098: AB_10959600"		"unprognostic (1.04e-1)"	"unprognostic (1.06e-1)"			"unprognostic (2.61e-1)"	"unprognostic (4.14e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.36e-2)"		"unprognostic (1.25e-5)"	"unprognostic (2.90e-5)"				"unprognostic (5.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.08e-1)"			"unprognostic (5.69e-2)"	"unprognostic (1.54e-1)"			"unprognostic (8.53e-2)"		"unprognostic (1.29e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.35e-2)"
VEGFD	"FIGF, VEGF-D"	ENSG00000165197	"Vascular endothelial growth factor D"	O43915	X	15345596-15384413	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 41.4"	"Cell type enriched"	"Detected in some"	8	"Fibroblasts: 65.4"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Liver Hepatocellular Carcinoma (TCGA): 2.5;Lung Adenocarcinoma (TCGA): 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"Neuroblastoma: 7.8"	"Stomach - Fibroblasts"	"Group enriched"	"Detected in many"	4	"amygdala: 2.1;cerebral cortex: 3.5;hippocampal formation: 3.3;white matter: 2.6"	"Low region specificity"	"Detected in single"			HPA027342	Uncertain				"Secreted to blood"	"Growth factor"	NA	NA	592000	300000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 24: Neurons - Mixed function"	"Cluster 61: BICR 18 - Protein kinases"	"Cluster 53: Fibroblasts - ECM organization"	21			"HPA027342: AB_1848597"														"unprognostic (1.64e-2)"		"unprognostic (2.15e-5)"	"unprognostic (5.40e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.02e-1)"												
VEPH1	"FLJ12604, KIAA1692"	ENSG00000197415	"Ventricular zone expressed PH domain containing 1"	Q14D04	3	157259742-157533619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 19.6;kidney: 26.1;lung: 28.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 69.5;Alveolar cells type 2: 172.7;Early spermatids: 49.1;Late spermatids: 93.5;Melanocytes: 44.7"	"Group enriched"	"Detected in many"	5	"choroid plexus epithelial cell: 140.1;ependymal cell: 35.2;lower rhombic lip: 59.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"choroid plexus: 24.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adrenal gland - Adrenal cortex cells, Minor Salivary Gland - Minor salivary gland ductal cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA026645	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol			NA	NA			"Cluster 4: Neutrophils - Degranulation"	"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 44: Non-specific - Mixed function"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 72: Alveolar cells - Lung function"		"Nucleoplasm, Nucleoli, Cytosol"		"HPA026645: AB_1858741"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.60e-1)"			"unprognostic (6.26e-3)"	"unprognostic (8.74e-2)"	"unprognostic (2.04e-2)"		"unprognostic (3.29e-1)"	"unprognostic (3.33e-7)"	"unprognostic (3.00e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.12e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.92e-4)"	"unprognostic (3.32e-2)"			"unprognostic (1.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.07e-2)"			"unprognostic (5.71e-2)"
VIPR1	"HVR1, RDC1, VPAC1, VPAC1R"	ENSG00000114812	"Vasoactive intestinal peptide receptor 1"	P32241	3	42489299-42537573	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 128.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 39.6;Distal enterocytes: 54.6;Intestinal goblet cells: 52.2;Paneth cells: 89.4;Proximal enterocytes: 45.2"	"Cell type enhanced"	"Detected in many"		"deep-layer near-projecting: 65.5"	"Cancer enhanced"	"Detected in many"		"Prostate Adenocarcinoma (TCGA): 30.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	22	"dendritic cells: 2.1;monocytes: 1.8;T-cells: 2.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 22.7"	"Colon - Colon enterocytes, Prostate - Prostate glandular cells"	"Group enriched"	"Detected in many"	4	"amygdala: 6.4;basal ganglia: 4.5;cerebral cortex: 9.6;hippocampal formation: 7.7;white matter: 2.5"	"Low region specificity"	"Detected in all"			HPA026777	Approved						NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 45: Intestine - Digestion"	"Cluster 53: Neurons - Mixed function"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 16: Intestinal goblet cells - Mucin production"	118			"HPA026777: AB_10604003"	"unprognostic (8.77e-5)"	"unprognostic (1.02e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.96e-2)"		"unprognostic (1.47e-2)"		"unprognostic (3.50e-5)"	"unprognostic (6.26e-4)"		"unprognostic (1.42e-3)"	"unprognostic (1.24e-4)"	"unprognostic (2.09e-3)"	"unprognostic (6.44e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"		"unprognostic (8.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.89e-1)"
VSIG4	"CRIg, Z39IG"	ENSG00000155659	"V-set and immunoglobulin domain containing 4"	Q9Y279	X	66021738-66040125	"Plasma proteins, Predicted membrane proteins"	"Complement alternate pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 160.9"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 875.5;Kupffer cells: 649.1;Macrophages: 406.1"	"Cell type enriched"	"Detected in some"	12	"central nervous system macrophage: 52.9"	"Cancer enriched"	"Detected in all"	4	"Glioblastoma Multiforme (TCGA): 145.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	26	"classical monocyte: 18.7;intermediate monocyte: 11.1;myeloid DC: 17.8"	"Group enriched"	"Detected in many"	30	"dendritic cells: 17.8;monocytes: 18.7"	"Cancer enriched"	"Detected in single"	7	"Leukemia: 2.7"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003903, CAB026000, HPA072756"	Enhanced		Uncertain	"Nucleoli,Plasma membrane,Cytosol"			NA	NA		36000000	"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 57: Lung - Lung function"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	86	"Plasma membrane, Cytosol"	Nucleoli	"CAB026000: , HPA003903: AB_1858776, HPA072756: "	"unprognostic (3.04e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.93e-2)"	"unprognostic (5.28e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.07e-1)"	"unprognostic (8.87e-3)"	"unprognostic (2.67e-1)"	"unprognostic (3.82e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.84e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.84e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.56e-1)"
